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ABSTRACT
The rab b it m uscle  p h o sp h o fru c to k in ase  (RM-PFK) gen e  is p re ­
dom inan tly  expressed  in skeletal m uscle. Its m uscle-specific transcrip tion  
w as in v es tig a te d  u sin g  tran s ie n t tran sfec tion  s tu d ies , e lec tro p h o re tic  
m obility  shift assays, and D N asel footprin ting  experim ents. The evidence 
p resen ted  here  provides the first exam ple o f the m yogenic basic-Helix-Loop- 
Helix proteins regulating a gene that encodes a glycolytic enzym e.
The 3 kb 5 '-flanking sequence of this gene d irected  the expression of 
the  chloram phenicol acetyltransferase gene in m uscle an d  non-m uscle cells. 
M yoD , M yf5, an d  m y o g en in  e x h ib ite d  d iffe re n tia l tra n sa c tiv a tio n  
capabilities. M yoD had  the m ost p ronounced transactivational effect, and its 
N -term inal transactivation dom ain and the basic D N A -binding region w ere 
requ ired  for its function. The RM-PFK gene has a t least tw o muscle-specific 
prom oters tha t are approxim ately  1.9 kb apart, and  that w ere stim ulated  by 
the m yogenic regu la to rs to  d ifferen t extents. The proxim al p rom oter w as 
th e  m ajor p ro m o te r  re sp o n d in g  to tra n sa c tiv a tio n  of th e  m yogen ic  
regu la to rs. P rogressive deletional analysis revealed  that there  w ere tw o 
positive  a n d  tw o negative  reg u la to ry  reg ions con tro lling  the  prox im al 
prom oter. An enhancer region, E l, contains a CAGCTG E-box that w as 
recognized  by M yoD g lu ta th ione  S-transferase fusion in vitro. A long w ith 
this E-box, tw o o ther specific sequences w ere also recognized by the  nuclear 
proteins of C2C12 cells.
The TATA-less proxim al p rom oter w as localized to  a 268 b p  region, 
w ith  its core prom oter lying w ith in  region -95 to +23 w ith respect to  the cap 
site. A pyrim id ine-rich  in itiator an d  a m yotube-specific AG-rich sequence 
w ith in  the core prom oter w ere recognized by the nuclear p ro teins of C2C12
cells. M yoD  stim u la tion  w as m ed ia ted  th ro u g h  the  sequences a ro u n d  the 
co re  p ro m o te r, m ain ly  th ro u g h  the reg ion  (-195 to -95) co n ta in in g  a crucial 
CAGATG E-box. A CAGCTG E-box an d  a CCATCGT sequence dow nstream  
o f th e  core p rom o te r w ere  also recognized  by th e  nuc lear p ro te in s o f C2C12 
cells. In con trast, the  d istal p rom oter b  w as localized w ith in  a 671 bp  region 
a n d  m igh t con ta in  a TATA e lem en t (TTATTTATT). T hus, th e  d ifferences 
in reg u la tio n  o f these  p ro m o te rs  m ay  b e  co rre la ted  w ith  th e ir  d iv e rg en t 
D N A  com positions.
CHAPTER 1 
LITERATURE REVIEW
1.1 Enzyme Kinetic Properties and Physiological Relevance of PFK
Phosphofructok inase  (ATP: D -fructose-6-P-l P hosphotransferase, EC 
2.7.1.11, PFK) catalyzes the  A T P-dependent phosphory la tion  of fructose-6- 
phosphate  (Fru-6-P) to fructose- 1,6-bisphosphate (Fru-1,6-P2) and  ADP. This 
reaction  is the  rate-lim iting  step  in the glycolytic p a th w ay  (Bloxham and 
Lardy, 1973; U yeda, 1979; D unaw ay, 1983). Thus, the kinetic and  allosteric 
behavior, as w ell as the  stru c tu re  of PFK, have been  s tu d ied  extensively 
(Passonneau and  Lowry, 1963; U yeda, 1979; K em p and  Foe, 1983; Kolb et at., 
1980; Poorm an et a/., 1984; Y ounathan et a/., 1984; H ellinga and  Evans, 1985; 
V aldez et at., 1989; Schirm er and Evans, 1990; French and  Chang, 1987; Lee et 
a/., 1987a; N akajim a et at., 1987; G ehnrich et at., 1988; Sharm a et at., 1990; 
Yam asaki et at., 1991; U  et at., 1993).
PFK activ ity  is sensitive  to the in trace llu la r energy  s ta te  an d  is 
m odu la ted  by several m etabolites that act as allosteric effector m olecules. 
N egative effectors (for exam ple, ATP and citrate) decrease the affinity of PFK 
for the  substra te  Fru-6-P, w hile positive effectors (for exam ple, Fru-2,6-BP, 
AMP, and ADP) increase PFK affinity for Fru-6-P.
PFK activity  is stim ula ted  by fructose-2 ,6-bisphosphate (Fru-2,6-BP) 
w hich functions as a m aster sw itching signal betw een gluconeogenesis and  
glycolysis. The synthesis of Fru-2,6-BP is con tro lled  by  a cAM P pro tein  
k inase  cascade th rough  the  opposing  activities of the  p ep tid e  horm ones 
g lu cag o n  a n d  in su lin . W hen g lucagon  in te rac ts  w ith  its  m em brane  
receptor, adeny late  cyclase activity is increased and  in tracellu lar levels of 
cAM P rise. Insulin , on the  o ther hand, reduces in tracellu lar cAM P levels.
1
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A cA M P -dependent p ro tein  k inase can ph o sp h o ry la te  6-phosphofructo-2- 
k inase (PFK2), w hich is the  enzym e responsible for synthesis o f Fru-2,6-BP. 
O nce p h o sp h o ry la ted  the  k inase  activ ity  of PFK2 is inh ib ited , reducing  
synthesis o f Fru-2,6-BP. Thus, a reduction in Fru-2,6-BP by glucagon inhibits 
PFK activ ity , w hereas an increase in Fru-2,6-BP by insulin  stim ula tes PFK 
activity.
M any biological even ts can activate  or inh ib it g lycolysis th rough  
m an ipu la tion  of PFK activity. For exam ple, the  inhibition of glycolysis by 
aerobic resp ira tion , know n as the Pasteur effect, is d u e  to  an  inhib ition  of 
PFK activ ity  by  ATP an d  citrate (Tejwani, 1978). A lternation  in  cardiac 
glycolytic rates, that is activation du ring  anoxia or inhibition d u rin g  insulin  
deprivation , is the resu lt of changes in PFK activity d u e  to the  action of its 
effectors (D unaw ay, 1983). In m am m als, the  influence of these effectors on 
PFK activity depends on the  com position of the PFK isozym ic subunits (Tsai 
et at., 1975; D unaw ay and  Kasten, 1985; D unaw ay et at., 1988; D unaw ay and 
Kasten, 1989).
The vital role of PFK function is evidenced by PFK-deficiency diseases 
of hum ans and  canines (Vora et at., 1985; G iger and H arvey, 1987; G iger et 
at., 1988a; G iger et a i, 1988b; N akajim a et at., 1990b; Y am ada et at., 1991). 
Inherited  deficiency of the  m uscle-type PFK in hum ans is associated w ith  a 
num ber of clinical syndrom es. T arui-L ayzer syndrom e, for instance, is 
characterized by m uscle w eakness upon exertion a n d /o r  hem olysis due  to a 
lack of PFK activity in m uscle cells and erythrocytes, respectively.
P art o f the  p rog ression  of even ts d u rin g  m uscle  m a tu ra tio n  or 
m yogenesis appears to be an increase in the levels of glycolytic enzym es. 
These include  increases in  the specific activ ities of PFK, creatine  kinase, 
f ru c to se  b is p h o s p h a te  a ld o la se , p y ru v a te  k in a se , a n d  g ly co g e n
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phosphory lase. As pro liferating  m yoblasts (the non-differentia  ted m uscle 
cells) d iffe ren tia te  in to  m yo tubes and  m yofibers, th e  en e rg y  dem an d  
changes from  a need to  su p p o rt cell g row th  and  d iv ision  to the  need  to 
re sp o n d  to  changes in  the e n v iro n m en t d u rin g  m u scu la r con traction . 
M u scu la r co n trac tio n  d e m a n d s  a co n stan t su p p ly  of ATP at a ra te  
p roportiona l to its consum ption. G lycolysis is rap id  an d  m eets read ily  the 
A TP d em an d s of all m uscle cells. D uring  con traction  th e  in trace llu lar 
levels of AM P and  ADP rise, a n d  the m uscle PFK isozym e is capable of 
re sp o n d in g  w ith  an increase  in its activ ity , resu ltin g  in an increase in 
glycolysis (Wills and  M ansour, 1990). Thus, as the rate-lim iting enzym e in 
glycolysis, PFK is particu larly  su ited  to respond  to  energy  needs, and  its 
activ ity  is stim ulated du ring  myogenesis.
The cata ly tically  active  m am m alian  PFKs a re  hom o- o r hetero- 
tetram ers com posed of th ree  distinct isozymic subunits each encoded by one 
of th ree  genes. These genes or enzym es are  designated  m uscle (M), liver (L), 
an d  b ra in  (C) in  rabbit. In hum ans, the  C -type  is referred  to  as P-type 
(platelet) (Tsai and  Kem p, 1974; T hrasher et at., 1981; D unaw ay, 1983; Foe 
an d  Kem p, 1985). The PFK isozym ic subunits associate random ly, and  thus 
the  relative abundance  of the three subun its in  a g iven  tissue accounts for 
the  isozym ic com position of the tetram ers.
A lthough each PFK isozym ic subun it has a sim ilar m olecular m ass of 
85,000+5000 daltons, they have d istinctive kinetic and  allosteric behaviors 
(D u n a w a y  et at., 1988). The M4 hom o-tetram er has the highest affinity for 
Fru-6-P. Inclusion of L- o r C -subunits in the tetram er reduces the enzym e's 
a ffin ity  for Fru-6-P. M oreover, the  M4 te tram er is m ore sensitive  to 
activation by AM P and ADP than the L4 tetram er. ATP is a substrate  of PFK, 
bu t is also a m ajor inhibitor. ATP inhibits the activity of all isoform s, w ith
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the  C4 te tram e r be ing  the  m ost sen sitiv e  a n d  the  M 4 te tram e r the  least 
affected. Fru-2,6-BP an tagon izes ATP inh ib ition  by substan tia lly  enhancing  
the  Fru-6-P affin ity  o f M- a n d  L-rich isozym es, b u t no t th e  C -rich  isozym e 
(Pilkis an d  El-M aghrabi, 1988).
12 Tissue-Specific Distribution of PFK Isozymes and Their mRNAs
T he a b u n d a n c e  o f v a rio u s  PFK su b u n its  is tis su e -sp ec ific  an d  
d e v e lo p m en ta lly -sp ec ific . T he PFK iso zy m e  iso la ted  from  ra t ske le ta l 
m uscle  is the  M4 te tram er, w hereas the L4 te tram er is the  d o m in an t species 
in liver a n d  p lacenta. C4 tetram ers a re  found  p red o m in an tly  in fibroblasts, 
p la te le ts  a n d  b ra in  cells (D unaw ay , 1983; D u n a w a y  et al., 1988; Foe and 
K em p, 1985).
D uring  dev elo p m en t, th e  increase in to ta l PFK syn thesis  in a g iven  
tis su e  is co in c id en t w ith  a d ram a tic  a lte ra tio n  of PFK isozym e p a tte rn s  
(D u n aw ay , 1983). For exam p le , in  d ev e lo p in g  ra t ske le ta l m uscle , the  
p ro p o rtio n  o f M4 te tram ers  increases from  0.5% at th e  m yob last stage  to 
a lm ost 100% by  the  m yotube stage. C oncom itan t w ith  th is increase, there  is 
a decrease  in the LA tetram ers from  8.8% to nearly  0%. D uring  ra t fetal heart 
m a tu ra tio n , how ever, the  PFK C -su b u n it increases 79-fold, w h ile  th e  b l­
an d  L -subunits increase only 8- and  2-fold, respectively . S tarting  from  equal 
expression  of the th ree  subun its  in fetal liver, the  L -subunit increases 4-fold 
in neonata l liver, w h ile  the  M -subun it rem ains co n stan t an d  the  level o f 
th e  C -subun it becom es negligible.
A ltera tions of PFK isozym es occur in m ouse  C2C12 ceils (Yaffe and 
Saxel, 1977) th a t u n d e rg o  cell d ifferen tia tion  from  m yob lasts to m yo tubes 
u n d e r  tissue  cu ltu re  conditions. The th ree  PFK su b u n its  are  all syn thesized  
in  p ro life ra tin g  m y o b la s ts . S y n th esis  o f th e  M -su b u n it d ra m a tic a lly
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increases 10-fold 48 h o u rs  after cell d iffe ren tia tio n  is in d u ced  a n d  w hen  
m y o tu b es firs t becom e visible. Synthesis o f th e  L- an d  C -subun its , on  the 
o th e r  h an d , declines an d  then  rem ains a t re la tive ly  low  levels (G ekakis et 
al., 1989). T hese resu lts  im ply  tha t expression  of PFK in C2C12 cells m im ics 
tha t in m uscle  tissue.
A nalysis of m R N A  levels by N o rth ern  b lo t an d  reverse  transcrip tion- 
p o ly m erase  chain  reaction  (RT-PCR) by  severa l g ro u p s  rev ea led  tha t the 
exp ression  p ro file  o f PFK m R N A s closely  app rox im ates th e  d is trib u tio n  of 
th e  PFK isozym es in a given tissue (G ehnrich et al., 1988; G ekakis et al., 1989; 
N a k a jim a  et al., 1990a; N akajim a et al., 1994; Sharm a et at., 1990; T am asaki 
et al., 1991; Xiao, 1995). The m R N A s of h u m an  m uscle  PFK (HM -PFK), for 
instance, a re  expressed  to h igh levels in m uscle  an d  k idney , b u t a re  w eakly 
e x p re ssed  in stom ach  an d  reticu locy tes, a n d  can be scarcely  d e tec ted  in 
p lacen ta , liver and  pancreas (Sharm a et al., 1990). S im ilarly , the  m R N A s of 
rab b it m usc le  PFK (RM-PFK) a re  p red o m in an t in m uscle , w h ile  th ey  a re  
d e tec ted  a t low  levels in h eart, k idney , liver, an d  b ra in  (Xiao, 1995). In 
m o u se  C2C12 cells, th e  m R N A s of m usc le  PFK (M M -PFK) g ra d u a lly  
in c re a se  a b o u t 90-fo ld  d u r in g  d iffe ren tia tio n , w h e rea s  L-PFK m R N A s 
sligh tly  increase  4-fold (G ekakis et al., 1989). U nlike the  m R N A s of the  M- 
an d  L-PFKs w hich a re  found  in m ore th an  one  tissue, ra t C-PFK m RN A s are 
o n ly  d e te c ted  in  b ra in  (G ekakis et al., 1994). T he h u m an  L-PFK m RN A s, 
how ever, a re  p red o m in an tly  expressed  in k idney  an d  are  exp ressed  at low  
levels in liver an d  reticulocytes (N akajim a et al., 1990a, 1990c). In add ition , 
th e  levels of L-PFK m R N A s are  u n d e r n u tritio n a l an d  h o rm onal contro ls 
( G e h n r i c h  et al., 1988). T hese  re su lts  su g g e s t th a t m R N A s o f the  
m a m m a lia n  PFK  g e n e s  a re  r e g u la te d  in  a t is s u e -s p e c if ic  a n d  
developm en ta l-specific  m anner. This reg u la tio n  cou ld  be at the  levels of
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m R N A  syn thesis a n d /o r  m R N A  stability . Therefore, transcrip tiona l a n d /o r  
post-tran scrip tiona l con tro ls m ay be involved  in the regu la tion  o f PFK gene 
expression .
D evelopm en ta l an d  tissue-specific  tran scrip tio n a l con tro l a p p ea rs  to  
be  m ed ia ted  via in terac tions betw een  trans-acting  regu la to ry  factors an d  cis- 
a c tin g  e le m e n ts  e m b e d d e d  5* to  o r w ith in  p ro te in -co d in g  reg ions. The 
m am m alian  PFK genes, M-, L-, a n d  C-PFK, a re  located  o n  th ree  d ifferen t 
ch rom osom es (V ora, 1982). The 5 -flan k in g  reg ions of these  PFK genes a re  
h e te ro g en o u s  (Li et al., 1990; N akajim a et al., 1994; G ekakis an d  Sul, 1994). 
This suggests th a t each PFK gene encom passes a un iq u e  com plem ent of cis~ 
e lem ents th a t can be  specifically recognized by d ifferent sets o r com binations 
o f frans-acting  factors. T hus, the  m echan ism  of tran scrip tio n a l regu la tion  
for each PFK gene m ay  be different. The identification of cis-acting elem ents 
a n d  tra n s -a c tin g  fac to rs  is a p re re q u is ite  to  u n d e rs ta n d in g  th e  basic  
m echan ism s th a t m ed ia te  d ifferential PFK gene expression.
1.3 Structural Organization of the PFK Genes
T he s tru c tu re s  of th e  PFK genes a re  w ell-characterized  a n d  h igh ly  
hom ologous. The RM-PFK gene w as the first eu k ary o tic  PFK gene to  be 
cloned, and  its exon-in tron  a rrangem en t has been defined  (Lee et al., 1987a).
The cloned RM-PFK gene is 20 kb in length (Fig. 1-1 ). T he pred ic ted  
cod ing  sequence o f 789 am ino  acids (Poorm an et al., 1984) is d iv id ed  in to  22 
exons ran g in g  from  15 to 63 codons in size. Sequence a lignm en ts  reveal 
th a t th e  exon -in tron  a rran g em en ts  of th e  HM -PFK, HL-PFK, a n d  ML-PFK 
a re  very  s im ila r to  th a t of RM -PFK (Fig. 1-2 & 1-3) (Lee et al., 1987a; 
Y am asaki etal., 1991; R ongnoparu t et al., 1991).
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Fig. 1-1. Schem atic d iag ram  of the exon -in tron  com position  of the  rabb it 
m uscle  PFK gene. Panel a. cDNAs of the rabb it m uscle  PFK a re  aligned  
w ith  th e  g en o m ic  seq u en ce  to sh o w  the  5' UTR p ositions . Panel b. 
C o m p ariso n  of th e  cDNAs of the h u m an  m uscle PFK w ith those  of rabbit 
m uscle PFK (A dap ted  from  Li et a t,  1990 w ith  perm ission).




Fig. 1-2 Comparison of the gene organizations of the rabbit muscle PFK and the mouse liver PFK (Adapted from 
R ongrcparut et al, 1991 with permission).
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Fig. 1-3. Schematic representation of the six mRN As of the rabbit muscle PFK gene (Xiao,. 1995). The positions of 
the probes lor Northern blots and RT-PCR are shown. Dash lines indicate the splicing mtrons. Transcription start 
sites are indicated with arrows a, b, c, and d.
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C om parison  of m am m alian  PFK cod ing  sequences revealed  tha t 
there is substantial sim ilarity in am ino a d d  sequence betw een the N - and C- 
te rm in a l h a lv es of th e  m olecule, and  th a t each  ha lf has sim ila rity  to 
p ro k ary o tic  PFK. H ow ever, th e  sequence  of th e  N -te rm in a l ha lf of 
m am m alian  PFK is m ore  sim ilar to the bacterial sequences w ith  36-43% 
iden tity  th an  is the  C -term inal half w ith  25-33% iden tity . In add ition , the 
N -term inal half possesses a fu lly  functional active  site, w hereas the C- 
term inal half does not.
A lthough the sizes of the in trons are  variable, the  coding sequences 
of the  m am m alian  PFK genes are highly hom ologous. The HM-PFK is 96% 
hom olo g o u s in  am ino  acid sequence  an d  89% iden tica l in  nuc leo tide  
sequence to  the  RM-PFK (Nakajim a et al., 1987). In contrast, the am ino acid 
sequence of ML-PFK show s less iden tity  (68%) to RM-PFK. U nlike E. coli, 
the  n em ato d e  Haemonhus coHforfws, and  Drosophila  w hich all contain  a 
single copy PFK gene (Klein et al., 1991; C urrie  and Sullivan, 1994), yeast has 
tw o  PFK genes w ith each having  a single open  read ing  fram e (H einisch et 
al., 1989). The tw o yeast PFK genes share 55% am ino a d d  hom ology , and 
are  also hom ologous to  RM-PFK.
O n the basis o f sequence com parisons, it is believed  th a t the N- 
term inal half o f the m am m alian  PFK is ancient (Fothergill-G ilm ore and  
M ichels, 1993), and  tha t the m am m alian  PFK evolved from  a prokaryotic  
p rogen ito r th rough  a process of gene dup lication , d ivergence, and  fusion, 
lead ing  to  the  transcrip tional coupling  of tw o PFK genes (Poorm an et al., 
1984). The conserved gene structures and the  tissue-specific d istribu tions of 
th e  m am m alian  PFK isozym es im plies th a t th e re  m igh t be a sim ilar 
tran scrip tio n a l reg u la tio n  schem e govern ing  the expression  of the PFK 
genes across species. Thus, it is an tic ipa ted  that s tud ies of the  m uscle-
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specificity of the  RM-PFK gene will ex tend  the  know ledge  o f transcrip tional 
regu la tion  of o ther m uscle PFK genes as well.
1.4 Transcriptional Control of the Muscle PFK Genes
T he availab ility  o f genom ic an d  cDNA probes has a llow ed researchers 
to  analyze  the  transcrip ts  of the PFK gene in  d ifferen t tissues. S tudies from  
p rim e r ex tension , SI m ap p in g , and  RN ase p ro tec tion  (Xiao, 1995) ind icate  
th a t  th e  RM -PFK g en e , like  o th e r  m u sc le  PFK g e n e s , h a s  m u ltip le  
transcrip tion  s ta rt sites.
A tw o-p rom oter system  has been  p ro p o sed  for the  M M - an d  HM -PFK 
g e n es  (N ak a jim a  et al., 1990c; N akajim a et al., 1994). S im ilarly , tw o  full 
le n g th  RM -PFK cD N A s hav e  been  id en tifie d  w h ich  d iffe r  in th e ir  5' 
u n tran s la te d  reg ions (UTR) (Li et al., 1990). cDNA-a of RM-PFK (Fig. 1-1) is 
fo rm ed by a splicing even t that rem oves a 1.7 kb in tron  located u p stream  of 
th e  ATG transla tion  in itia tion  codon. cD N A -b, on the  o th e r  h an d , contains 
th e  3' p o r tio n  of th is in tron . A  co m p ariso n  o f the 5' UTRs am o n g  the  
cD N A s o f th e  RM-, H M -, an d  M M -PFK su g g ests  th a t bo th  u tiliza tio n  o f 
m u ltip le  p ro m o te rs  an d  a lte rn a tiv e  sp licing  m ay p lay  a ro le  in con tro lling  
d ifferen tial expression  of these m uscle PFK genes.
T he 5' UTRs of cD N A -b o f the  H M - an d  RM-PFK a re  s im ila r to a 
pa rticu la r MM-PFK cDNA referred  to as the  EcoR I (+) type  (N akajim a et al.,
1994). It is in te re s tin g  to  n o te  th a t th e  m R N A s c o rre sp o n d in g  to these  
cD N A s a re  p re d o m in a n t in skele ta l m usc le  (N akajim a et al., 1994; Xiao,
1995). T he  s im ila r ity  of th e  5' UTRs in d ic a te s  th a t  th e  p ro m o te r  
co rre sp o n d in g  to  these  m R N A s is conserved  and  m uscle-specific . The 5' 
UTRs of the  HM -PFK cDNA-c and  of the MM-PFK cDNA referred  as EcoR I 
(-) type  a re  highly  hom ologous, bu t d ifferent from  that of RM-PFK cDNA-a.
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This suggests that the  prom oter for transcrip tion of cDNA-a of the RM-PFK 
is un ique  to  the RM-PFK gene.
It w as recen tly  d e te rm in ed  tha t there  a re  four RM-PFK m RN A  
species in  ad d itio n  to  the  aforem entioned cDNA-a an d  -b (Fig. 1-3) (Xiao,
1995). A m ong these six mRNAs, mRNA-a correlates to  cDNA-b, w hereas 
m RN A -b (b l an d  b2) correlates to  cDNA-a (Fig. 1-1 & 1-3). These b-type 
m R N A s a re  tw o  a lterna tive  sp licing  v a rian ts  transcribed  from  the  sam e 
prom oter. mRNA-a, -b, and  -c are  preferentially  detected  in skeletal muscle. 
W hereas m RNA-a and  -b are  equally  abu n d an t in skeletal m uscle, the level 
of m RN A -c is very  low . U nlike these m uscle-specific m RN A s, m RN A -d 
appears to  be d istribu ted  in all tissues exam ined. This m RNA-d is sim ilar to 
the  cDNA-a of HM -PFK and  to the  cDNA EcoR I (-) type  of MM-PFK in 
term s of its expression pattern.
Taken together, these observations indicate that the RM-PFK gene, as 
w ell as th e  MM- and  the  HM -PFK genes, contains a conserved  proxim al 
p ro m o ter w hich  d irec ts  skeletal m uscle-specific expression ; the  RM-PFK 
gen e  has a t least three p rom oters d is trib u tin g  over th e  3 kb 5 '-flanking 
sequence (Xiao, 1995). W hen the 5 '-flanking sequences of the  HM-PFK, 
MM-PFK, an d  RM-PFK genes are  com pared, it reveals tha t these sequences 
share  very little hom ology (Gekakis and  Sul, 1994; Johnson and  M cLachlan, 
1994). In sp ite  of the divergence of their control DNA sequences, each of the 
m am m alian  m uscle PFK genes ap p ea rs  to have  tran scrip tio n a l con tro l 
m echanism s to  ensu re  high levels of transcrip tion  in skeletal m uscle. This 
suggestion is suppo rted  by  the fact that the sequence resposibte for m uscle- 
specific expression of the MM-PFK gene was located betw een -4800 and -3900 
b p  in respect to  the proxim al transcription start site (Gekakis an d  Sul, 1994), 
w hereas m u ltip le  S p l sites su rro u n d in g  the tran scrip tion  in itia tion  site
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w ere show n to be requ ired  for h igh level expression of the HM-PFK gene 
from  the proxim al prom oter (Johnson and  M cLanchlan, 1994).
It is cu rren tly  unclear w h e th er o r no t these  six RM-PFK m RN A s 
iden tified  to  d a te  have sim ilar PFK coding po ten tia l since the  full length 
sequences o f th e  la tte r four m R N A s are unknow n . F u rtherm ore , these 
m RN A s have not been  q uan tita ted , and  th u s the ir re la tive  abundance  in 
d ifferent tissues is no t conclusively know n. A lthough the d ifferent 5' ends 
m ay endow  the transcrip ts w ith  vary ing  stability, there  yet is no  evidence 
for po ten tia l involvem ent of m RN A  stab ility  regu la tion  in the  control of 
RM-PFK gene expression. In sum m ary , to da te  there is no indication yet of 
the  possible biological relevance of having  so m any different mRNAs.
S tudies o f the MM-PFK in m uscle tissue of d iabetic  m ice have also 
raised  som e in teresting questions. Earlier stud ies by Bauer and  Younathan 
(1984) dem onstra ted  for the  first tim e that a d rop  in PFK activity in diabetic 
rats w as caused  at both genetic and  allosteric regulation  levels. Coincident 
w ith  a decrease in the  MM-PFK activity in cardiac and  skeletal m uscles of 
ketotic  d iabetic  m ice (D unaw ay et al.r 1986a, 1986c), the  level of total MM- 
PFK m RN A  declines in these tissues (N akajim a et al., 1994). This decrease 
in m RNAs can be reversed  by insulin  treatm ent, indicating  tha t nu tritional 
and horm onal conditions regulate the m RNA level o f MM-PFK. It rem ains 
u n c lea r w h e th e r  these  cond itions affect m RN A  stab ility  o r a lte r the  
transcription patterns of the MM-PFK gene by changing the p rom oter usage.
1.5 C ontrol M echanism s of M uscle G ene Expression
The m ajority  of m uscle p ro teins exist in m ultip le  isoform s tha t are  
characteristic  of d ifferent types of m uscle. In particu lar, actin , the m ajor 
contractile  protein , has six different isoform s in higher vertebrates: two in
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stria ted  m uscles (a-card iac  and a-skeletal); tw o in  sm ooth m uscles (a- and  
Y*smooth); an d  tw o in  all non-m uscle cells ((3-and ycy top lasm ic). C reatine 
k inase  (CK), a m ajor enzym e in m uscle m etabolism , is p resen t in m uscle 
an d  in  non-m uscle cells as MCK and  BCK isozym es, respectively. H ow  such 
d iversity  o f m uscle isoform s is generated  has been a m ajor focus of studies 
in m uscle gene expression.
U tilization of m ultip le  prom oters a n d /o r  alternative splicing at the  5' 
en d  of the  m uscle genes are  im portan t m echanism s that lead to  m ore than 
one  isoform  from  a single m uscle gene. This resu lts in d ifferent 5' exons 
th a t m ay hav e  different 5’ UTRs o r d ifferent N -term inal pro tein  sequences. 
The m yosin  alkali light chains of fast skeletal m uscle a re  p ro d u ced  from  
these m echanism s. Based on the  p rev ious discussion of the struc tu res of 
the RM-PFK cDNAs, the RM-PFK gene m ay also fall into this category.
A lternatively , som e m uscle genes u tilize  m u ltip le  po lyadeny la tion  
sites th a t cause  transcrip tion  to be term inated  d ifferen tially , resu lting  in 
d iffe ren t 3’ exons, o r d ifferen t C -term inal p ro te in  sequences. A nother 
im portan t m echanism  that allow s m ultip le  isoform s to be p roduced  from  a 
s ing le  m usc le  gene is in te rna l a lte rn a tiv e  sp licing . T his leads to the  
presence of d ifferent internal sequences d u e  either to alternative  splicing of 
one  or m ore exons, o r to retention of one or m ore in trons, o r to  u tilization 
of m ultip le  splice sites w ithin a single exon.
T he tro p o n in  T (TnT) g en e  p resen ts  the g rea tes t com plex ity  of 
a lte rn a tiv e  sp lic ing  in m am m alian  m uscle genes to date. By d ifferen t 
com binations of internal exons, tw o near the 3' end  and four near the 5' end 
of the  gene, 64 TnT m RNAs are  p roduced  (for rev iew , see B uckingham , 
1989). Yet it is unknow n w hether each mRNA represen ts a un ique  isoform , 
o r how  this a lternative splicing m ay be regulated. It is clear, how ever, that
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it  takes p lace  in a tissue-specific  m anner. Several s tu d ies  h av e  ind icated  
th a t th e  splice signals for a lte rna tive  sp lid n g  of th e  TnT gene a re  no t tissue- 
specific, b u t that p ro te in  factors req u ired  for correct a lte rn a tiv e  sp licing  are 
in d u ced  d u rin g  m yogenesis (Breitbart an d  N adal-G inard , 1987).
In  the  cases o f m u ltigene  fam ilies, expression  o f m o st m uscle-specific 
g e n es  is p r im a rily  co n tro lled  a t the  tra n sc rip tio n a l level. M yogenesis 
(m uscle  cell d ifferen tia tion  from  m yob lasts  to  m yo tubes a n d  m yofibers) is 
m an ip u la ted  by a lte ring  the  signals p ro v id ed  by  g ro w th  factors, horm ones, 
a n d  c o m p o n en ts  o f  th e  ex trace llu la r m atrix . O nce  m yob lasts  e n te r  the  
d ifferen tia tion  pa th w ay , they  w ith d ra w  from  the cell cycle a t the G1 phase, 
a n d  fuse  w ith  n e ig h b o rin g  m yob lasts  to  form  m u lti-n u c lea ted  m yotubes. 
T his com plex  process is accom pan ied  by  the  tran scrip tiona l activation  o f a 
series o f m uscle-specific genes, w hich  p ro d u c ts  a re  req u ire d  for th e  u n iq u e  
c o n tra c tile  a n d  m etab o lic  p ro p e rtie s  of th e  m u sc le  fib e r (L assar an d  
W ein traub , 1992).
A cen tral q uestion  rem ain ing  is w he ther co-expression of th e  various 
u n lin k ed  m uscle-specific  gen es is g o v e rn ed  by com m on o r d iv erse  tran s­
ac ting  factors. Recently, several labo ra to ries have  iden tified  specific D N A  
co n sen su s  seq u en ces  th a t con tro l ex p re ss io n  of g en es  e n co d in g  sev era l 
con tractile  p ro te ins. The m uscle-specific genes that harbo r these consensus 
c is-elem ents in c lu d e  those  enco d in g  a -a c tin  (W alsh an d  Schim m el, 1988), 
m uscle  creatine  k inase (MCK) (Trask et al., 1992; A dolph  et al., 1993), m yosin 
h eav y  chain  (J (Shim izu et al, 1992a; A do lph  et al., 1993), tro p o n in  I (Lin et 
at., 1991), TnT (M ar and  O rdah l, 1990; Farrance et al., 1992), d esm in  (Li and  
P au lin , 1993), nicotin ic acety lcho line recep to r P su b u n it (P rody  and  M erlie, 
1992), a n d  d y s tro p h in  (G ilg en k ran tz  et aL, 1992). Several tran sc rip tio n a l 
activa to rs capable of specifically associating w ith  these regu la to ry  sequences
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a n d  tr a n s a c tiv a tin g  m u sc le  g e n e  e x p re ss io n  h a v e  b een  in te n s iv e ly  
investiga ted .
1.6 Structure, Function, and Regulation of the 
Myogenic bHLH Proteins
T he b est-ch arac te rized  m uscle-specific  tran sc rip tio n  fac to rs are  th e  
m yogen ic  basic-helix -loop-helix  (bH LH ) p ro te in s. T hese in c lu d e  M yoD  1 
(D a v is  et al., 1987), m y o g en in  (E dm onson  an d  O lson , 1989; W righ t et al.,
1989), M yf5 (B raun  et at., 1989a), an d  M R F 4 /m y f6 /h e rc u lin  (R hodes and  
K onieczny , 1989; B raun et al., 1990c; M iner an d  W old, 1990). M em bers of 
th is p ro te in  fam ily have been identified  in a variety  of vertebrates, as w ell as 
in in v erteb ra tes , such  as Drosophila, n em atodes an d  sea u rch in  (V enuti et 
al., 1991; K rause an d  W ein traub , 1992). These p ro te in s  share  80% hom ology 
w ith in  th e ir  bH L H  m otifs th a t consist of ab o u t 70 am in o  acids. T he 
m yogen ic  factors iso la ted  from  sea u rch in s a n d  n e m a to d e s  can  ac tiva te  
m y o g en esis  in  m am m alia n  cells, in d ic a tin g  th a t th e  m ech an ism s th a t 
reg u la te  m uscle  gene  expression  a re  conserved  th ro u g h o u t ev o lu tio n  (for 
rev iew , see O lson an d  Klein, 1994).
P ro te in s  th a t  sh a re  th is  bH L H  m o tif  a re  t ra n s a c tiv a to rs  of 
tran scrip tion  and  a re  found in yeast, p lan ts, an d  m am m als. T hese p ro teins 
p lay  an  im p o rtan t ro le  in th e  m etabolic  reg u la tio n  o f yeast, in  the sex- 
d e te rm in a tio n  o f Drosophila, an d  in the  d iffe ren tia tio n  of m uscle, neura l, 
m yelo id , B-cells a n d  e ry th ro id  cells of m am m als (L assar a n d  W ein traub , 
1992).
The bH L H  p ro te ins can be classified in to  th ree  subfam ilies based  on 
th e  com position  o f their bH L H  dom ains. T hese inc lude  the b H L H /Z IP , the 
bH L H , an d  the H LH  subfam ily . P roteins of th e  b H L H /Z IP  subfam ily , such 
as m yc p ro te in  fam ily , con ta in  a leucine z ip p e r m otif (ZIP) fo llow ing  the
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bH L H  dom ain . P ro te ins of the bH L H  subfam ily  do  no t have  th is ZIP m otif 
(for exam ple , E -p ro te ins an d  the  M yoD  p ro te ins), w h ereas p ro te in s  of the 
H L H  su b fam ily , su ch  as Id  ( in h ib ito r of d iffe ren tia tio n ) p ro te in s , have  
ne ither the ZIP m otif n o r th e  basic reg ion  (Lassar an d  W ein traub , 1992).
T he  bH L H  p ro te in s  m ay  b e  e x p re sse d  e ith e r  u b iq u ito u s ly  or 
sp ec ifica lly  in  c e rta in  cell types. T he E -p ro te in s , E l2 a n d  E47, a re  
u b iq u ito u s ly  e x p re ssed  in  all tissu es a n d  cells tes ted . In  co n tras t, the  
m yogen ic  bH L H  pro te in s are  found  exclusively  in skeletal m uscle. As will 
b e  d isc u sse d  la te r , th e  u b iq u ito u s  bH L H  p ro te in s  p re fe re n tia lly  fo rm  
h e te ro d im ers  w ith  th e  cell-specific bH L H  p ro te in s  to facilita te  th e ir D N A  
b in d in g . A ll th ese  bH L H  p ro te in s  reco g n ize  th e  co n sen su s  seq u en ce  
CA N N TG  (E-box), w here  N  refers to any nucleotide.
Functional s tu d ies  of the m yogenic bH L H  pro te in s have  been  carried  
o u t u s in g  d iffe ren t genetic  ap p ro ach es in c lu d in g  sequence  d e le tio n , base  
su b s titu tio n , d o m ain  sw ap p in g , an d  transgenics. M utagenesis  has show n 
th a t th e  H L H  m o tif serves as an in terface for p ro te in  d im eriza tion , w hich  
b rin g s together th e  basic regions of the bH L H  pro te in s to form  a com posite  
D N A -b in d in g  d o m ain  (V oronova an d  B altim ore, 1990; D avis et al., 1990). 
M em bers of the  M yoD  fam ily do  no t efficiently form  hom odim ers, b u t they 
d o  read ily  form  he te ro d im ers  w ith  the  u b iq u ito u s  E -proteins (M urre  et al., 
1989b; M urre  and  Baltim ore, 1992).
All bH L H  p ro te in s  d esc rib ed  to  d a te  b in d  to  v a ria tio n s  o f th e  
consensus sequence CAN NTG; how ever, on ly  the  m yogenic bH L H  pro teins 
a re  ab le  to activate  m uscle-specific transcrip tion  (D avis et al., 1987; B raun et 
al., 1990b; E dm onson an d  O lson, 1989; R hodes a n d  K onieczny, 1989; W righ t 
et al., 1989; M in er a n d  W old , 1990). T h is  c e ll- ty p e  sp e c if ic ity  of 
tran sc rip tio n a l activa tion  is d e p e n d e n t on  re s id u es  A la-114, Thr-115 and
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Lys-124 w ith in  the basic regions of the m yogenic bH LH  proteins (Davis et al. 
1990; B rennan and  O lson, 1991; W ein traub  et a l ,  1991a , 1991b; Schw arz et 
al., 1992). These th ree  residues are  specific to an d  conserved  in  all the 
m yogenic H LH  proteins. W hen in troduced  in to  the DN A b ind ing  dom ain 
of E l2, these  th ree  residues are  enough  to confer on  E l2 th e  ability  to 
transactivate  m uscle-specific transcrip tion (Davis and  W eintraub, 1992).
M utagenesis o f th e  basic reg ion  p rev en ts  D N A  b ind ing , bu t not 
d im erization . HLH p ro teins that lack functional basic regions function as 
negative regu la to rs o f E -box-dependent transcrip tion . Tw o such pro teins 
a re  Id an d  th e  M yoD  basic reg ion  de le tion  m u ta n t (M yoDAB). They 
d im erize  p referen tia lly  w ith  E -proteins an d  thereby  inactiva te  m yogenic 
bH L H  pro teins by sequestering  their d im erization  p artners  (Benezra et al.,
1990). The presence of Id at h igh levels in undifferentiated  m yoblasts and  its 
dow n-regulation  du ring  differentiation suggests that it m ay play a role as a 
negative regu la to r of m yogenesis.
The crystal struc tu res of the bH LH  dom ain-D N A  com plexes of four 
bH LH  pro teins (Max, E47, USF, and  MyoD) have been solved and  refined at
2.8 A resolution (Ferre-D’Am are et a l, 1993, 1994; Ma et a l, 1994; Ellenberger 
et a l, 1994). It appears that the  bH LH  struc tu re  is very  well conserved in 
sp ite  of th e  low  sequence hom ologies betw een p ro te in  subfam ilies. Max 
and  USF are  b H L H /Z IP  p ro teins, bu t the  p resence of the  leucine z ipper 
m otif does not significantly affect the structure  of the bH LH  dom ain.
In general, these p ro teins b ind  to DN A in th e  m ajor groove as a 
d im er (Fig. 1-4). Each m onom er form s tw o long a  helices connected by  a 
flexible loop. The first helix contains the basic region and  the helix 1 region 
(H I); the second helix corresponds to the  helix 2 region (H2) an d  the ZIP 
region in the case of a bH L H /Z IP  protein. The hydrogen-bond netw orks
3' 5'
Fig. 1-4 D iagram  of the MyoD bH LH  d o m a in /D N A  complex. MyoD 
h o m o d im er  is show n to interact w ith  the m ajor groove of the b inding 
sequence (containing CAGCTG) through the com posite  basic region DNA 
b ind ing  motif. The bH LH  dom ains of M yoD diinerize through their HLH 
regions. (A dapted from Ma et a l., 1994 with permission).
stab ilize  the  conform ation  of the  loop  as w ell as the o rien ta tion  o f helices 1 
an d  2 w ith in  each  m onom er. T w o m o n o m ers  fo ld  in to  a  pa ra lle l, left- 
h a n d e d , four-helix  b u n d le , a n d  th e  conserved  h y d ro p h o b ic  re s id u es  in the 
hy d ro p h o b ic  core a re  packed toge ther by van  d e r  W aals in teractions. The 
leucine z ip p e r regions of M ax an d  USF ex tend  th e  p ro te in  d im er interface, 
th e reb y  in creas in g  th e  efficiency of d im e riz a tio n  a n d  D N A  b in d in g . It 
seem s th a t d ifferen t d im eriza tio n  m echan ism s b e tw een  th e  bH L H  an d  the 
b H L H /Z IP  p ro te in s  p ro v id e  spec ific ity  fo r th e se  p ro te in  d im e riz a tio n  
in teractions. This m ay  exp la in  w hy  the b H L H /Z IP  p ro te in s u su a lly  fail to 
d im erize  w ith  th e  bH L H  pro teins. The bH L H  p ro te in  E47, how ever, has an 
u n iq u e  sa lt b rid g e  be tw een  a h is tid in e  res id u e  o f helix  1 an d  a g lu tam ate  
res id u e  of helix 2. This feature  allow s the  E47 m onom er to  be m ore  stable, 
an d  facilitates d im eriza tion  of E47 w ith  MyoD.
T he bH L H  d o m ain s  of M yoD  in te rac t w ith  E-box D N A  th ro u g h  
re s id u es  w ith in  the basic reg ion , the  loop, an d  the  am ino -te rm ina l en d  of 
helix 2. In p a rticu la r, residues in  the  basic  reg ion  m ak e  m ost o f the  DN A 
contacts. Each m onom er recognizes one-half of the  d y a d  o r p seu d o -d y ad  
D N A  b in d in g  site  CA N N TG  w ith D N A  contacts at m ore  than  ten  positions. 
A  conserved  g lu tam ate  residue  (Glu-118 of M yoD , Glu-345 o f E47, G lu-32 of 
M ax, an d  G lu-208 of USF) recognizes CA of the  C A N N TG  by accep ting  one 
h y d ro g en  bond  from  both  the residues C an d  A  . In teresting ly , Arg-111 of 
M yoD hyd rogen  bonds w ith  the G of the  C A N N T Q  an d  w ith  Thr-115, w hich 
in tu rn  m akes hyd rophob ic  contacts an d  a hyd rogen  bond  w ith  the  T of the 
C A N N T G . T he c o rre sp o n d in g  a rg in in e  re s id u es  in  th e  n o n -m yogen ic  
bH L H  pro te in s do not m ake D N A  contacts as Arg-111 o f M yoD does.
In co n trast to  the  conserved  recogn ition  m echan ism  for th e  CA of 
C A N N TG . bH L H  pro teins have sub tle  preferences for the  central 2-bp. Glu-
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118 of M yoD m akes a w ater-m ed ia ted  H -bond  w ith  the  C in C A G £T G . 
Therefore, CAGCTG is the preferred sequence for MyoD binding. E47 m akes 
H -bonds w ith  the left-side G of the  low er strand , an d  contacts the DNA 
backbone of the  left-side C of the  u p p er strand  CA£CTG. Thus, a CACNTG 
is p referred  by  E47. M ax and USF prefer CACGTG because of H -bonding 
w ith  the G of CACGTG by Arg-36 of Max and  Arg-212 of USF. In addition, 
the  M yoD protein  has a preference for purines on the 5 '-flanking side of the 
E -box (R A -C A N N T G ) a n d  p y r im id in e s  on  th e  3 '- f la n k in g  s id e  
(CANNTGTY).
The crystal s truc tu res also p rov ide  som e im plications for m yogenic 
transactivation  of M yoD. As prev iously  described , the  bH LH  dom ain  of 
M yoD  is necessary  an d  su ffic ien t for D N A  b in d in g  and  m uscle  cell 
conversion. A region of about 50 residues located at the N -term inus of 
M yoD  is re fe rred  to  as the transac tiva tion  dom ain . In ad d itio n , three 
residues (Ala-114, Thr-115, and  Lys-124) of the  basic region are critical for 
transcrip tional activation. The crystal struc tu res show  that only Lys-124 is 
exposed  on  the  surface of the M yoD-DNA com plex, and  tha t it does not 
m ake  contact w ith  th e  DNA. This suggests  th a t Lys-124 can read ily  
partic ipa te  in  p ro tein -p ro te in  interactions. Ala-114 and  Thr-115, how ever, 
are  b u ried  in the  DN A m ajor groove. Im portan tly , these  th ree  residues 
have  been recently  show n to be requ ired  for M yoD in teraction  w ith  the 
m yocyte-specific enhancer factor 2A (MEF-2A). As w ill be described later, 
MEF-2A is a m yogenic factor that induces M yoD expression and  cooperates 
w ith  M yoD to activate m uscle gene expression (Kaushal et al., 1994).
It is speculated that A r g - l l l ’s burial in the m ajor groove is necessary 
for the transactivation activity of the m yogenic bH LH  proteins. Ala-114 and 
Thr-115 are  critical in de te rm in ing  the conform ation of Arg-111. Ala-114
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w ith  its sm all s id e  chain  p ro v id es room  for Arg-111 to fit in to  th e  groove. 
Thr-115 m akes a H -bond  w ith  Arg-111 to stab ilize  its  conform ation . The 
co rresp o n d in g  arg in ine  res id u es in the  non-m yogenic bH L H  pro teins sw ing 
o u t from  th e  m ajo r g roove, a n d  th u s d o  no t con tact D N A  as Arg-111 of 
M yoD  does. In troducing  o th er res idues at positions 114 an d  115 m ay force 
Arg-111 o u t o f th e  m ajo r g roove, an d  m ay  in te rfe re  w ith  tran scrip tio n a l 
ac tiva tion  o f M yoD. This a ssu m p tio n  is based  on the fact tha t the residues 
o f th e  c o rre sp o n d in g  p o sitio n s  114 an d  115 in E47 a re  n o t a lan in e  an d  
th re o n in e .
T he  m y o g en ic  bH L H  re g io n  fu n c tio n s  o n ly  in  c e r ta in  ce llu la r  
con tex ts . In  co n tra s t, th e  tran sc rip tio n  ac tiv itie s of the  tran sac tiv a tio n  
d om ains of the  m yogenic regulators, located in e ither the ir N - o r C- term ini, 
a re  no t restric ted  to  m uscle cells (W ein traub  et al., 1991a, 1991b; Schw arz et 
al., 1992; B raun et al., 1990b). F u rth er investiga tion  has suggested  th a t the  
specific  D N A  b in d in g  a lo n e  is in su ffic ien t to  ac tiv a te  the  m u sc le  gene  
expression , an d  th a t tran scrip tio n a l activa tion  by  H LH  reg u la to rs  req u ires  
cell-specific recognition  factors o r cofactors.
M uscle LIM p ro te in  (MLP) ap p ea rs  to be one  of these cofactors that 
p lay  im p o rtan t ro les in q u a lita tiv e  and  q u an tita tiv e  aspec ts of m yogenesis 
a n d  m uscle-specific  gen e  expression  (A rber et al., 1994). The M LP gene is 
e x p re ssed  exclusively  in m yo tubes, b u t n o t in p ro life ra tin g  m yoblasts. 
T ransfection  s tu d ies  revealed  th a t th e  req u irem en t of M LP for m yogenesis 
is first de tec ted  a t the  exit from  the cell cycle. E arly d ifferen tia tion  even ts 
preced ing  exit from  the cell cycle apparen tly  d o  no t d ep en d  on MLP.
T he  fu n c tio n a l a c tiv itie s  o f the  m y o g en ic  bH L H  p ro te in s  a re  
con tro lled  by th e  signal tran sd u c tio n  netw ork . It w as in itia lly  ev id en t in 
C 2C 12 cells th a t d iffe ren tia tio n  from  m y o b la sts  to  m y o tu b e s  req u ire s
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w ith d raw a l of g row th  factors from  the m ed iu m  (T apscott et al., 1988; Y utzey 
et al., 1990). F ibrob last g ro w th  factor inh ib its  m yogenesis by  inac tiva ting  
m y o g en ic  H L H  p ro te in s th ro u g h  p h o sp h o ry la tio n  o f  a conserved  site  in 
the ir basic  regions. This m odification  is m ed ia ted  via the  p ro te in  k inase  C- 
d e p e n d e n t p a th w ay , resu ltin g  in the loss of D N A -b ind ing  abilities o f these 
m y o g en ic  p ro te in s  (Li et al., 1992a, 1992c). S im ila rly , cA M P -d ep en d en t 
p ro te in  k in a s e  in a c tiv a te s  th e  m y o g e n ic  b H L H  p ro te in s  th ro u g h  
p h o sp h o ry la tio n  (Li et al., 1992b; W inter et al., 1993). T ransfo rm ing  g ro w th  
fa c to r-P  (TGF-P), o n  th e  o th e r  h an d , se lectively  in h ib its  function  o f the  
m yogen ic  bH L H  p ro te in s , b u t no t th a t of E -proteins. This inac tiva tion  is 
in d e p e n d e n t o f  D N A  b in d in g , an d  it is m ed ia te d  by  th e  bH L H  reg ion  
(B ren n an  et al., 1991; M artin  et al., 1992). It has been p ro p o sed  that TGF-P- 
d e p e n d e n t p a th w a y  in te rfe re s  w ith  th e  ex p ress io n  o r  ac tiv ity  of a co­
activa to r tha t recognizes the  m yogenic basic region.
A v arie ty  of tran sfo rm ing  genes (such as src, ras, fos, jun , fps, erbA , 
m yc, an d  E1A) a lso  in h ib it m yogen ic  d iffe ren tia tio n  (H o ltze r et at., 1975; 
L assar et al., 1989; O lson et al., 1987; LaRocca et al., 1989; W ebster et al., 1988; 
Su et al., 1991). The g ro w th  factor-inducib le p ro te in s Jun, Fos, an d  Ras can 
in h ib it exp ression  an d  activ ities of the  m yogenic bH L H  p ro te in s  (L assar et 
al., 1989; Bengal et al., 1992). Since c-Jun can physically  associate w ith  M yoD 
b e tw ee n  th e  bH L H  reg io n  o f M yoD  an d  th e  leuc ine  z ip p e r  of c-Jun, it 
p re v e n ts  M yoD  from  b in d in g  to cognate  D N A  sequences (B engal et al.,
1992).
T he  re tin o b la s to m a  p ro te in  (pRB) is a tu m o r  su p p re s s e r  th a t 
fu n c tio n s as a n eg a tiv e  g ro w th  reg u la to r  (Lee et al., 1987b; H u a n g  et al.,
1988). T he u n p h o sp h o ry la ted  form  o f pRB actively  m ain ta in s the  cells in 
the  G o /G i  p h ase  of the  cell cycle (B uchkovich et al., 1989; G oodrich  et at..
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1991). In  p a rticu la r, pRB p lays an im p o rtan t ro le  in the  p ro d u c tio n  and  
m ain tenance  of th e  term ina lly  d ifferen tia ted  p h en o ty p e  of m uscle  cells (Gu 
et al., 1993). It is know n  th a t pRB m ed ia tes th e  M yoD -induced  cell cycle 
a rre s t a n d  p e rm an en t w ith d raw a l of m uscle  cells from  th e  cell cycle. M yoD 
an d  pRB o f th e  u n p h o sp h o ry la ted  form  in te rac t specifically  in vitro an d  in 
v iv o , fo rm in g  a h e te ro d im er th a t does n o t b in d  to  E-box sequence. The 
sequences req u ired  for M yoD  an d  pRB in terac tion  inc lude  a p o rtio n  of the 
pRB pocket a n d  the  bH L H  dom ain  of M yoD , w hich a re  a lso  kn o w n  to  be 
invo lved  in o th er p ro te in -p ro te in  in teractions. M yoD in terac ting  reg ions of 
pRB o v e r la p , b u t  th ey  a re  d is tin c tiv e  fro m  b in d in g  s ite s  o f v ira l 
o n c o p ro te in s  SV40 T an tig en  a n d  El A (D eC aprio  et al., 1988; W hyte  et al., 
1988; K aelin et al,, 1990).
It is su g g ested  that M yoD  locks pRB in its u n p h o sp h o ry la ted  form  
su ch  th a t pRB is u n resp o n siv e  to  g ro w th  factor signals. F u rth e r s tu d ies  
have  show n  that pRB o r a rela ted  p ro te in  p l0 7  is requ ired  for the  m yogenic 
effect o f M yoD. Form ation  of E12 hom o- an d  M yoD-E12 he tero -d im ers are 
n o t d is ru p te d  by add ition  of pRB. H ow ever, E-box D N A  b in d in g  activ ity  is 
a b o lish e d  w h en  pRB is rem o v ed  from  m u sc le  cell ex trac ts , e ith e r  by 
dep le tio n  w ith  an anti-pRB m onoclonal an tibody  o r w ith  El A p ro tein . This 
re su lt  a lo n g  w ith  o th e r  o b se rv a tio n s  su g g e s t th a t pRB is in v o lv e d  in 
fo rm a tio n  o r  s tab iliza tio n  of the  E -box-contain ing  com plex , a n d  th u s is 
req u ired  for the  transactivation  function  of MyoD.
In trigu ing ly , the  m yogenic bH L H  factors a re  p resen t in p ro lifera ting  
m y o b la s ts  (T ap sco tt et al., 1988; W rig h t et at., 1989; B raun et al., 1989b), 
w h e re  th ey  d o  n o t actively  fo rm  D N A -b ind ing  com plexes, do  no t act as 
m uscle-specific  tran scrip tion  factors, an d  do  not act as inh ib ito rs of the  cell 
cycle (M ueller and  W old, 1989). This inactivation  is partia lly  d u e  to  the fact
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th a t c-Jun  is a b u n d a n t in  se ru m -s tim u la te d  cells. In a d d itio n , pRB 
p referen tia lly  associates w ith  E2F th rough  its  pocket reg ion  in p ro liferating  
cells; th u s, it is no t available for M yoD  interaction. E12 or E47 is sequestered  
by  Id  p ro te in s  an d  th u s  is p rev e n ted  from  in te rac tin g  w ith  th e  m yogenic  
bH L H  pro teins. Id  p ro te in s also in teract w ith th e  u n p h o sp h o ry la ted  form  of 
pRB to exert its inh ib ition  of M yoD  (Iavarone et al., 1994).
T here  a re  th ree  Id genes th a t h av e  been  id en tified  in c lu d in g  Id-1 
(B e n e z ra  et al., 1990), Id-2  (Sun et al., 1991; Biggs et al., 1992), a n d  Id-3 
(C h ris ty  et at., 1991; E llm eier et al., 1992; D eed et al., 1993). T he Id genes are  
re g u la te d  by g ro w th  factors (O gata et al., 1993), an d  a re  h igh ly  expressed  
d u rin g  early  d ev e lo p m en t w h ile  p ro life ra tion  is occurring . T hese p ro te in s 
a re  ty p ica lly  n o t e x p re ssed  in m ost m a tu re  tissu es. T hey specifically  
associate  w ith  th e  bH L H  pro te in s of the E-class b u t no t w ith  the  b H L H /Z IP  
p ro te in s , th u s  inh ib itin g  m yogen ic  effect of th e  m yogenic  bH L H  p ro te in s  
(S un  et al., 1991; Jen et at., 1992). In teresting ly , Id-2 p ro te in  p referen tia lly  
b in d s to  pRB th ro u g h  the H LH  dom ain  o f Id-2 an d  an  in tact pocket dom ain  
o f pRB (Ia v a ro n e  et al., 1994). T his asso c ia tio n  b locks the  in te rac tio n  
be tw een  pRB a n d  M yoD. T herefore, Id  p ro te in s an tag o n ize  th e  function  of 
the  m yogenic bH L H  pro teins e ither d irectly  o r indirectly .
T he m yogenic  bH L H  pro te in s p lay  an  im p o rtan t ro le  in  de te rm in ing  
m yob last p ro life ra tion  o r d ifferen tia tion . W hen exp ressed  ectop ically  in a 
v arie ty  o f non-m uscle  cells, each of the  four m yogenic  bH L H  p ro te in s can 
ac tiva te  skeletal m uscle  gene  tran scrip tio n . In ad d itio n , these  m yogenic  
factors b in d  to the  consensus E-box w ith  lim ited  sequence  p reference, and  
activa te  their ow n  an d  one  an o th er's  expression  (au to regu la tion). W hether 
o r  n o t th ey  p o ssess  id en tica l o r  d is tin c tiv e  ac tiv itie s  in vivo  has been  
u n certa in  from  transfection  experim ents.
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R ecently , gene  knockou t experim en ts (in w hich  in d iv id u a l m yogenic 
reg u la to ry  genes w ere  inactived  by  D N A  hom ologous recom bination) have 
rev ea led  v e ry  su rp r is in g  resu lts . In  tran sg en ic  M yoD -nu ll m ice, M yoD  
a p p ea rs  n o t to be  requ ired  for m yogenesis in the m o u se  em bryo; M yoD -null 
m ice a re  fu lly  v iab le  an d  show  no  obv ious m uscle  abno rm alities  (Rudnicki 
et al., 1992). The on ly  ap p a ren t effect of M yoD  inactivation  is an  increase in 
th e  level o f M yf5 m R N A s in skeletal m uscle, consisten t w ith  th e  reciprocal 
functions of these  tw o  genes in tissue cu ltu red  cells. H ow ever, M yoD  is no t 
essen tia l for activation  of genes for m yogenin  and  MRF4 (or Myf6).
S im ilarly , M yf5-null m ice also d ev e lo p  no rm al ske le ta l m uscle , bu t 
th ey  d ie  at b ir th  d u e  to the  absence  o f the d is ta l p a rts  o f th e  ribs w hich  
re su lts  in an  inab ility  to b rea th e  (B raun et al., 1992b). T he o n ly  a p p a re n t 
a lte ra tio n  w ith in  the  skeletal m uscle  in these  m ice is a 2-day  de lay  in the 
in itia tion  o f exp ression  of the m uscle  m arkers. M oreover, d esp ite  the  fact 
th a t  M yf5 is th e  f irs t  m y o g en ic  b H L H  p ro te in  e x p re s s e d  d u r in g  
e m b ry o g e n e s is , M yf5-nu ll m ice tra n sc r ib e  n o rm a l leve ls  o f th e  o th e r  
m yogenic  bH L H  m RNAs.
T he  s tu d ie s  o f th e  M yoD  a n d  M yf5 d o u b le -n u ll  m ice  fu r th e r  
confirm ed  th a t the functions of these genes a re  overlapp ing . T hese m u tan t 
m ice p ro d u ce  no  detectab le  m yoblast m arker desm in  (R udnicki et al., 1993), 
su g g estin g  th a t both  M yoD  and  M yf5 act early  in th e  m yogenic lineage  and  
d e te rm in e  m yoblast conversion  from  m yogen ic  stem  cells.
In  c o n tra s t, m y o g en in -n u ll m ice d isp la y  se v e re  sk e le ta l m u sc le  
deficiencies, an d  d o  no t express several m uscle-specific genes (H asty  et al., 
1993; N a b e s h im a  et al., 1993). T he fact th a t th e re  is  a n o rm al level 
exp ression  of M yoD  b u t a reduced  level of MRF4 in  these  m u tan t m ice also 
suggests  th a t M yoD  is insufficient for norm al m uscle  d ifferen tiation  in the
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Fig. 1-5. M yogenic regulatory  pa thw ay. (A dap ted  from  O lson and Klein, 
1994 w ith  perm ission).
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absence of m yogenin; further, it suggests that the absence of m yogenin does 
no t affect M yoD expression. Therefore, m yogenin is no t requ ired  for the 
com m itm en t o f cells to  the  m yogenic lineage, b u t it is im p o rtan t for 
term inal d ifferentiation. O lson and  Klein (1994) p roposed  a "hypothetical 
regu la to ry  pathw ay" (Fig. 1-5) to sum m arize  the function of each of these 
m yogenic bH LH  proteins in m yogenesis.
Even though  these m yogenic bH LH  pro teins share  the  sam e DNA 
b in d in g  sequence  an d  have in ter-changeab le  transac tivation  activ ity  in 
vitro , they show  un ique  expression p a tte rn s  in vivo (B uckingham , 1992). 
Myf5 is the first of them  to be expressed du ring  m ouse em bryogenesis, w ith 
transcrip ts appearing  in the  som ite at day  8.0 postcoitum  (p.c.). M yogenin 
transcrip ts appear in the m yotom e by day  8.5 p.c., while MRF4 and  MyoD are 
expressed  in the  m yotom e at day 9 and 10.5 p.c., respectively. In addition , 
M yoD is p referentially  expressed in fast-tw itch m uscle fiber (H ughes et al., 
1993). T hus, expression  of the  m yogenic bH L H  p ro te in s  is tem poral, 
sequential, and auto-regulated. This expression profile m ay be necessary for 
m a in ta in in g  m u sc le -sp ec ific  tra n s c r ip tio n  c o n s titu tiv e ly  th ro u g h o u t 
d if fe ren tia tio n , once m uscle  gen e  tran sc rip tio n  is in d u c e d  by  these  
m yogenic regu la to ry  p ro te ins (B raun et al., 1989a; R hodes and  Konieczny, 
1989; Thayer et al., 1989; M iner and  W old, 1990).
E-boxes are  p resen t in the control regions of m ost skeletal m uscle 
genes w here  they m ediate  m uscle-specific transcrip tion  and  transactivation 
by the  m yogenic HLH proteins. These E-boxes are generally su rrounded  by 
b in d in g  sites for o th e r tran scrip tio n  factors th a t co llabo ra te  w ith  the 
m yogenic regulators to induce m uscle-spccific transcription. M yoD proteins 
cooperatively  bind  to DN A that con tains m ultip le  E-boxes for high level 
in d u c tio n  of m usc le  gene  tra n sc rip tio n  (W ein trau b  et al., 1990). For
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in stance, the  coopera tive  in te rac tions betw een  M yoD , serum  response  
factor, and  S p l regu la te  the a -ac tin  gene p ro m o te r (Sartorelli et at., 1990), 
w h e reas  in te rac tions of m yogenic bH L H  p ro te in s  an d  MEF-2 enhance  
transcrip tion  of the m uscle creatine kinase (MCK) gene (Gossett et al., 1989; 
Cserjesi and  O lson, 1991). O ther se rum -indudb le  factors and MyoD proteins 
a re  invo lved  in m yoblast-specific expression  of desm in  (Li an d  Paulin ,
1993). H ow ever, there are also exam ples o f m uscle genes that a re  regulated  
by  the  m yogenic H LH  pro teins, b u t w hich  lack E-boxes in  their control 
reg ions. A ctivation  of these types of m uscle-specific  genes is d irectly  
regulated  by MEF-2 w hose expression is controlled by the M yoD proteins.
M uscle-specific  gene  ex p re ss io n  a p p e a rs  to  b e  sy n e rg is tica lly  
co n tro lled  by the  m uscle-specific  reg u la to ry  factors. S ynerg ism  of 
tran sc rip tio n a l ac tiv a to rs  is a com m on phenom enon . T his is s im ply  
because the  regulatory  regions of eukaryotic genes often contain clusters of 
b ind ing  sites for several different activators (or repressors), w ith  som e of the 
activators (and repressors) having  m ultip le  b ind ing  sites. Synergism  refers 
to g rea ter than  add itive  increase or decrease in transcrip tion  w hen two or 
m o re  a c tiv a to rs  o r rep re sso rs  a re  p re se n t s im u lta n eo u s ly , o r  w hen  
add itional b ind ing  sites for a single activator or repressor are  presented . It 
also im plies that activators facilitate a single transcrip tional even t in w hich 
activators stim ulate  the sam e transcrip tion com plex.
As proposed  by H erschlag and  Johnson (1993), synergistic effects can 
be c lassified  as positive  cooperativ ity  an d  negative  cooperativ ity . For 
positive cooperativity, activators interact w ith each o ther as well as w ith the 
tran scrip tiona l ap para tu s . A lternatively , b in d in g  of one  activa to r to the 
tran scrip tiona l com plex cou ld  facilitate the  b in d in g  of ano ther activator. 
Thus, the presence of one activator strengthens the b ind ing  of another. For
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negative cooperativ ity , the  b ind ing  of one  activator h inders b ind ing  of the 
o ther.
D uring  m yogenesis, it appears that synergistic regulation  of m uscle 
genes is im portan t for coordinating  responses from  m any d ifferen t signals, 
a n d  for am p lify in g  these  resp o n ses from  sm all changes in  ac tiv a to r 
c o n c e n tra tio n s  (H ersch lag  a n d  Jo h n so n , 1993). T his re g u la tio n  is 
accom plished by  m yogenic bH LH  factors, o ther m uscle-specific activators, 
and  the ubiqu itous transcrip tional factors.
1.7 Other Muscle-Specific Regulatory Factors
M yogenic bH LH  proteins are not the  only  pa thw ay  for activation of 
m uscle-specific  gene  expression . For instance, MEF-2 w as o rig ina lly  
identified  as a m uscle-specific DNA binding  activity that recognizes an A+T 
rich sequence [CTA(A/T>4TAG] found in the control regions of num erous 
m uscle  genes (G ossett et al., 1989; A dolph  et al., 1993; Cserjesi et al., 1994; 
L e ib h am  et at., 1994; Li and  C apetanak i, 1994). A nother m uscle-specific 
fac to r, M -CA T b in d in g  fac to r (M CBF), h as b een  re p o r te d  to act 
in d e p e n d e n tly  of the  m yogen ic  bH L H  p ro te in s , a n d  to  re g u la te  the  
expression of several cardiac genes (M ar et at., 1988; M ar and  O rdah l, 1990; 
T hom pson  et at., 1991; Shim izu et al., 1992b; Flink et at., 1992; Parm acek et 
al., 1992; Iannello et at., 1991; S tew art et al., 1994).
MEF-2 com prises a g roup  of tissue-restricted MADS box transcrip tion 
factors (Yu et at., 1992; M artin  et al., 1993; M artin  et al., 1994). The term  
"MADS" is the abbreviation for MCM1, w hich regulates m ating type-specific 
genes in yeast, A ga mo us and  D eficiens, w hich are  the  hom eogenes in 
p lan ts, and  se ru m  response  factor, w hich regu la tes  m uscle-specific and  
serum -inducible  gene expression (Pollock and  Treism an, 1991). M em bers of
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the  M ADS fam ily  share  hom ology  w ith in  a reg ion  called  the  M ADS box; 
th is  reg io n  is com prised  o f ab o u t 56 am in o  ac ids w hich  m e d ia te  D N A  
b in d in g  a n d  d im eriza tion . Im m ed ia te ly  ad jacen t to  the  M ADS box is an  
a d d itio n a l 29 -am ino -ac id  reg io n  ca lled  M EF-2 d o m ain , th a t is h ig h ly  
conserved  on ly  am ong  MEF-2 proteins.
Four d istinc t genes encod ing  MEF-2 p ro te in s (MEF-2A, -2B, -2C, and  
-2D) h a v e  been  c loned . T hey a re  p re d o m in a n tly , if n o t exclu sively , 
ex p re ssed  in skeletal, card iac , an d  sm oo th  m usc le  as w ell as in n eu ro n a l 
cells (Yu et al., 1992; Pollock a n d  T re ism an , 1991; C h a m b e rs  et a/., 1992; 
B re itb a rt et at., 1993; Leifer et al., 1993; M cD erm ott et at., 1993; M artin  et al., 
1993; N g u y e n  et a l ,  1994; Lilly et a l ,  1994). MEF-2D accum ula tes in the 
C2C12 m yoblasts; MEF-2A, B, and  C can only be detected  in m yotubes.
M EF-2 p ro te in s  form  hom o- o r he te ro -d im ers u p o n  b in d in g  to  the 
D N A  reco g n itio n  sequence; these  d im e rs  a re  e sse n tia l fo r h ig h  level 
expression  of m any  s tria ted  m uscle genes (Braun et a l ,  1989a; G ossett et a l, 
1989; H orlick  a n d  Benfield, 1989; W en tw o rth  et a l ,  1991; Z h u  et a l ,  1991; 
Ia n n e llo  et a l,  1991; Lee et al., 1992; N akatsu ji et a l , 1992). In m any  m uscle 
g en es, M EF-2 sites a re  o ften  ju x tap o sed  to o n e  o r m o re  E-boxes. M ore 
im portan tly , MEF-2 pro te ins, such as MEF-2A, cooperate  w ith  the  m yogenic 
bH L H  pro te in s to synerg istically  activate  tran scrip tion  of the  m uscle genes 
(K au sh a l et a l, 1994). T hese in terac tions a re  m ed ia ted  th ro u g h  the  MADS 
dom ain  of MEF-2A an d  the  th ree  un ique  am ino  acid residues (A la-114, Thr- 
115, Lys-124) in the  basic region of the  m yogenic bH L H  p ro te in s (K aushal et 
a l., 1994). M EF-2A itse lf  can  in d u ce  m y o g en ic  d e v e lo p m e n t w h en  
ectopically  expressed  in non-m uscle cells. The fact that ectopic expression  of 
m yogen in  o r M yoD  induces MEF-2 exp ress ion  in  m an y  non -m uscle  cells
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suggests that MEF-2 genes are  dow nstream  of the  m yogenic bH L H  genes in 
the  h ierarchy  of m yogenic regulators.
H ow ever, functional MEF-2 D N A -bind ing  sites are  also fo u n d  in the 
con tro l reg ions of bo th  the  m ouse  m yogen in  a n d  Xenopus M yoD  (XMyoD) 
g en es , in d ic a tin g  th a t MEF-2 p ro te in s  a re  im p o r ta n t  re g u la to rs  o f the  
m yogenic  bH L H  gene expression. In the 5 '-flanking  region o f XM yoD gene, 
th e re  is a 58-bp fragm en t con ta in ing  the tran scrip tio n  in itia tion  site, a GC- 
rich  reg io n , a n d  o v e rla p p in g  b in d in g  sites  for th e  g en era l tran sc rip tio n  
fac to r TFIID an d  for MEF-2; th is frag m en t is su fficien t to d irec t m uscle- 
specific tran scrip tio n  (Leibham  et al., 1994). This m inim al XM yoD p rom ote r 
is ac tiv a ted  in  non-m uscle  cells b y  the  co-expression  of X enopus  MEF-2, 
w hich  requ ires b ind ing  of bo th  TFIID and  MEF-2 to the  TATA box (Leibham  
et al., 1994). T herefore, skeletal m yogenesis is m ed ia ted  by  tw o  d istinc t bu t 
m u tu a lly  in d u c ib le  a n d  in te ra c tiv e  tra n s c r ip tio n  fac to r fam ilie s , the  
m yogenic  bH L H  pro teins an d  MEF-2 proteins.
MCBF, the  th ird  class o f the  m uscle-specific regu la to r, w as first found  
in the  reg u la tio n  of m uscle-specific  tran scrip tion  of the  card iac  tro p o n in  T 
(cTNT) gene  (M ar an d  O rd ah l, 1988; M ar an d  O rd ah l, 1990; S tew art et al.,
1994). T his cTNT gene is exp ressed  co n stitu tiv e ly  in  card iac  m uscle, b u t 
tra n s ie n tly  in  sk e le ta l m u sc le  d u r in g  e m b ry o n ic  d e v e lo p m e n t. It is 
tran sc rib ed  a t the  onse t of te rm ina l d ifferen tia tion  and  rep re ssed  in a d u lt 
m u sc le  — u n le ss  it is ac tiv a ted  in  sa te llite  cells d u r in g  sk e le ta l m usc le  
reg en era tio n  (M ar and  O rdah l, 1990). MCBF recogn izes th e  conserved  M- 
C A T  seq u en ce  CATTCCT that has been  fo u n d  in the  con tro l reg io n s of 
severa l m uscle-specific  genes (N ikov its et al., 1986; T hom pson  et al., 1991; 
S h im u z u  et at., 1992a).
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In  an y  e v en t, M C B F -dependen t genes a p p e a r  no t to  re q u ire  the  
m yogen ic  bH L H  pro te in s for their transcrip tion . The en richm en t o f MCBF 
in  nu c lear ex tracts o f m uscle, b u t n o t from  o th er tissues, is consisten t w ith  
its function . A lthough  th e  s tru c tu re  a n d  function  o f th is p ro tein (s) has no t 
been  s tu d ie d  in g rea t d e ta il, MCBF rep re sen ts  a n  a lte rn a te  bH L H  pro tein - 
in d ep e n d en t p a th w ay  of m uscle  gene  regu la tion  (Farrance et al., 1992).
1.8 Gene Tissue-Specific Inactivation by DNA Methylation
It is be lieved  th a t d iffe ren tia tio n  req u ire s  co n tin u o u s reg u la tio n  of 
th e  tissue-specific  genes (Blau an d  B altim ore, 1991). T his reg u la tio n  is 
th o u g h t to  be  contro lled  by an  active m echanism . T hus, con tinuous activity  
of p o sitiv e  an d  negative  reg u la to rs  is requ ired  to  m ain ta in  d ifferen tia tion  
d u r in g  n o rm al developm en t. For instance, activa tion  o f th e  silen t M yoD  
g en e  in  fibrob lasts (und ifferen tia ted  cell types) causes a com plete  m yogenic 
c o n v e rs io n , in d ic a tin g  th a t th e  M yoD  gen e  is ac tiv e ly  co n tro lled . In 
c o n tra s t, th e  se q u en tia l ex p ress io n  and  a u to re g u la tio n  of th e  m yogen ic  
b H L H  genes en su res  th a t levels of these  reg u la to rs  a re  stable, lead ing  to 
co n tin u o u s contro l of m uscle  gene expression.
In fact, g en e  silenc ing  by m e th y la tio n  m od ifica tion  of th e  5' CpG  
is la n d s  d u r in g  th e  ea rly  d e v e lo p m e n t re su lts  in  in ac tiv a tio n  o f certa in  
g e n es  in  a tis su e -sp e c ific  m a n n e r. W hile  tis su e -sp e c if ic  g e n es  a re  
m e th y la te d  in  m o st cell ty p es , h o u se k ee p in g  g e n es  a re  co n stitu tiv e ly  
u n m e th y la ted  (Y israeli and  Szyf, 1984; Bird, 1986; C ed ar, 1988; C om b and 
G o o d m an , 1990; B ird, 1992; R hodes et a t ,  1994). C pG  is lands are  DN A 
sequences averag ing  1 kb long  that a re  found  a lm ost exclusively  a t the 5'- 
f la n k in g  reg io n s  o f b o th  th e  h o u se k e e p in g  a n d  tis su e -sp e c ific  g en es
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(A n teq u e ra  a n d  B ird, 1993). The C pG  d in u c le o tid e  is th e  ta rg e t for 
m ethy ltransferase  th a t m ethylates the C res idue  at the  carbon 5 position .
D N A  m eth y la tio n  at C pG  islands p resum ab ly  affects gen e  expression  
in  th ree  w ays. F irst, it  can  d irec tly  red u ce  th e  D N A -b ind ing  ac tiv ity  of 
tran sc rip tio n  ac tiva to rs o r rep resso rs  by a lte ring  th e  con fo rm ation  o f their 
D N A  cognate  sequences (C om b a n d  G o odm an , 1990; K lem p n au er, 1993; 
F ren d erg as t a n d  Ziff, 1991; B ednarik  et al., 1991). S p l a n d  NF-1, how ever, 
a re  in sen s itiv e  to  D N A  m eth y la tio n  (H a rrin g to n  et at., 1988; H oller et al., 
1988; B e n -H a tta r  et al., 1989). Second, D N A  m eth y la tio n  can  a lte r  th e  
ch rom atin  s tru c tu re  such  that genes becom e transcrip tiona l inactive (K eshet 
et al., 1986). T he fac t th a t h is to n e  H I , a tra n s c r ip tio n a l re p re sso r , 
p re fe ren tia lly  b inds to the  m ethy la ted  D N A  suggests  th a t H I p ro te in s a re  
in v o lv ed  in  m eth y la tio n -m ed ia ted  in h ib itio n  o f tran sc rip tio n  (W ein traub , 
1984; C ro n s to n  et al., 1991; Levine et al., 1993). F inally , D N A  m eth y la tio n  
can inh ib it tran scrip tion  th rough  5-m ethyl-C -binding  p ro te in s  (H uang  et al., 
1984; M eehan  et al., 1989). T hese p ro te in s specifically b in d  m ethy la ted  CpG  
sequences, possib ly  b lock ing  tran scrip tiona l ac tiva to rs to the  access of cis- 
e le m e n ts .
T he u n m e th y la ted  a n d  m eth y la ted  sta tes of the  h o u sek eep in g  an d  
tissue-specific  genes p ro d u ce  a b im odal p a tte rn  of m e th y la tio n  in som atic 
cells. This b im odal som atic m ethylation  is p robab ly  estab lished  th rough  the 
com bined  action  of a general de novo m e th y la tio n  m echan ism  w ith  som e 
stage-specific factors tha t e ither pro tect islands from  m ethy la tion  o r actively 
d e m e th y la te  these  sequences (B randeis et al., 1994). D em ethy la tion  of the 
CpG  islands can be directed by the GC-box of the S p l b ind ing  sites, indicating 
th a t S p l m ay be  invo lved  in th is p rocess (Bird 1986; H o lle r et al., 1988; 
M acleod etal., 1994).
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In the case of RM-PFK gene, there is a 1 kb C pG  island w hich is 2 kb 5* 
u p s tre am  o f the ATG codon. To d e te rm in e  if th e  ch rom atin  s tru c tu re  an d  
D N A  m ethy la tion  m ay p lay  a ro le  in the tissue-specific  regu la tion  of th is 
gene , th e  p a tte rn s  o f the  D N asel h y p e rsen s itiv e  sites an d  m ethy la tion  in 
d if fe re n t t is su e s  w e re  s tu d ie d  (K naak , u n p u b lis h e d  d a ta ) . R esu lts  
d e m o n s tra te d  th a t the  C pG  is lan d  o f the  RM -PFK g en e  is a lm o st no t 
m ethy la ted  in skeletal a n d  card iac  m uscle, w h ile  it  is h igh ly  m eth y la ted  in 
liver, and  less m ethy lated  to  d ifferent extents in k idney, sp leen  an d  brain.
1.9 Tissue-Specific Expression of the L- and C-PFK Genes
M echanism s for tran scrip tio n a l regu la tion  o f the  o th e r  m am m alian  
PFK  g en es  L-, a n d  C-PFK  rem ain  u n d e te rm in e d . In g e n e ra l, th re e  
m am m alian  PFK genes a re  located  on sep a ra te  ch rom osom es, an d  their 
expression  seem s to be  regu la ted  independen tly .
T ranscrip tion  o f the m ouse L-PFK gene, how ever, is u n d e r  horm onal 
a n d  n u tritio n a l con tro ls (G ehnrich  et al., 1988; G ekakis et al., 1989). D N asel 
fo o tp rin tin g  experim en ts show ed  th a t there  a re  five reg ions on its contro l 
seq u en ce  w h e re  liv e r n u c lea r p ro te in s  m ay  in te rac t (R o n g n o p a ru t et al., 
1991). A lthough  evidence is lacking on h o w  the liver-specific expression  of 
the  L-PFK gene  is con tro lled , s tu d ies  from  th e  exp ression  o f several o th er 
live r-spec ific  g en es  im p ly  th a t severa l liver-specific  tra n sa c tiv a to rs  a re  
invo lved  in regu la tion  o f liver gene specificity.
T he PFK2 gen e  con ta in s a liv e r-ty p e  p ro m o te r  th a t is u n d e r  the  
co n tro l of h ep a to cy te  n u c lea r fac to r (H N F) 3, C A A T /e n h a n c e r-b in d in g  
p ro te in  (C /EB P) re la ted  factors, a n d  o ther liver-specific factors (L em aigre et 
al., 1991 & 1993). HNF1 regu la tes  transcrip tion  in early  liver deve lopm en t 
(M e n d e l et al., 1991); C/EBPoc is active  d u rin g  la te  fetal liv e r an d  early
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p o s tn a ta l liv e r d e v e lo p m e n t (B irkenm eier et al., 1989); bo th  liver activator 
p ro te in  (LAP) an d  D -elem ent-b ind ing  p ro te in  (DBP) a re  m ost active in the  
po stn a ta l liver d u rin g  developm en t (D escom bes an d  Schibler, 1991; M ueller 
et al., 1990). T hese liver-specific factors also contro l tem poral expression  of 
th e  h u m a n  a lc o h o l d e h y d ro g e n a s e  g e n e  fa m ily  (O oij et al., 1992). 
In te re stin g ly , C /E B P a , LAP, and  DBP are p ro te in s w ith in  the  basic-leudne  
z ip p e r  (bZIP) p ro te in  fam ily. Like bH L H  p ro te ins, bZ IP  p ro te in s  recognize 
sp e c if ic  D N A  se q u en c es  th ro u g h  th e ir  b asic  d o m a in s  u p o n  p ro te in  
d im eriza tio n  a t their leucine z ip p e r m otifs (Johnson and  M cK night, 1989).
1.10 Research Objectives
It is believed  th a t the regu la tion  of m uscle-specific expression  of the 
RM -PFK g en e  occurs m ain ly  at the  tran scrip tiona l level. To illu stra te  th is 
con tro lling  m echan ism , the  cis-acting e lem ents an d  the  trans-acting  factors 
in v o lv e d  in  th is  re g u la tio n  m u s t be  id e n tif ie d . For th is  rea so n , 
ap p ro x im ate ly  3 kb of the  5' u p stream  sequence  of the  RM-PFK gene had  
been  p rev iously  sequenced (Fig. 1-6).
Sequence analysis show s tha t RM-PFK has a h igh GC conten t at its 5 -  
re g io n  w ith  50 C pG  loci, m u ltip le  tra n s c r ip tio n  in itia tio n  s ites , an d  
a lte rn a tiv e  sp lice  d o n o r  sites . M ore im p o rta n tly , th e re  a re  m u ltip le  
p u ta tiv e  E-boxes an d  o th e r  m uscle-specific  enhancer e lem ents such as M- 
C A T sequences (CATTCCA) and  the  MEF-2 AT-rich sequence. In add ition , 
th e re  is n o  TA TA -box in th e  1 kb reg ion  up- an d  d o w n -s tre am  of the  
tran scrip tion  in itia tion  site a (Figs. 1-3 an d  1-6), ind icating  th a t the  proxim al 
p ro m o te r  a m ay  be a TA TA -less p rom oter. T ran sc rip tio n  of m R N A -b is 
in itia ted  from  the d is ta l p ro m o te r b  w hich  is fa rthe r u p stream  of a TATA 
consensus sequence (Fig. 1-6). It w as no t clarified w hether or not this TATA
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sequence is functional. P rom oters that d irec t tran scrip tion  o f the  m RN A -a, 
-b, an d  -c ap p ea r to be  m uscle-specifically contro lled  (Xiao, 1995).
T herefore, the  p u rp o se  o f th is project w as to  e luc ida te  th e  m olecular 
m echan ism  th a t con tro ls m uscle-specific tran scrip tion  of th e  RM-PFK gene. 
The specific  goa ls  of th is  research  a re  as fo llow s: (1) d e m o n s tra tio n  of 
transactivation  of th e  RM-PFK gene by th e  m yogenic  bH L H  pro te in s (M yoD, 
M yf5 , a n d  m y o g e n in )  u s in g  tr a n s ie n t  c o tra n s fe c tio n  s tu d ie s ; (2) 
id en tifica tio n  of the  p o sitiv e  an d  negative  reg u la to ry  e lem en ts w ith in  the 
c o n tro l re g io n  o f th e  RM -PFK  g e n e  by  d e le tio n a l  a n a ly s is ; (3) 
d e te rm in a tio n  of the b o u n d arie s  o f the m uscle-specific p ro m o te rs  (proxim al 
p ro m o ter a an d  d ista l p ro m o ter b) by dele tional analysis; (3) exam ination  of 
th e  activ ity  p rofiles of these p rom oters in  m uscle  an d  non-m uscle  cells; (4) 
dem o n stra tio n  o f the d irect in teraction  o f the m yogenic bH L H  pro teins w ith  
th e  p o sitiv e  reg u la to ry  e lem en t o f the  RM-PFK gene in vitro  u sin g  EMSA 
an d  D N asel foo tp rin ting  experim ents; (5) characteriza tion  o f th e  s truc tu ra l 
fe a tu re  o f th e  p ro x im a l p ro m o te r  b y  e x am in in g  p ro te in  reco g n itio n  
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CHAPTER 2 
M ATERIALS A N D  M ETH O D S
2.1 Materials
2.1.1 Enzymes and Sera
R estriction endonucleases an d  D N A  m odify ing  enzym es [including  T4 
D N A  Hgase, E xonuclease III (Exo in), SI nuclease, T4 po lynucleo tide  kinase, 
K lenow  fragm ent DN A polym erase, and  T4 D N A  polym erase] w ere purchased  
from  B ethesda R esearch  L abora to ries (BRL) (B ethesda, M D), B oehringer- 
M annheim  Biochem icals (Ind ianapolis, IN), P rom ega C orpora tion  (M adison, 
W l), a n d  N ew  E ngland  Biolabs, Inc. (Beverly, MA). T rypsin-E D T A  w as 
ob tained  from  GIBCO-BRL (Bethesda, MD). RN ase A, D N ase I, Protease K, and 
ly sozym e w ere  o b ta in ed  from  Sigm a C hem ical C om p an y  (St. Louis, MO). 
Sequencing Kits w ith Sequenase version 2.0 w ere purchased  from  U nited  States 
B iochem icals C orporation  (USB) (C leveland, O H ) an d  A m ersham  C orporation  
(A rlington H eights, IL). Polym erase chain reaction (PCR) reagen t kits w ith  Taq 
D N A  po lym erase  w ere  p u rch ased  from  Perk in  E lm er C e tu s (N orw alk , CT). 
Fetal calf serum  (PCS) an d  horse serum  (HS) for cell cu ltu re  w ere  ob tained  from  
H yclone Laboratories, Inc. (Logan, UT).
2 .1 . 2 C hem icals a n d  C u ltu re  M edia
C hem icals used  for E. co/i cell cu ltu re  inc luded  tryp tone , yeast extract, 
an d  ag ar that w ere  p u rchased  from  Difco L aboratory  (D etroit, MI). T ype I 
agarose, low  m elting po in t Seaplaque agarose, an d  am m onium  persu lfa te  were 
p u rch ased  from  GIBCO BRL. C esium  chloride, acry lam ide, N , N ’-m ethylene- 
b isacry lam ide  (BIS), acry lam ide stock so lu tion  ACRYL-40, sa tu ra ted  phenol,
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an d  sa tu ra ted  p h en o l/ch lo ro fo rm  w ere ob tained  from  A m erican Research 
Products Co. (AMRESCO) (Solon, OH). Urea w as obtained from BRL or USB. 
G lycerin w as purchased  from C urtin  M atheson Scientific, Inc. (H ouston, TX). 
P iperid ine and  dim ethyl sulfate (DMS) w ere  obtained from  A ldrich Chemical 
C om pany , Inc. (M ilw aukee, W I). O -n itropheny l-b -D -galac topy ranoside  
(ONPG) w as pu rchased  from Prom ega. M ost of the  o th er reagen ts w ere 
ob tained  from  Sigma. These included Tris-(hydroxym ethyl) am inom ethane 
(Tris), Trizm a base, N -(2-hydroxyethyl) p iperazine-N ’-(2-ethanesulfonic acid) 
(HEPES), N onidet P-40, Triton X-100, ethlenediam inetetraacetic acid (EDTA), 
sod ium  dodecyl su lfate  (SDS), d ith io th reito l (D TD , sucrose, isopropyl-b-D  
th io g a la to p y ran o sid e  (IPTG), C hick em bryo  extract; an tib io tics such  as 
am picilline, chloram phenicol; sperm idine, sperm ine, poly (dl-dC); protease 
inhibitors such as phenyl-m ethylsulfonyl fluoride (PMSF), leupeptin , pepstatin, 
apro tin in , chym ostatin , and benzam idine; reduced  g lutathione, and  reduced 
g lu ta th ione-agarose resin. Penicillin and  streptom ycin for cell cu ltu re  w ere 
pu rchased  from  Pfizer, Inc. (New York, NY). Sephadex G-50 an d  G-25 spin 
colum ns w ere  purchased  from 5 Prim e - 3 Prim e, Inc. (Boulder, CO). Maxi 
D N A  Prep  Kits and  G ene C lean  kits w ere  o rd e re d  from  Q iagen , Inc. 
(C hatsw orth, CA) and Bio 101, Inc. (Lo Jolla, CA), respectively. Protein assay 
reagent w as obtained from  Bio-Rad Laboratories (Richm ond, CA). W hatm an 3 
MM filter p ap ers  w ere ob tained  from  Fisher Scientific (P ittsburgh , PA). 
Polaroid 667 films, and  Kodak XAR-5 and XRP-5 X-ray films w ere  purchased 
from  Polaroid  (C am bridge, MA) and  K odak (Rochester, NY), respectively. 
T issue cu ltu re  m edia including H am 's F-12 and  Dulbecco's m odified Eagle's 
m ed ium  (DMEM) w ere p repared  by Dr. Robert T ruax in  the Dept, of Vet. 
M icrobiology and Parasitology, in the School of Veterinay M edicine, Louisiana 
State U niversity (Baton Rouge, LA).
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2.1. 3 Cell Lines, Bacterial Strains, and Helper Phage
M ouse C2C12 an d  fibroblasts NIH 3T3 w ere  pu rch ased  from  A m erican 
Type C u ltu re  Collection (Rockville, MD). The frozen cell stocks w ere stored in 
liqu id  n itrogen  tanks in the T issue and  O rgan  C u ltu re  Lab of th e  School of 
V e terinary  M edicine, L ou isiana  S tate  U n iversity  (B aton Rouge). Bacterial 
stra in s HB101, JM109 an d  he lper ph ag e  R408 w ere  ob ta in ed  from  Prom ega, 
w hereas stra ins X Ll-blue and  D H 5 a  w ere  pu rchased  from  S tra tagene C loning 
System s (La Jolla, CA).
2.1. 4 DNA Plasmids
T he p la sm id  pG EM -7zf(-) c o n ta in in g  T7 e x p re ss io n  sy stem  w as 
pu rch ased  from  Prom ega. The p lasm id  pSV -fi-galactosidase for m onito ring  
transfection  efficiency is u n d er the control of the  sim ian v irus 40 (SV40) early  
p ro m o ter an d  th e  72-bp enhancer, an d  it w as p u rchased  from  Prom ega. The 
ch lo ram phen ico l ace ty ltran sfe rase  (CAT) rep o rte r  p la sm id  pCAT-Basic (or 
pCAT-B) w as p u rch ased  from  Prom ega. T his pCAT-B lacks e u k a ry o tic  
p ro m o ter and  enhancer sequences; thus, expression  of the  CAT gene o f this 
p lasm id  is d ep en d en t on  insertion  of a functional p ro m o ter u p stream  of the 
CAT gene.
M yoD  g lu ta th ione  S-transferase (GST) fusion expression  p lasm ids w ere 
the  generous gifts of Dr. W eintraub. The full length  cD N A  of M yoD (Davis et 
qI„ 1987) w as ligated  in to  a Sma I-cleaved pGEX-3X (Sm ith and  Johnson, 1988) 
(Fig. 2-1). M yogenic bH LH  protein expression vectors w ere  based  o n  a p lasm id 
pEM SVscribe w hich contains the  M oloney sarcom a v irus LTR prom oter a n d  the 
SV40 poly  A sequence flanking the un ique  EcoR I cloning site. The full length 







p G £ X - 3 X
Factor Xa 
I--------------------------1
Leu lie Glu Gly Arg Gly lie Pro Gly Asn Ser Ser ----
CTG ATC GAA GGT CGT GGG ATC CCC GGG AAT TCA TCG
I_______ I 1_______ I
BamHI | | EcoRI
Sma I
Fig, 2-1. Schem atic d iag ram  of the  GST (g lu ta th ione  S -transferase) fusion 
expression  p lasm id . M yoD cDNA w as subcloned in to  the  un ique  Sma I site of 
pGEX-3X. GST sequence in this p lasm id  encodes the C- term inal po rtion  of the 
GST protein. The arrow  indicates Factor Xa cu tting  site.
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pEM SVscribe, genera ting  pEMSV-MyoD (or pEM cIIs), pEMSV-MyoG, and 
pEMSV-Myf5, respectively (Davis et a l, 1987; W right et a l,  1989; Braun et a l, 
1989a) (Fig. 2-2). D eletion m utan ts o f M yoD w ere also cloned by  the sam e 
strategy. Plasm id pEMSV-MyoDAB expresses MyoDAB protein (102-135) that is 
devoid  of the basic region of the MyoD, w hereas pEMSV-MyoDAN expresses 
MyoDAN (3-56) that is a N -term inal dele tion  m utan t of M yoD (D avis et al., 
1987). Constructs of the MyoD expression vectors w ere kindly provided by Dr. 
H. W eintraub. pEMSV-MyoG and  pEMSV-Myf-5 w ere the  generous gifts from 
Drs. V. t i n  and H. A rnold, respectively.
2 .1 . 5 R adioisotopes and  O ligonucleotides
32P-labeled nucleotides including  (a -32P]-dCTP, [y-32P]-ATP, [a -32P]- 
dATP, [a-35SJ-dATP, and [14CJ-butyryl coenzym e A w ere purchased from ICN 
Biochem icals, Inc. (Irv ine, CA) or Du Pont C om pany  (W ilm ington, DE). 
O ligonucleotides w ere syn thesized  by e ither the G eneLab in  the School of 
V eterinary Medicine, Louisiana State University (Baton Rouge, LA), or by Ana- 
Gen Technologies, Inc. (Palo Alto, CA).
2 .2  M ethods
2. 2 .1  C onstruction of PFK-CAT C him eras
The RM-PFK genom ic DNA fragm ent orig inally  cloned into plasm id 
pUC18 at the  Kpn I and BamH  I sites (Fig. 2-3) w as approxim ately  6 kb long. 
The fragm ent included the N-term inal sequence of RM-PFK gene and the 3 kb 
of the  5'-flanking region located im m ediately upstream  of the ATG translation 
initiation codon. The plasm id generated by this process is referred to  as pUC- 






Fig. 2-2. Schematic d iagram  of the m yogenic cDNA expression vectors. The 
cDNAs of the MyoD, MyoD m utants, m yogenin, and Myf5 w ere cloned into the 
un ique  EcoR I site o f the vector pEMSVscribe (Davis et al., 1987; W right et al., 
1989; Braun et al., 1989a). Plasm id pEMSVscribe was derived from  pBluescribe 





Xbal Exon 1 Intron 11 pUC18
p U C -P F K  6 .0
H ind i/E coR I J Xbal
PstI '  PstI PstI pUC19
H ind lll PstI
pU C -P F K  3.0
HindIU
PstI PstI AccI PsO PstI
pB 3.0
Fig. 2-3. C loning schem e for plasm ids pUC-PFK and pB3.0. The 6 kb genom ic 
DNA fragm ent o f the RM-PFK gene including the  3 kb of the  5' flanking region 
w as first subcloned into pU CI8. The 3 kb  EcoR I (filled w ith  K lenow )/X ta  I 
fragm ent corresponding to the 5'-flanking sequence w as then further subcloned 
in to  the H inc II (filled w ith  klenow ) and X fra I sites of pUC19 to yield pUC- 
PFK3.0. This 3 kb sequence w as finally inserted  into pCAT-Basic vector as a 
H ind HI/Xba  I fragm ent, generating pB3.0.
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w ith  K lenow  enzym e p rio r to  Xba I d igestion . The pu rified  EcoR I fX b a  I 
fragm ent w as then  su b d o n e d  in to  the H tnc n  (filled w ith  Klenow) and  Xba I 
sites of pUC19, p ro d u c in g  pUC-PFK3.0. The PFK 5 '-flanking  fragm en t in 
pUC-PFK3.0 w as cu t o u t w ith H ind m  an d  Xba I, a n d  w as inserted  in to  the 
H ind III and  Xba I sites of pCAT-B, generating  pB3.0 for transien t expression 
stud ies (Fig. 2-3). The sam e H ind HI/X ba  I PFK fragm ent w as also inserted  
in to  the H ind HI and  Xba I sites o f pGEM-7zf(-) to yield pGEM3.0 for deletion 
by  Exo m  ex o n u d ease  digestion.
To p in p o in t the  regu la to ry  regions w ith in  the above 3 kb PFK sequence, 
th e  in ternal deletions w ere generated  by Pst I partia l digestion (Sam brock et al.,
1989). P rogressive deletions in the  5' to 3’ d irection  w ere perfo rm ed  by using 
the  E rase-a-base Exo III system  (Prom ega). Briefly, pGEM 3.0 w as cu t w ith  Sma 
I an d  Kpn I to  create b lu n t ends at the 5' side  of the D N A  insert for Exo III 
d igestion , an d  to create the 3' overhangs for p reven ting  Exo m  digestion in the 
3’ to 5’ d irection. A fter Exo III d igestion  for d ifferent tim e periods, th e  DN A 
frag m en ts  w e re  re p a ire d  w ith  SI nuclease  a n d  K lenow  en zy m e  p rio r  to 
ligation. The end  po in t of each deletion m utan t w as de te rm ined  by single­
s tran d ed  d ideoxy  D N A  sequencing. The confirm ed m uta tion  constructs w ere 
selected, an d  the PFK fragm ents w ere  cut an d  subcloned into the H ind III and  
Xba I sites of pCAT-B (Fig. 2-4).
To delineate  the b o u n d ary  of the proxim al p rom oter, PFK-CAT fusion 
constructs w ere  m ade as follows. The 3 kb PFK insert of pB3.0 w as separa ted  at 
the  un iq u e  Acc I site in to  1.8 kb an d  1.2 kb fragm ents . P lasm id pB1.2 contains 
the  3 ’ sequence  of -994 to +73 w ith  respect to +1 position  of the  proxim al 
p rom oter. It w as created  by inserting the  Acc 11 Xba I DN A fragm ent o f pB3.0 
in to  the Hin c II/X ba  I sites of pCAT-B w here  the Acc I site of the insert an d  the 
Hin c II site of the vector have been filled-in w ith K lenow enzym e (Fig. 2-5).
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Fig. 2-4. Schem atic d iagram  of the 5* to 3' deletion o f p lasm id  pGEM3.0 by Exo 
III d igestion . The H in d  Ill/X fra  I PFK frag m en t from  pU C-PFK 3.0 w as 
subc loned  in to  th e  sam e sites of pGEM -7Zf(-) vector, c rea ting  pGEM 3.0. 
pGEM 3.0 w as d igested  w ith Kpn I and  Sma I w hich are  at the 5' en d  and  in the 
PFK insert (-2533 in respect to proxim al transacrip tion  start site as +1 position), 
respectively . The b lu n t en d s generated  by Sma I d igestion are  sensitive to Exo 
in . By contrast, Kpn I d igestion  creates 3 ’ overhangs th a t a re  Exo m  resistant. 
T hus Exo III d igestion  w as unid irectional from  5' to 3' o n  the  PFK insert. DNA 
sam ples w ere  trea ted  w ith  Exo III for different tim e periods, an d  im m ediately  
rep a ired  w ith  SI an d  K lenow  trea tm en ts . The d e le tio n  e n d  p o in ts  w ere 
checked by sequencing. From  those deletion constructs, th e  desired PFK inserts 
w ere  cut w ith  H ind III and  Xba I, and  subcloned in to  vector pCAT-Basic. The 
polycloning  sites of pGEM  7Zf(-) a re  also show n in this figure.
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Fig. 2-5. C loning schem e for p lasm ids pB1.2 and pB1.8. P lasm id pB3.0 was 
d igested w ith Acc I, and filled in w ith Klenow prior to H ind in  digestion. To 
create pB l.8, the H ind  III/A cc  I fragm ent of about 1.8 kbp w as purified  and 
subcloned into the Hind IU/Acc  I sites of pCAT-B, of w hich the Acc I ends were 
also b lunt-end repaired. To create pBl.2, theAcc I /Xba  I insert o f about 1.2 kbp 
from  pB3.0 w as su b d o n ed  into the H ind HI/Xba  I sites of pCAT-B, of which 
H ind  III en d s w ere K lenow repaired . T ranscrip tion s ta rt sites including  a 
(proximal) and  b are indicated w ith arrows.
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Plasm id pB268 (-195 to +73) contains the 268 b p  Pst I/Xba  I fragm ent harboring  
the  proxim al transcrip tional start site (Fig. 2-6). It w as generated  by subcloning 
this 268 bp  Pst I /Xba  I fragm ent in to  the Pst I and  Xba I sites of pCAT-B (Fig. 2- 
6). T his pB268 w as then  d igested  w ith  Nhe  I and  Xba I to rem ove a 50-bp 
frag m e n t (+23 to  +73) co n ta in in g  an  E-box (CAGCTG) to  y ield  pB218. 
A lternative ly , pB268 w as d igested  w ith  H ind  HI and  Dra in  to rem ove the  5' 
en d  100-bp fragm ent (-195 to -95) includ ing  an  E-box (CAGATG), genera ted  
pB168 (-95 to +73). This pB168 w as fu rther d igested  w ith Nhe  I an d  Xba I to 
dele te  the 3’ end  Nhe I /Xba  I fragm ent o f 50-bp, y ield ing  pB118 (-95 to +23).
In  a para lle l s tu d y , PFK-CAT fusion  construc ts  co n a tin in g  various 
sequences of the  d istal p rom oter b  corresponding to the  transcrip tion  start site b 
w ere  m ad e  as follows. The 1.8 kb H ind in/Acc  I (filled w ith  K lenow  at Acc I 
end ) fragm ent (-2783 to  -994) of pB3.0 w as subcloned in to  th e  H ind III andAcc 1 
(filled w ith  Klenow) sites of pCAT-B to yield pB1.8 (Fig. 2-5). This pB3.0 w as 
d ig ested  w ith  H in d  III an d  X m n  I; th is genera ted  a 1.4 kb fragm en t (-2783 to  
-1642) w hich w as then subcloned in to  the H ind in  andAcc I (filled w ith  Klenow) 
sites of pCAT-B, y ielding pB1.4 (Fig. 2-7). The Exo III deletion m utan ts  pGEM5- 
2 (-2313 to +74) and  pGEM  3-4 (-1898 to  +74) w ere  doubly  d igested  w ith  H ind 
m  an d  Xm n  I. These two H ind  III/X m n  I PFK fragm ents w ere  subcloned into 
th e  H in d  III /A c c  I sites o f pCAT-B sim ilarly  to pB1.4, g e n e ra tin g  pB671 
(pGEM 5-2: -2313 to -1642) an d  pB256 <pGEM3-4: -1903 to -1642). P lasm ids 
pB1.4 and  pB671 contain  the  transcrip tional s ta rt site  b, w hereas pB256 only  
contains m ost o f the  sequence of exons B and  Br (Figs. 1-6 and  2-7) includ ing  a 
TATA sequence (-1706). This TATA sequence lies 230 bp  dow nstream  of the 
tran scrip tio n a l in itia tion  site  b, an d  is im m ed ia te ly  fo llow ed  by a G C-rich 
region w hich p resum ably  form s a stable G-C stem  loop secondary  structure . It 
w as speculated that this stem  loop preven ts the transcriptional com plex from
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Fig. 2-6. Schematic d iagram  of the proximal prom oter CAT constructs. Plasm id 
pB268 co n ta in s 268 bp  p rox im al p ro m o te r sequence  su rro u n d in g  the 
transcrip tion  start site a (as arrow  indicates). Plasm id pB218 is the  deletion 
m u tan t of pB268 of w hich the 50-bp Nhe I /Xba  I fragm ent has been rem oved; 
thus, it contains the 218 bp  Pst l /N h e  I prom oter fragm ent. After rem oval of the 
Pst I /Dra  III 100-bp fragm ent by Hind  IH and  Dra in digestions (Hind  III site is 
5’ to  the  Pst I cloning site) and  w as repaired w ith  T4 polym erase, pB268 w as 
then religated to yield pB168. This pB168 thus contains the Dra III/Xba 1 168 bp 
prom oter sequence. This plasm id w as then cut w ith Nhe I and Xba I to rem ove 
th e  50-bp fragm en t, an d  w as b lu n t-en d  rep a ired  w ith  T4 po lym erase , 
generating pB118. This pB118 thus contains the 118 bp  core prom oter sequence. 
The E-boxes and the transcription start site a are shown.
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assem bling  a ro u n d  th is TATA-box sequence. T herefore, th is G-C stem  loop 
w as d is ru p te d  by base  su b s titu tio n  u sing  PCR. A low er p rim er (1249-mu) 
co n ta in in g  th e  su b s titu ted  bases a n d  th e  Sp6 p ro m o te r p rim er (as u p p e r 
prim er) w ere  ad d ed  to a PCR reaction w ith  pGEM 3-4 (-1898 to +74) as the  DN A 
tem pla te  (Fig. 2-7). T he 230 bp  PCR fragm ent w as pho sp h o ry la ted  an d  end- 
rep a ired  w ith  T4 po lym erase  before it w as inserted  in to  the  Acc  I (filled w ith  
K lenow ) site of pCAT-B, y ield ing  pB230mu. For control, a  low er p rim er o f the 
w ild  type  sequence (1249-wt) and  Sp6 p rom oter p rim er (as u p p e r prim er) w ere 
used  to  am plify  th e  w ild  type  D N A  fragm ent o f the sim ilar size to generate  
pB230wt.
2. 2. 2 C ell C u ltu res
M ouse C2C12 m yoblasts an d  NIH3T3 fib rob lasts w ere  p ro p ag a ted  in 
DM EM su p p lem en ted  w ith  10% (v /v )  FCS. C2C12 cell d ifferen tia tion  from  
m yoblasts to m yotubes w as in itiated  by sw itching  cells to DMEM supp lem en t 
w ith  2% (v /v )  HS. M yotubes w ere  visualized  four days after induction  u n der 
th is condition . Rabbit skeletal m uscle  p rim ary  m yoblasts w e re  p rep a red  by 
follow ing the m odified  m ethod  o f Blau and  W ebster (1981). Briefly, leg m uscle 
of the 3-day old rabbit w as dissected and cut in to  sm all cubes o f abou t 1 m m 3. 
M uscle pieces w ere  rin sed  w ith  cold p hospha te  buffered  saline (PBS; 0.14 M 
N aC l, 0.15 M K H 2P O 4 , 0.27 M KC1, 0.8 M N a2H P 0 4, pH  7.4) con ta in ing  
pen id llin -strep tom ycin  before they w ere transferred  in to  H am 's F-10 m edium  
for overn igh t incubation at 4°C. The next day , m uscle cells w ere dissociated by 
th ree  successive 30-m inute trea tm en ts of 5 ml of 0.25% trypsin-ED TA  at 37°C, 
w ith  occasional stirring. A fter each treatm ent, the  re leased  cells w ere pooled  
an d  d ilu ted  w ith  15 m l of G row th M edium  2 (GM2; 80% H am 's F-10, 20% horse 
serum , 0.5% chick em bryo  extract, 1% pen-strep) to term inate fu rther pro tease
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Fig. 2-7. Schematic d iagram  of the prom oter b CAT constructs. (A). The 1.4 kb 
H ind HI/X m n  I PFK fragm ent from  pB3.0 was subcloned into the H ind III/Acc  I 
sites o f pCAT-B in w hich the Acc I site w as filled in w ith  Klenow, generating 
pB1.4. This pB1.4 thus contains the 5' end  of the 3 kb PFK flanking sequence 
w hich harbors transcrip tion  start sites b, c, and  d (Fig. 1-3). P lasm id pB671 
contains the  671 bp H ind III/X m n I fragm ent (-2313 to -1642) that w as inserted 
in to  H ind  III/A c c  I sites o f pCAT-B. This 671 bp  fragm ent is 140 bp  dow n­
stream  of the  transcription start site c, but retains die sequence upstream  of the 
transcrip tion  start site b. Plasm id pB256 contains a 256 bp H ind  H I/Xm n I 
fragm ent 40 bp  w hich is dow nstream  of the  s ta rt site b, and  is w ith in  the 
sequence of Exon b  (Fig. 1-6). (B). PCR schem e for cloning pB230mu and 
pB230wt w ith pGEM3-4 as the DNA tem plate. Sp6 prom oter prim er of 19-mers 
w as the u p p e r prim er. The lower prim er was either 1249-mu or 1249-wt w ith 
the  m uta ted  bases underlined . The PCR p roducts w ere  subcloned into the 
filled-in Acc I site of pCAT-B to yield pB230mu and  pB230wt, respectively. The 
TATA sequences and the G-C stem  loop reg ion  are  also underlined , and  a 
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activity. Cells w ere pelleted  at <1000 rpm  for 10 m in, an d  resuspended  in GM2 
m ed iu m  p rio r  to  p la tin g  on  co llagen-coated  35 m m  tissue  cu ltu re  d ishes. 
M yoblasts selectively attach to the  d ishes u n d e r th is condition, separa ting  from 
fibrob lasts a n d  o th e r  cells in the  p o p u la tio n  (Blau and  W ester, 1981). These 
m yoblasts w ere  allow ed to proliferate in G row th  M edium  1 (GM1; 80% H am ’s 
F-10, 20% FCS, 0.5% chick em bryo  extract, 0.1% pen-strep) p rio r to transfection. 
O n ly  the  first an d  th e  second  passages w ere  u sed  for tran s ien t expression  
stud ies in th is report. The m yoblast popu la tion  is usua lly  g rea ter than  90% in 
th ese  p rim a ry  cells w hen  th is m eth o d  is fo llow ed acco rd ing  to  Blau and  
W ebster (1981).
2. 2. 3 T ransfec tion  an d  Enzym atic A ssays
A pprox im ately  2-3 x 105 cells w ere  p la ted  in each w ell (35 m m  6-well 
plate) for o n e  o r tw o days until they reached 70-85% confluency. Cells w ere 
g iv en  a sing le  feed ing  w ith  DM EM  p lu s  10% FCS just fou r h o u rs  before 
transfection. D N A  p lasm ids w ere  am plified  in the E. coli HB101 host strain , 
an d  pu rified  e ither by tw o ro u n d s of cesium  ch lo ride  d ensity  cen trifugation  
(Fordis a n d  H o w ard , 1987) o r by ch ro m atog raphy  u sing  Q iagen ’s Maxi kit. 
Superco iled  D N A  p lasm id s w ere  ad d ed  to the  cells in a calcium  p h o sp h a te  
p recip ita te  (Fordis and  H ow ard , 1987). For each 35 m m  well, CAT constructs (5 
pg ) a n d  pSV -p-gal (1 pg) w ere  co tran sfec ted  w ith  th e  m yogen ic  cDNA 
expression  vector (5 pg) or pEMSV, respectively. P lasm id pEMSV substitu tes 
for the  m yogenic cD N A  expression  vectors such tha t the am o u n t of D N A  in 
each transfection is norm alized. The pSV-p-gal p lasm ids w ere cotransfected in 
each transfection to  control for transfection efficiency. P lasm id  pSV2CAT w as 
u sed  as the  positive  control p lasm id  for CA T activity . A fter rem oval o f the 
calcium  p h o sp h a te  p rec ip ita te  6-7 hours post-transfection , cells w ere  w ashed
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once w ith  PBS, glycerol-shocked for 2 m in w ith  10% glycerol in HBS (HEPES- 
buffered saline; 280 mM NaCl, 50 mM  HEPES acid, 1.5 mM N a2HPC>4), and 
refed w ith  fresh DMEM plus 10% FCS. To induce differentiation in transfected 
cells, they w ere  sw itched to  DMEM plus 2% HS after glycerol shock, for tin 
additional three to four days.
Cells w ere harvested  an d  lysates w ere  p rep a red  by th ree  cycles of 
freezing and  thaw ing (Fordis and  H ow ard , 1987). Briefly, cells w ere  rinsed 
tw ice w ith  cold PBS, and  then detached  by  the addition  of TEN solution (40 
m M  Tris-HCl pH  7.5, 1 mM EDTA pH  8.0, 150 mM  NaCl; 0.5 ml per well). 
Cells w ere transferred into Eppendorf tubes, pelleted at 14,000 rpm  for 1 m in at 
4°C, and resuspended  in 100 pi of 0.25 M Tris-HCl (pH  7.5). Cells w ere then 
p u t th rough  th ree free ze /th a w  cycles in w hich they w ere frozen in a d ry  
ice /e th an o l bath  for 3 m in, and  thaw ed in the 37°C w ater bath  for another 3 
min. Cell lysates were collected by a 5 m in centrifugation (14,000 rpm ) at 4°C.
A proportion of the cell lysates (10 to 30 pi) from each sam ple w as taken 
for the ^-galactosidase assay, w hile the  rest of the lysates w ere heat-treated for 
15 m in at 65°C for the CAT assay, ^-gal activities w ere m easured according to 
the  supplier's recom m endations (Promega). A 300 pi reaction contained 150 pi 
of lysate d ilu ted  w ith distilled deionized w ater and 150 pi of 2x buffer (200 mM 
sodium  phosphate  pH  7.3, 2 mM  M g C h ,100 mM p-m ercaptoethanol, and  1.33 
m g /m l ONPG). Reaction m ixtures w ere incubated at 37°C until a yellow  color 
w as present (6 hours to overnight), and the reaction was term inated w ith the 
addition  of 500 pi of 1 M Na;>C0 3 . Absorbency at 420 nm  w as determ ined w ith 
a Gilford spectrophotom eter.
Lysate volum es contain ing  equ ivalen t un its o f p-gal activ ity  w ere 
assayed for CAT activity  by the kinetic diffusion m ethod  (N eum ann et at., 
1987). The CAT reaction w as perform ed in a 17 ml scintillation vial. The lysate
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w as ad justed  to 50 pi w ith  100 m M  Tris-HCl (pH  7.8), an d  m ixed w ith  200 pi of 
1.25 m M  chloram phenicol solution. The reaction w as in itiated  by ad d in g  5 pi of 
[,4C]- bu ty ry l coenzym e A. T hree m l of scintillation so lu tion  (Econofluor-2, Du 
Pont) w ere  gently  ad d ed  to  the  top  of the CA T assay  m ixture. The counts per 
m inu te  (cpm) of each reaction w as counted  d u rin g  a 10 m in  interval in a liquid  
scin tilla tion  spectrom eter (LS60001C, Beckman). The slope  o f the  linear CAT 
reaction  w as p resen ted  as the  CAT activity . The re la tive  CAT activ ity  w as 
p resen ted  as a percen tage of the expression level o f pSV2CAT. A lternatively , 
the fold changed  in CAT activ ity  by  cotransfection w ith  th e  m yogenic cDNA 
ex p ress io n  p la sm id s  w as re la tiv e  to  th e  basal CA T activ ity  o f th a t CAT 
construct in cotransfection w ith  the control p lasm id  pEMSV.
2. 2. 4 P repara tion  o f G lu ta th io n e  S -transferase  (GST) F usion  P ro te ins
GST a n d  G ST-M yoD  fu s io n s  w e re  p u r if ie d  a c c o rd in g  to  th e  
m a n u fa c tu re r 's  rec o m m e n d a tio n  (D av is et al., 1987). E. coli HB101 cells 
tran sfo rm ed  w ith  GST expression  vectors w ere  g row n  at 37°C in 400 m l LB 
w ith  am picilline at a final concentration of 100 p g /m l. IPTG stock solution w as 
ad d ed  to  the cu ltu re  to a final concentration of 0.1 m M  w hen  the OD^oo reached 
0.4-0.5. C u ltu res w ere  incubated for an add itional 3-4 hours p rio r to harvesting 
b y  cen trifugation  (5000 rpm , 20 m in) w ith  Sorvall GSA rotor. Cell pellets w ere 
re su sp e n d ed  in buffer A (50 m M  Tris p H  8.0, 25% sucrose, 10 m M  EDTA). 
C ells w ere  then  incubated  on ice for 1 h o u r w ith  lysozym e (2 m l, 20 m g /m l 
stock  in bu ffer A), an d  pe lle ted  a t 8000 rpm  for 10 m in. Cell pellets w ere 
re su sp en d ed  in 10 m l of buffer B (10 m M  Tris p H  7.4, 1 m M  EDTA, 1 mM  
PMSF, 1 m M  DTT, 1 g g /m l of leupeptin , 1 M g/ml of pepstatin) w ith an  addition  
o f 0.4 m l ap ro tin in  solution (5 m g /m l in buffer C). Cells w ere  com pletely lysed 
b y  freezing an d  thaw ing at least twice. The com pletion of lysis w as determ ined
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m icroscopically  (430X). Tw o volum es of buffer C (20 m M  HEPES p H  7.6, 100 
m M  KC1, 0.2 m M  EDTA, 20% glycerol, 1 m M  PMSF, 1 m M  DTT, 1 p g /m l  of 
each  leupep tin  an d  pepstatin ) w as then  ad d ed , fo llow ed by an  add ition  of 1 /3  
vo lum e o f 10% T riton  X-100. Four m l of reduced  g lu ta th ione-agarose  (1:1 in 
bu ffe r C) w as a d d e d , an d  th e  lysa te  m ix tu res w ere  incubated  w ith  gen tle  
rocking for an  add itional 1-2 hours at 4°C. The g lu ta th ione  agarose beads w ere 
th en  pelleted  (2000 rpm , 1-2 m in) in  a  clinical centrifuge, an d  batch-w ashed five 
tim es w ith  20 volum es of buffer C. P roteins w ere e lu ted  from  beads w ith  5 mM 
red u c ed  g lu ta th io n e  (in buffer C). The p ro te in  peaks w ere  d e te rm in ed  at 
O D 28O/ an d the  collected fractions w ere a liquo ted , quick-frozen, and  sto red  at 
-80°C. The concentration of the  purified  pro teins w as determ ined  by  using  Bio- 
R ad 's reagen t, fo llow ing the  m odified  m ethod  of B radford (1976). Finally, the 
pu rity  o f the  purified  pro teins w as clarified on a 10% SDS-PAGE gel.
2 .2 . 5 P repara tion  o f N uclear Extracts
N u c lea r ex trac ts  w ere  p rep a red  based  on  the  m od ified  m eth o d  of 
D ignam  et al. (1983) and  Li an d  Paulin  (1993). Fifteen flasks (125 cm 3 each) of 
cu ltu red  cells w ere  harvested  after tw o rounds o f cold PBS w ashes. Cells w ere 
sc ra p p e d  off in  co ld  PBS, poo led  in to  tw o  50 ml cen trifu g e  tubes , and  
cen trifuged  for 2 m in at 2200 rp m  in a clinical centrifuge. All subsequent steps 
w ere  perfo rm ed  on ice. Cell pellets w ere  resuspended  by gentle  p ipetting  in 5 
m l of buffer A  (10 m M  HEPES p H  8.0, 50 m M  N aCl, 0.5 M sucrose, 1 m M  
EDTA, 0.5 m M  sperm id ine, 0.15 m M  sperm ine, 0.1% N onidet). Cells w ere  then 
tran sfe rred  to a g lass D ounee hom ogenizer (type A pestle), an d  hom ogenized  
w ith  10 strokes. Lysis w as checked m icroscopically until it exceeded 95%. The 
h om ogena te  w as centrifuged  for 10 m in  at 1500 rpm  in  a clinical centrifuge. 
The nuclear pellets w ere resuspended  by  gen tle  shak ing  w ith 5 m l of buffer B
59
(10 m M  HEPES p H  8.0, 50 m M  N aC l, 25% glycerol, 0.1 m M  EDTA, 0.5 mM  
sperm id ine, 0.15 m M  sperm ine, 2 m M  benzam id ine, 1 m M  PMSF, 1 m M  DTT, 
an d  p ro tease  inhib itors of pepstatin , leupeptin , ap ro tin in , an tipa in , chym ostatin  
at 50 p g /m l each). The c rude  nuclei w ere  collected by cen trifugation  for 10 m in 
a t 1500 rpm , an d  incubated  w ith  2 m l o f extraction buffer (10 m M  HEPES p H  
8.0, 400 m M  N aCl, 25% glycerol, 0.1 m M  EDTA, 0.5 m M  sperm id ine, 0.15 mM  
sperm ine, 1 m M  DTT, 2 m M  benzam idine, 1 m M  PMSF, a n d  p ro tease  inhibitors 
o f p ep s ta tin , leu p ep tin , ap ro tin in , an tip a in , chym osta tin  at 50 p g /m l  each). 
N uclear p ro teins w ere extracted for one  ho u r at 4°C w ith  gen tle  shak ing  on a 
ro ta to r, fo llow ed  by cen trifuga tion  for 30 m in  in the e p p e n d o rf  cen trifuge  
(14,000 rpm ) to rem ove the  cell debris. The su p e rn a ta n t from  this s tep  w as 
d ia lyzed  for 5 h ou rs at 4°C w ith  1 L of dialysis buffer (20 m M  HEPES p H  8.0, 50 
m M  KC1, 20% glycerol, 0.2 m M  EDTA, 1 m M  DTT, 1 m M  PM SF, 2 m M  
b e n z a m id in e ) . T he n u c le a r  e x tra c ts  w ere  c la rif ied  a fte r  d ia ly s is  by 
cen trifu g a tio n  again  in  the e p p e n d o rf  con trifuge  (10 m in , 14,000 rpm ) to 
rem ove the  precipitate. The extracts w ere  a liquoted , quick-frozen  in a d ry  ice 
ba th , and  sto red  at -80°C. Protein concentration w as de te rm ined  as p reviously  
m entioned. This p rocedure  yields about 7-10 m g of proteins.
2.2. 6 [32P] End-labeling of DNA Probes
D N A  probes used  for electrophoretic  m obility  shift assay  (EMSA) and 
D N asel foo tp rin ting  experim ents, and  for M axam -G ilbert sequencing  (M axam 
an d  G ilbert, 1980) w ere 32P end-labeled . For the  EMSA experim ents, d igested  
D N A  frag m e n ts  w ith  3 ’-recessed  e n d s  w e re  K len o w -lab e led  w ith  the  
inco rpo ra tion  of [a -32P]-dCTP o r [a -32P]-dATP. In the case of D N A  probes 
genera ted  by  PCR, both the u p p e r an d  low er p rim ers w ere  5 ’ end-labeled  w ith 
[•y_32p]_ATP by T4 polynucleotide kinase reaction. The labeled oligonucleotides
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w ere  th en  sep a ra ted  from  the free  nuc leo tides by th e  S ephadex  G50 sp in  
co lum n procedure, an d  directly used  for the PCR reaction.
For th e  D N asel fo o tp rin tin g  a n d  th e  M axam -G ilbert reaction , PCR 
fragm ents an d  th e  d igested  DN A fragm ents w ere  singly 32P end-labeled. DNA 
p lasm ids w ere  d igested  w ith  the  first endonuclease  that genera ted  3-recessed  
ends, and  the [a-32P]-dCTP o r [a -32P]-dATP w as inco rpora ted  in to  the 3' ends 
b y  K lenow  reaction . This singly-cut fragm ent w as fu rth e r  d igested  w ith  a 
second endonuclease  to rem ove one  side of the end-label, thus leaving on ly  one 
s tra n d  labe led  a t once. A lternative ly , if th e  second  en zy m e  g en era te s  5'- 
recessed ends, the  D N A  p lasm ids w ere d igested  w ith  bo th  endonucleases, and  
w e re  K lenow -labeled  d irec tly . T he d igests  w ere  e lec tro p h o resed  on  a 6% 
n o n d e n a tu rin g  po lyacry lm ide  gel (0.5 x TBE, 90 volts). The gel w as e ither 
sta ined  w ith  e th id iu m  b ro m id e  o r subjected to  au to rad io g rap h y  to locate the 
d esired  D N A  bands. The excised gel slabs w ere  crushed  w ith  a m icropippet 
tip , a n d  soaked  in 500 p i  o f 1 M N aC l (in TE) o v e rn ig h t a t 37°C. The 
su p e rn a ta n t w as collected an d  ethano l-p recip ita ted . The p rep a ra tio n  of PCR 
probes for the foo tprin ting  and  sequencing reaction is sim ilar to that for EMSA, 
except that there  w as only  one  end-labeled p rim er in the  PCR reaction.
2. 2. 7 Electrophoretic Mobility Shift Assay (EMSA)
EMSA w as perfo rm ed  in a 20-pl reaction consisting of 20 m M  Tris-HCl 
(pH  7.9), 2 m M  M gCl2, 50 m M  NaCl, 1 m M  EDTA, 10% glycerol, 0.1% N onidet 
P40, 1 m M  DTT, 50 p g /m l  BSA, lO ^lO 5 cpm  of p robe (0.5-1.0 ng), 0.5-1.0 pg of 
po ly  (d l-dC ) o r sa lm on sperm  DN A, an d  d ifferen t a m o u n ts  of the  nuclear 
ex tract o r pu rified  GST pro teins (G arabedian et al., 1992). The p ro te ins w ere 
incubated  w ith  D N A  carrier at room  tem pera tu re  for 10 m in before the  labeled 
D N A  probe w as added . T he b ind ing  reactions w ere ex tended  for additional 20-
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30 m in , an d  im m edia te ly  loaded  on a  p re-e lec tropho resed  (1-2 hr) 6% n o n ­
d en a tu rin g  po lyacry lm ide gel (200 volts). The ru n n in g  buffer w as recirculated  
w ith  a  p u m p  to m ain tain  an  even  p H  grad ien t. For com petition  stud ies, excess 
am o u n ts  o f un labeled  DN A fragm ents o r  th e  m uscle  creatine  k inase (MCK) 
enhancer (upper s trand , 5'-GATCCCCCCAACACCTGCTGCCTGA-3'. w here  E- 
box is u n d erlined ) w ere  ad d ed  p rio r to  add ition  of labeled probes. For no n ­
specific com petition , o ligo  AT (a gift from  Dr. Sue B artlett in the  D ept, of 
Biochem istry, L ouisiana S tate U niversity) w as ad d ed  instead  (u p p er strand , 5’- 
G  ACCTTTT A T n T T T T A T  A A A AAA AG A ATTG A A AG-3’). G els w ere  d ried  
and  subjected to  autoradiography.
2. 2. 8 DNasel Footprinting
Footprin ting  experim ents w ere based  on  the  m ethod  of G arabedian  et al. 
(1992). Fifty pi of the  p ro te in  m ix ture  contained  nuclear extracts (30-60 pg) o r 
GST fusions (5-10 pg) in a b ind ing  buffer (20 m M  Tris-H Cl (pH  7.9), 2 mM  
M gC l2, 50 m M  NaCl, 1 m M  EDTA, 10% glycerol, 0.1% N on ide t P40, an d  1 m M  
DTT). A no ther 50 p i of DN A m ix tu re  con ta in ing  sing ly  end -labe led  DN A 
probe  (20-50 kcpm ) and  poly  (dl-dC ) (0.5-1 pg) in lxTE buffer w as com bined 
w ith  the  p ro te in  m ix tu re  an d  incubated  a t room  tem p era tu re  for 20-30 m in. 
D N asel d ig estio n  w as carried  o u t b y  a d d in g  10 p i of th e  d ilu te d  D N asel 
so lu tio n  (2 m g /m l stock in b in d in g  buffer) for exac tly  1 m in  at room  
tem p era tu re  after the  add ition  of 10 pi of salt m ix ture  (100 m M  M gCl2, 5 m M  
C aC h) for 1 m in. Tw o h u n d red  pi of the D N asel stop  so lu tion  (0.2 M  N aC l, 40 
m M  EDTA, 1% SDS, 125 p g /m l tRNA, 100 p g /m l p ro teinase  K) w ere ad d ed  to 
each  tube  for 30 m in  at 37°C. The d ig es ted  p robes w ere  ex trac ted  w ith  
ph en o l/ch lo ro fo rm  and precip ita ted  w ith  ethanol. The D N A  w as d issolved in 
10 p i fo rm am id e -lo ad in g  d y e  (95% fo rm am id e , 4% EDTA pH  8.0, 0.1%
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B rom ophenol Blue, 0.1% xylene cyanol). Equal am oun ts o f rad ioactiv ity  
(determ ined by  Cerenkov counter o r liquid scintillation counter) w ere loaded 
on to  a 6% sequencing gel. The gel was d ried  and subjected to autoradiography.
M axam -G ilbert sequencing  w as u sed  to  g en era te  D N A  lad d e r for 
sequence m arker (M axam and Gilbert, 1980). For the G+A reaction, 10 pi of the 
labeled p robe w ere m ixed w ith  25 pi of form ic acid and  incubated  at room  
tem peratu re  for 10 m in. The reaction w as stopped  by  addition  of 200 pi DMS 
stop  solution (1.5 M NaOAc, 1 M f5-mercaptoethanol, and 100 p g /m l tRNA; pH  
7.0). DNA probes w ere precipitated w ith 750 pi of e thanol for 30 m in in a dry 
ice /e th an o l bath , and  w ere centrifuged for 20 m in a t 14,000 rpm  at 4°C. The 
D N A  pelle ts  w ere resu sp en d ed  in 250 pi of 0.3 M N aO A c (pH  5.2), and  
p rec ip ita te d  again  w ith  750 p i of e thano l for an o th e r 15 m in. A fter 
cen trifugation  for 10 m in, the DNA pellets w ere  w ashed  w ith  ethanol and  
Speed vac d ried  com pletely. O ne h u n d red  p i of 1 M p ip erid in e  (freshly 
prepared , 1:10 d ilu ted w ith distilled dionized water) w ere added  to each DNA 
sam ple. The cleavage reaction w as carried o u t in a 90°C heat-block in tubes 
that w ere sealed w ith tw o layers of Telfon tape to elim inate volum e reduction. 
The DNA w as precipitated w ith 2.5 volum es of ethanol in the presence of 1 /10  
volum e of 3 M N aO A c for 20 m inutes before centrifugation. The DNA pellets 
w ere  w ashed  tw ice w ith 90% ethanol, an d  the  rem ain ing  p ip erid in e  w as 
rem oved  com plete ly  by Speed vac-drying  th e  pellets for at least 1 hour. 
Loading dye  (10-15 pi) w as ad d ed  to resu spend  the DNA. As m entioned 
before, equal am ounts of radioactivity w ere loaded on the sequencing gel.
CHAPTER 3 
RESULTS AND DISCUSSION
3.1 Transactivation of the RM-PFK Gene by 
the Myogenic bHLH Factors
To u n d e rs ta n d  the m olecu lar m echan ism  for the tran scrip tio n a l 
control of the  RM-PFK gene, I chose to  investigate the  possib ility  that the 
RM-PFK gen e  is reg u la ted  by  the  m yogen ic  bH L H  factors. T hus, I 
constructed  a CAT plasm id, pB3.0, in w hich the CAT coding sequence w as 
linked at the  dow nstream  end of the 3 kb 5’-flanking region of the  RM-PFK 
gene (Fig. 2-1). For transien t transfection studies, pB3.0 w as cotransfected 
w ith three different m yogenic cDNA expression vectors in to  different types 
o f tissue cu ltu re  cells.
T ransfection  s tu d ies  of pB3.0 w ere first carried  o u t in  th e  m ouse 
C2C12 cell line for tw o reasons. First, C2C12 m yoblasts can  u n d erg o  
differentiation  from the proliferating stage to m yotubes under conditions of 
serum  depletion . Thus, the CAT activity  of the PFK-CAT chim era in the 
transfected  cells can be m easured  and  com pared  betw een  these  tw o cell 
stages. Second, C2C12 is a stable m uscle cell line th a t allow s the  m uscle- 
specific p ro m o te r to  be ac tiva ted  and  the  m yogenic bH L H  p ro te in s  to 
function in a norm al cellular context.
A s show n  in F igure 3-1, co transfec tion  w ith  M yoD sign ifican tly  
e n h an c ed  th e  CAT ac tiv ity  o f pB3.0 in C2C12 m y o b lasts , and  th is  
s tim u la tion  w as even  g rea te r in m yotubes. The CAT activ ity  of pB3.0 
w ith o u t M yoD  cotransfect ion show ed  very  little  d ifference betw een  the 
m yoblast and  the m yotube stages (Fig. 3-1). W hen tested in C2C12
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Fig. 3-1. CAT activ ity  rep resen ta tio n  of pB3.0 in C2C12. The cpm  of the 
[1'*C]-butyryl ch loram phenico l (p roduct of the  CAT reaction) w as m easured  
as a tim e course, an d  the  slope of each reaction  rep resen ts  th e  C A T activ ity  
level o f th a t reaction . L ysate  vo lum es co n ta in in g  0.2 u n its  o f the  [3-gal 
activ ity  w ere  used  in th is s tudy . P lasm id pB3.0 w as transfected  in to  C2C12 
w ith  (+) o r w ith o u t (-) M yoD cotransfection. T ransfected  cells w ere  e ith er 
m ain ta ined  as m yoblast (MB) o r induced  to be m yotubes (MT).
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m yoblasts, M yoD  transac tiva tion  of pB3.0 p e rs is ted  u p  to  five day s p o st­
transfection, a lthough  it decreased  slightly  (Fig. 3-2).
T he forced  expression  of the  exogenous m yogenic p ro te in s can induce 
exp ress io n  of th e  e n d o g en o u s p ro te in s  (D avis et al., 1987). T herefore, cell 
lysa tes w ere  p rep a red  from  th e  transfec ted  cells an d  the  CAT assays w ere 
p e rfo rm e d  tw o  to  th ree  day s p o st-tran sfec tio n , w h ile  th e  ch an g e  in the  
e n d o g e n o u s  m y o g en ic  p ro te in s  w as s till m in im a l. To o p tim iz e  th e  
co n d itio n s  for co transfec tion , d iffe ren t a m o u n ts  o f th e  M yoD  exp ression  
p lasm id  pEM SV -M yoD  w ere tested  for th e ir ab ilities to  tran sac tiv a te  the 
CAT expression  of pB3.0. As show n in Figure 3-3, increasing pEM SV-M yoD 
from  0 to  5 p g /w e ll  (35 m m ) increased the CAT activ ity  of pB3.0 abou t seven 
fold. A fu rth e r increase  in th e  am o u n t o f pEM SV -M yoD to  10 p g / w e l l  
re su lte d  in no  ad d itio n a l increase in tran sac tiva tion  activ ity . T herefore , 5 
p g /w e ll  a p p ea red  to be  sufficient to  com plete  activa tion  of th e  C A T gene, 
an d  th is level w as u sed  in subsequen t co transfection  studies.
A sim ila r transfec tion  experim en t w as co n d u c ted  in  p rim a ry  rabb it 
skeletal m uscle m yoblasts. As w as seen w ith  C2C12 cells, the  CA T activ ity  of 
pB3.0 w as enhanced  by increasing  the  am o u n ts  of pEM SV-M yoD (Fig. 3-4). 
A t 5 p g /w e ll ,  M yoD  exh ib ited  six fold stim u la tion  of th e  CA T activ ity  of 
pB3.0. W hen  th ese  co tran sfec tio n  s tu d ie s  w e re  c o n d u c ted  in  N IH 3T3 
fibrob last cells, M yoD stim u la ted  the CAT activ ity  of pB3.0 to tw o  fold (Fig. 
3-5). T hese resu lts p ro v id e  the  first ind ication  tha t th e  p ro m o te r of the  RM- 
PFK gene is transac tivated  by M yoD  in vivo. T hat pB3.0 expression  in C2C12 
cells m im ics its  exp ression  in th e  rab b it p rim a ry  cells a lso  su g g ests  th a t 
C2C12 is a su itab le  system  in w hich to s tu d y  the m echanism  for the  m uscle- 
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Fig. 3-2. C o m p ariso n  o f the  pB3.0 CAT activ ities a t d iffe ren t day s post 
tran sfec tio n . C2C12 m y o b lasts  w ere  co tran sfec ted  w ith  pEM SV -M yoD  
(+M yoD) o r w ith  pEMSV (-M yoD). Lysates w ere  p rep a red  three, four, and  
five day s after transfection. Lysate volum es w ith  0.2 u n its  of (3-gal activ ity  
w ere  analyzed  for CAT activity. The m ean  from  tw o  separa te  experim ents is 
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Fig. 3-3. C oncentration effect of pEMSV-MyoD on stim ulation of pB3.0 CAT 
activ ity  in C2C12. P lasm id  pB3.0 w as cotransfected  w ith  pEM SV-M yoD 
(+MyoD) at 1, 5, and  10 pg  (per well). Lysate volum es w ith 0.5 un its of fi-gal 
activity w ere analyzed for the CAT activity. The relative CAT activity  over 
the  basal level of CAT expression in cotransfection w ith  control pEMSV (- 
M yoD) is p resen ted  at the right side of each colum n. The m ean  from two 
separa te  experim ents is show n.
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Fig. 3-4. C oncen tra tion  effect of pEM SV-M yoD on  stim ula tion  of pB3.0 CAT 
activ ity  in p rim ary  m yoblasts. P lasm id  pB3.0 w as transfected  in to  p rim ary  
rab b it sk e le ta l m usc le  m yob lasts  w ith  c o tran sfec tio n  o f pEM SV -M yoD  
(+M yoD) at 1, 5, and  10 pg  (per well). Lysate volum es con tain ing  0.5 un its  of 
(3-gal activ ity  w ere  analyzed  for the CA T activity. The re la tive  CA T activity  
o v e r th e  b asa l level o f CA T ex p ress io n  in  co tran sfec tio n  w ith  con tro l 
pEM SV (-M yoD) is p resen ted  at th e  r ig h t side  of each colum n. The m ean 
from  tw o  separa te  experim ents is show n.
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Fig. 3-5. C om parison  of the CAT activities of pB3.0 in 3T3 an d  C2C12 cells. 
P la sm id  pB3.0 w as co tran sfec ted  w ith  pEM SV -M yoD  (+M yoD ) o r w ith  
pEMSV (-M yoD). Lysate volum es contain ing  0.5 un its  o f fi-gal activ ity  w ere  
a n a ly ze d  for CAT activ ity . T he respec tive  v a lu e  o f th e  C A T activ ity  is 
exp ressed  as a  percen tage  of th e  activity level of pSV2CAT in  each  cell line. 
The m ean  ±  SE values from  th ree  experim ents are  show n.
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A long  w ith  M yoD , tw o  o th er m yogenic  bH L H  p ro te in s, m yogen in  
an d  M yf5, w ere tested  for their transactivation  activ ities in C2C12 cells. As 
sh o w n  in F igu re  3-6, co transfec tion  w ith  th e  cD N A  expression  vectors of 
M yoD , M yf5, a n d  m yogen in  increased  the  CAT activ ity  o f pB3.0 to 10, 5.5, 
and  2.1 fold, respectively . These d a ta  ind ica ted  th a t M yoD  h ad  the  h ighest 
tra n s a c tiv a tio n  a c tiv ity  a m o n g  th ese  th re e  m y o g en ic  fac to rs . M yf5 
s tim u la te d  the  PFK p ro m o te r to a b o u t 55% of th e  level o f M yoD , w hile  
m yogen in  w as on ly  ab o u t 21% as efficient as M yoD. In ad d itio n , M yoDAB, 
in  w hich the basic D N A -binding  region o f the  M yoD  has been dele ted  (Davis 
et al., 1987), failed to stim ulate  the CAT activity of pB3.0 (Fig. 3-6). M yoD  A N , 
in w hich  the  N -term inal tran sac tiva tion  dom ain  has been  rem oved  (D avis 
et al., 1987), d id  not exhibit any transactivation  effect (Fig. 3-6).
A  s im ila r d iffe re n tia l tra n sa c tiv a tio n  p a tte rn  o f pB3.0 by  th ese  
m yogen ic  p ro te in s w as a lso  observed  in th e  p rim ary  m yob lasts  (Fig. 3-7). 
C o tran sfec tio n  w ith  th e  cD N A  ex p ress io n  v ec to rs  o f M yoD , M yf5, an d  
m yogen in  resu lted  in  an  increase in the  CAT activ ity  of pB3.0 to  6, 3.1, and
1.1 fo ld , respective ly . T hus, M yoD  an d  M yf5 effic ien tly  s tim u la te d  the 
p ro m o te r activ ity  of pB3.0. M yogenin , on  the  o th er h an d , h a d  very  little 
tra n sac tiv a tio n  effect u n d e r  th is cond ition . T aken to g e th er, these  th ree  
m yogenic  bH L H  p ro te in s  exh ib ited  d ifferen tia l tran sac tiv a tio n  capab ilities 
on  th e  RM-PFK prom oter(s) in C2C12 an d  in the p rim ary  cells.
T he CA T activ ity  of pB3.0 w as d e p en d e n t o n  the  am oun t of the M yoD 
cD N A  ex p re ss io n  vecto r u sed  in a p a rtic u la r  co tran sfec tio n  ex p e rim en t 
(Figs. 3-3 & 3-4); thus, the  d ifferen tia l tran sac tiv a tio n  ac tiv itie s  of these  
m yogenic  factors could  be d u e  to their d ifferen t expression  levels. In fact, 
M yoD  m R N A s a re  exp ressed  constitu tive ly  at a low  level in p ro life ra tin g  








Fig. 3-6. D ifferential transac tivation  of pB3.0 CA T expression  in  C2C12 by 
the  m yogenic  bH L H  factors. For each of th e  cDNA expression  p lasm id s of 
M yoD , M yoD A B, M yoD A N , m yogenin , and  Myf-5, 5 jig  of p lasm id s w ere 
co transfec ted  w ith  pB3.0. M yoD AB is a M yoD  m u tan t w ith  de le tion  of the 
basic  reg ion , w hereas M yoD A N  is th e  M yoD m u tan t w ith  dele tion  of the N- 
term ina l tran scrip tio n a l activation  do m ain . L ysate  vo lum es w ith  0.5 un its  
of f}-gal activ ity  w ere  analyzed  for CAT activities. The relative CA T activity  
o v e r th e  b asa l level of C A T ex p ress io n  in co tran sfec tio n  w ith  con tro l 
pEM SV (+EMSV) is p re se n te d  a t th e  r ig h t s id e  o f each  co lum n . The 
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Fig. 3-7. D ifferen tia l tran sac tiv a tio n  o f pB3,0 CAT expression  in  p rim ary  
m yoblasts by the m yogenic bH L H  pro teins. T ransfection experim en ts here 
a re  iden tica l w ith  those  in F igure 3-5 except that the  rabb it m uscle p rim ary  
m yoblasts w ere  used  in stead  of C2C12. T be re la tive  CA T activ ity  over the 
b a sa l level o f C A T e x p re ss io n  in  co tran sfec tio n  w ith  c o n tro l pHMSV 
(+EMSV) is p resen ted  at the righ t side  of each colum n. The m ean from  tw o 
sep ara te  experim en ts is show n.
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m y o tu b es. By con trast, m yogen in  is n o t ex p re ssed  in C2C12 cells un til 
m y o b la s ts  e n te r  th e  d if fe re n tia tio n  p a th w a y  in  re s p o n se  to  m ito g en  
w ith d ra w a l. M yf5, o n  th e  o th e r  h a n d , is e x p re ssed  a t a m u ch  low er 
ab u n d an ce  com pared  to  M yoD, an d  its  expression  does n o t increase  d u rin g  
d iffe ren tia tio n  (B raun et al., 1989b). T herefore , d iffe ren tia l tran sac tiva tion  
effects o f these bH L H  pro te in s o n  pB3.0 m ay sim ply  be  co rre la ted  w ith  their 
concen tra tions. It is u n k n o w n  w h e th er these  th ree  m yogenic  bH L H  genes 
a re  active  in the  rabb it skeletal p rim ary  cells, b u t they  a re  all exp ressed  to 
sim ilar ex ten ts in h u m an  p rim ary  m yoblasts (B raun et al., 1989b).
H o w ev e r, th e  e n d o g e n o u s  levels o f th ese  e n d o g e n o u s  m yogen ic  
factors a re  neg lig ib le  w h en  excess am oun ts o f th e  exogenous c o u n te rp a rts  
are expressed  in the transfected  cells. T herefore, w hen  equal am oun ts of the 
cD N A  e x p re ss io n  v e c to rs  w e re  c o tra n s fe c te d  in to  C 2C 12 cells, th e  
co n cen tra tio n s  of M yoD , M yf5, a n d  m y o g en in  sh o u ld  be  sim ilar. As a 
resu lt, it is un like ly  th a t the  d ifferen tial tran sac tiva tion  of these  p ro te in s is 
p rim arily  de te rm in ed  by  their endogenous d ifferen tial expression  levels.
The observations h ere  suggest th a t th e  tran sac tiva tion  abilities of the 
m yogenic bH L H  pro teins are  no t identical. This notion  is su p p o rte d  by the 
p rev io u s  observations th a t m yogen in  and  MRF4 d ifferen tia lly  ac tiva ted  the 
tra n sc r ip tio n  o f the  m usc le  c rea tin e  k inase  (M CK) g en e  from  th e  MCK 
enhancer, w hereas M yoD and  Myf5 failed to d o  so (C hakraborty  et al., 1991; 
Y u tz ey  et al., 1990). T his MCK en h an cer co n ta in s  a functional CACCTG 
sequence, an d  it w as used  in the  later experim ents as a com petito r for M yoD 
b in d in g  s tu d ie s . M o reo v er, tran sg en ic  s tu d ie s  o f th e  m y o g en in  a lso  
revea led  tha t m yogen in  o n ly  transac tiva ted  som e -- no t all -- o f th e  m uscle 
g en e  ex p ress io n  (H asty  et al., 1993; N abesh im a  et al., 1993). It is now  d e a r  
th a t M yoD  a n d  M yf5 d e te rm in e  m yoblast conversion  from  m yogen ic  stem
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cells, and  activate m yoblast-specific gene expression (Olson an d  Klein, 1994). 
M yogenin , on  the o th e r h an d , m ain ta in s  te rm ina l d iffe ren tia tio n  and  
activates th e  m yotube-specific  gene  expression  (O lson and  Klein, 1994). 
Therefore, resu lts o f this study  agree that the m yogenic bH LH  proteins have 
d ifferential transactivation  activities.
F u rth e rm o re , th ese  m yogen ic  fac to rs reco g n ize  th e  co n sen su s 
C A N N T G  seq u en ce  w ith  s im ila r sp ec ific itie s  a n d  lim ite d  sequence  
p reference, th u s it is a lso  un like ly  tha t th e ir d ifferen tia l transac tivation  
activ ities a re  sim ply  d u e  to th e ir d ivergen t D N A -binding  abilities. It is 
believed tha t the  differences of their transactivation  abilities are  relative to 
th e ir  ab ilities to  in te rac t w ith  o th er tran scrip tio n  factors. The un iq u e  
functional dom ains o f these bH LH  proteins lie near their N- or C -term inus 
w here  they share  very  little sequence hom ology (C hakraborty  and  O lson, 
1991; Olson and  Klein, 1994).
The d iv erse  functions of these m yogenic reg u la to rs  m ay be also 
re la ted  to  th e ir tem poral and  com partm ental expression  pa ttern s. W hile 
m yogenin  m RN A s accum ulate preferentially  in slow -tw itch m uscle, M yoD 
mRNAs are enriched in fast-tw itch m uscles (H ughes et al., 1993). M yoD and 
M yf5 a re  e x p re sse d  e a r lie r  th a n  m y o g e n in  d u r in g  d e v e lo p m e n t 
(Buckingham , 1992). These observations im ply that the m yogenic regulators 
m ay control the expression of different subsets of the m uscle genes. Since 
M yoD is expressed preferentially  in slow m uscle, it w ill be in teresting  to see 
if th e  RM-PFK gene is m ore activated in slow  m uscle than  in fast muscle.
T ransactivation activities of the  m yogenic bH LH  pro teins have been 
p rev iously  show n to  be d ep en d en t on their b ind ing  as he terod im ers w ith 
the  ubiqu itous proteins El 2 o r E47 to a conserved DNA sequence referred to 
as an E-box (CANNTG) (M urre et al., 1989a, 1989b). C ooperative interactions
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am ong  E-box an d  b in d in g  sites of o th er m usc le -sped fic  a n d /o r  ub iqu itous 
factors w ere  show n  to  be requ ired  for m usc le-sped fic  tran scrip tion  (P iette  et 
al., 1990; Sartorelli et al., 1990; W ein traub  et al., 1990; W en tw orth  et al., 1991). 
C o n sis te n t w ith  th ese  f in d in g s , co transfec tion  w ith  pEM SV -M yoD A B or 
w ith  pEM SV -M yoD A N  failed to  transactivate the  expression  of pB3.0 (Fig. 3- 
6). pEM SV -M yoD A B expresses M yoD A B w hich  is devo id  of am in o  a d d  
res idues 102 to  135 w ith in  the basic reg ion  o f M yoD. pEM SV -M yoD A N , on 
the  o th e r  h an d , exp resses an o th e r tru n ca te d  M yoD  w ith  a d e le tio n  from  
res id u es  3 to  56 in th e  N -term inal tran scrip tio n  activa tion  dom ain . These 
resu lts  suggest tha t M yoD  is d irectly  invo lved  in en h an c in g  the activ ity  of 
the  RM-PFK prom oter.
T h e  tra n sa c tiv a tio n  ab ility  o f M yoD  w as also  ex am in e d  in  3T3 
fib rob lasts (Fig. 3-5). 3T3 fibroblasts lack endogenous m yogenic factors and 
th e ir en d o g en o u s M yoD  gene canno t be activated  by  the expression  o f the 
exogenous M yoD  p ro te in  (D avis et al., 1987). The tran sac tiva tion  e ffidency  
o f M yoD  w as m uch  low er in 3T3 fibroblasts than  in the  m uscle  cells (Figs. 3- 
5, 3-6, & 3-7). The low er sensitiv ity  of M yoD  function  observed  here  agrees 
w ith  the  reduced  ability  o f M yoD to  activate  m yogenesis an d  to transactivate  
th e  m uscle-spedfic  gene in 3T3 cells as observed by D avis et al., (1987).
T he C A T activ ities o f pB3.0 w ith o u t M yoD  co transfec tion  in C2C12 
m yob lasts  a n d  m yotubes show ed  no sign ifican t d ifference (Fig. 3-1). This 
m ay  be because a very  low  percen tage of the  cells fused  to form  m yotubes at 
th e  tim e of the  assay. If th e re  is a difference, a m yocyte cell line w o u ld  be 
be tter su ited  for detecting  it. In  add ition , it w ill be w orthw h ile  to  see if the 
RM-PFK gene  can be activated  by the fou rth  m em ber of th e  m yogenic bH LH  
p ro te in s , MRF4, w hich  h as  been  show n  to con tro l m yofiber-specific  gene
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expression  (see Fig. 1-5; M iner an d  W old, 1990; R hodes and  K onieczny, 1989; 
M ak etal., 1992).
T aken together, resu lts  p resen ted  h ere  suggest th a t the RM-PFK gene 
achieves its m uscle  specificity th rough  up -regu la tion  by  the m yogenic bH LH  
pro teins. M yoD , Myf5, an d  m yogenin  d ifferen tially  stim u la ted  transcrip tion  
o f th e  C A T re p o r te r  gen e  w h ich  is co n tro lled  by  th e  3 kb  5 '-flank ing  
sequence  of the  RM-PFK gene. T hus, th is 3 kb up stream  sequence contains 
b o th  th e  p ro m o te r(s) an d  the  reg u la to ry  e lem en ts w h ich  re sp o n d  to the 
stim u la tio n  of the  m yogenic regu lators.
3. 2 Delineation of the Positive and Negative Regulatory Elements 
within the RM-PFK 5*-Flanking Region
To identify  M yoD response  e lem ents w ith in  the 3 kb stretch  of the 5 - 
f lan k in g  sequence  of this PFK gene, v a rio u s de le tions w ere  m ad e  w ith in  
th is 3 kb region. T hese dele tion  constructs w ere  tested  for the ir p ro m o te r 
activ ities after being  in serted  upstream  of the CAT reporte r gene.
In terna l de le tion  constructs in w hich the 3 kb p ro m o ter sequence had  
been  p a rtia lly  d e le ted  w ere  g en era ted  by  p e rfo rm in g  Psf I d igestions. As 
show n  in F igure 3-8, there a re  fou r Pst I sites referred  to as Pst 1-1, Pst 1-2, Pst 
1-3, an d  Psf 1-4 in the 5' to  3' d irection . T hus, the  3 kb p ro m o te r sequence 
con ta in s th ree  Psf I /P s t  I fragm ents, includ ing  a 464-bp betw een  Psf 1-1 and  
Pst 1-2, a 1570-bp betw een Psf 1-2 an d  Psf 1-3, and  a 561-bp betw een Psf 1-3 and  
Psf 1-4. Psf 1-4 w as 268 bp  upstream  of the  Xba I cloning site. W hen one  or a 
com bination  o f tw o  of these  Psf I /P s f  I fragm ents w as d e le ted  from  pB3.0, 
fo u r de le tion  m u tan ts  w ere generated . The CAT activ ities o f these  dele tion  
m u ta n ts  w ere  c o m p a red  to  th e  e x p re ss io n  levels of pB3.0 u n d e r  the  
c o n d itio n s  o f co transfec tion  w ith  pEM SV -M yoD  a n d  pEM SV in C2C12 
m yoblasts.
Fig. 3-8. CAT activities of the internal deletions within the 3 kb prom oter sequence. pB3.0 was partially digested 
with Pst I to create these deletion constructs. CAT plasm ids were cotransfected w ith pEMSV-MyoD (+MyoD) or 
pEMSV (-MyoD) into C2C12 myoblasts. Lysate volumes containing 0.5 units of fi-gai activity w ere analyzed for 
CAT activity. The relative value in MyoD cotransfection (+MyoD) is relative to CAT activity of the construct in 
cotransfection with control plasmid pEMSV (-MyoD), ans is presented as fold in this figure. The m ean + SE values 
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T he p lasm id  pB60.3, in  w hich  the  464-bp sequence  has been  dele ted , 
sh o w ed  C A T activ ities of 12 an d  70.3 w h en  transfec ted  w ith o u t a n d  w ith  
M yoD , re sp ec tiv e ly . T h ese  a c tiv ity  leve ls  a re  c o m p a ra b le  w ith  the  
expression  levels of pB3.0 (8.5 an d  85) u n d e r  th e  sam e cond itions (Fig. 3-8). 
This suggests th a t the  464 b p  reg ion  contains no m ajor reg u la to ry  sequence, 
o r  th a t it exhib its a w eak positive  regu la to ry  activity. W hen bo th  the 464-bp 
and  th e  1570-bp reg ions w ere  d e le ted , pB831 w as g en era ted . T his pB831 
w ith o u t  M yoD  co tran sfec tio n  e x h ib ited  a C A T a c tiv ity  o f 16.8 th a t is 
co m p arab le  w ith  th e  no rm al level of pB3.0 (8.5). H o w ev er, w ith  M yoD 
co transfection , the CAT activ ity  of pB831 w as increased  43.2 w hich  is only 
50% o f the  cotransfection  level of pB3.0 (85.0). T hus, th is 1570-bp region is 
th o u g h t to con ta in  a M yoD positive  response  elem ent.
The reg u la to ry  function  of the  561-bp  sequence  w as ex am in ed  in 
p lasm id  pB30.1 in w hich  this fragm en t w as de le ted . The CAT activ ity  of 
pB30.1 w as drastically  reduced  (2.0), an d  show ed  no  stim u la tion  in response  
to M yoD  co transfection  (4.7). This reduc tion  m ay be  d u e  to  a loss o f the 
p o sitiv e  reg u la to ry  activ ity  of the  561-bp  sequence, a n d /o r  to  a nega tive  
re g u la to ry  e ffect w ith in  th e  1570-bp reg io n  u n d e r  th is  co n s tru c tio n . 
M oreover, w hen  bo th  th e  561-bp  an d  the  1570-bp reg ions w ere  d e le ted , 
pB60.2 w as generated . W ithout M yoD cotransfection, pB60.2 revealed  a  CAT 
activ ity  o f 10.4 that is com parab le  w ith  the norm al expression  level of pB3.0 
(8.5). W ith M yoD  cotransfection, pB60.2 resp o n d ed  to M yoD  stim u la tion  by 
increasing  its CAT activ ity  (41.7) to 50% o f the co transfection  level of pB3.0 
(85.0). T herefore, the  net activ ity  of the sequence betw een  Psf 1-2 and Pst 1-5 
is positive . T hese resu lts  suggest tha t there  m ay be m u ltip le  positive  and  
negative e lem ents w ith in  each of these Psf I /P s t  I regions.
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F urtherm ore , p rogressive  deletional analysis w ith in  the  3 kb flanking 
reg ion  in  th e  5' to 3* d irec tion  revealed  m ore  in te res tin g  resu lts  reg a rd in g  
the  reg u la to ry  cis-elem ents (Fig. 3-9). As show n  in F igure 3-9A, these CAT 
co n stru c ts  con ta in  the  sam e CA T coding  sequence, b u t d iffe ren t p ro m o te r 
fragm en ts th a t w ere  genera ted  by Exo in  d igestion  (Fig. 3-9A). The num ber 
on  each  co n stru c t ind icates the leng th  of p ro m o te r sequence  in base  pairs. 
These CAT constructs w ere  cotransfected w ith  pEM SV-M yoD an d  pEMSV in 
C2C12 m yoblasts, respectively , and  their expression  levels a re  sum m arized  
h ere  (Figs 3-9A & B). The p lasm id  pB268 w hich con ta ined  th e  268 b p  Pst  
l / X b a  I p ro m o te r sequence su rro u n d in g  the tran scrip tio n  s ta r t site  a, w as 
o rig in a lly  g en era ted  by subclon ing  from  pB3.0 (sam e as pB3000 here) in to  
pCAT-Basic at the  Pst l /X ba  I sites. This p lasm id  exhib ited  a CAT activ ity  of 
38.6 th a t is 4.5 fo ld  of th e  a c tiv ity  level o f pB3000 w ith o u t M yoD  
co tran sfec tio n . N o n e th e le ss , M yoD  co tran sfec tio n  s tim u la te d  th e  CA T 
activ ities of bo th  CAT p lasm ids to sim ilar levels (85.0 an d  85.5, respectively). 
T hese observations suggest tha t th is 268 b p  sequence  con ta ins the  proxim al 
p ro m o te r and  essential cis-elem ents responsive  to  M yoD  transactivation .
O n  th e  basis of CAT activ ity  analysis, th e  D N A  sequence  ex tend ing  
u p stream  of 268 b p  to 3 kb  contains several positive  an d  negative  regu la to ry  
reg io n s (Figs. 3-9A & B). First, a strong  negative  reg u la to ry  reg ion  w as 
localized  w ith in  the  557 bp  region  (designated  as R l) b e tw een  pB268 and  
pB825. This w as ev idenced by the fact that CAT activity of pB825 declined 10 
a n d  2 fo ld  re la tiv e  to  the  ac tiv ity  levels o f pB268 a n d  pB3000. This 
inh ib ition  could  no t be  reversed  by M yoD cotransfection; the CAT activ ity  of 
pB825 show ed  only 15% of the activ ity  level of pB3000 o r  pB268 (85 an d  85.6) 
in cotransfection w ith  MyoD. Second, the 157 bp  sequence (designated  as E l) 
th a t lies im m ediate ly  upstream  of R l exhibited a p ron o u n ced  M yoD
Fig. 3-9 CAT activities of the 5’ to 3’ deletion constructs. (A) Plasmid pGEM3.0 which contained the 3 kb 5'- 
flanking sequence between Hind III and Xba I sites of pGEM -7Zf(-) (Promega) was digested w ith Exo ID (see Fig. 2- 
4). The deletion fragments of the RM-PFK sequence were then subdoned into the H ind 111/Xba I sites of pCAT- 
Basic to generate the deletion CAT constructs. The num ber indicates the length of the prom oter sequence in base 
pairs Plasmids were cotransfected w ith pEMSV (-MyoD) or pEMSV-MyoD (+MyoD) into C2C12 myoblasts. 
Lysate volumes w ith 0.5 units of [5-gal activity were analyzed for CAT activity. The relative value in MyoD 
cotransfecbon is relative to the CAT activity of the CAT construct in cotransfection w ith control plasmid pEMSV, 
and is presented as fold in this figure. The mean + SE values from at least three separate experiments are shown 
here. Also shown are the positions of the positive regulatory regions El and E2, and the inhibitory regions Rl and 
R2. (B) Comparison of the CAT activities of the deletion constructs in a linear graph. The m ean + SE values from
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16.8 ±4.8 43.2 ±4.1 2.6
9.9 ±1.8 257.8 ±10.3 26
8.5 ±  0.2 57.1± 3.6 6.7
3.5 ±1.2 49.5 ±2.7 14.1
16.9 ± 6.7 104.3± 14.3 6.2
5.8 ± 0 .5 128.6± 14.5 22.2
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positive  response. This w as ev idenced  by  the  fact that CAT activity  of pB988 
w as increased  to  26 fold upon  M yoD  cotransfection, w hich is tw ice as h igh  as 
th e  CA T activ ity  of pB268 o r pB3.0 u n d e r these  cond itions. W ith  fu rth e r 
ex tension  o f a 255 b p  in the  5' d irection  (see pB1067 a n d  pB1243), the  CAT 
activ ities o f pB1067 a n d  pB1243 w ere  reduced  again  an d  cou ld  no t be  fully 
reco v ered  by  M yoD  co transfec tion . T hese resu lts  in d ica te  th a t th e re  is a 
second  n eg a tiv e  reg u la to ry  reg io n  (d esigna ted  as R2) w ith in  th is 255 bp  
sequence. The rem ain ing  1.6 kb p rom oter sequence a t the 5 ’ en d  ap p ea red  to 
h av e  p o s itiv e  reg u la to ry  activ ity  th a t is m ain ly  res id es  w ith in  th e  728 bp  
reg ion  (designated  as E2 ) im m ediate ly  up stream  o f R2. This w as ev idenced  
b y  th e  fact th a t pB1971, w h ich  co n ta in s  th is  E2 reg io n , rev e rse d  the 
inh ib ito ry  effect of the R2 region.
T aken together, by d o in g  de le tiona l an a ly sis  of the  3 kb  p ro m o te r 
sequence  o f th e  RM-PFK gene, tw o  negative  reg u la to ry  reg ions (R l an d  R2) 
an d  tw o  M yoD  positive  response  regions (El an d  E2) w ere  identified . These 
regu la to ry  sequences are located betw een the transcrip tion  s ta rt sites a an d  b; 
th u s , th ey  a p p e a r  to have  reg u la to ry  effects on th e  p rox im al p ro m o te r in 
these  dele tion  constructions. The proxim al p ro m o te r activ ity  resides w ith in  
th e  268 bp  Psf l /X b a  I fragm en t th a t is im m ed ia te ly  u p stream  of the ATG 
transla tiona l in itia tion  codon. T hus, it is w orthw h ile  to fu rth er characterize 
th is p ro m o ter and  the regu la to ry  elem ents.
3.3 Interactions of MyoD and the C2C12 Nuclear Proteins 
with the El Enhancer In Vitro
T he s tro n g  M yoD  p o sitiv e  re sp o n se  w ith in  the  157-bp reg ion  (E l) 
su g g ested  th a t M yoD  m igh t recogn ize  th e  cognate  D N A  sequence  w ith in
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th is  reg io n . F u rth e r  in v es tig a tio n  of th a t p o ss ib ility  w as p ro ceed ed  by 
m eans of EMSA and D N asel footprin ting .
In the  EMSA ex p erim en ts , p u rif ied  G ST-M yoD  fusions (Fig. 3-10) 
w ere  b o u n d  to  th e  El D N A  probes am plified  by  PCR, g iv ing  rise  to  C2 and  
C3 sh ifted  com plexes (Fig. 3-11, lane 3). These com plexes w ere absen t in the 
b in d in g  reactions th a t con ta ined  e ith e r no  p ro te in s o r  GST p ro te in s (Fig. 3- 
11, lanes 1-2), a n d  in reactions w here  GST-M yoD b ind ing  w as com peted  w ith  
the  MCK e n h an cer o ligos (Fig. 3-11, lanes 4-5) th a t con ta ined  a CACCTG 
sequence (C hak rabo rty  et at., 1991). C om plex  C l w as observed  in the  MCK 
com petition  experim en ts (Fig. 3-11, lanes 4-5), and  w as the  d o m in an t GST- 
M yoD  D N A  com plex w h en  low er am o u n ts  of GST-M yoD w ere  incuba ted  
w ith  the  E l p ro b e  (Fig. 3-12, lanes 2-4). B ecause th e re  is a CAGCTG 
c o n sen su s  sequence  w ith in  th e  E l reg ion , it is poss ib le  th a t G ST-M yoD 
specifica lly  recogn izes th e  CAGCTG sequence , re su ltin g  in fo rm atio n  of 
m u ltip le  D N A -pro te in  com plexes.
N uclear extracts of the  C2C12 m yoblasts and  m yotubes w ere  also used  
for th e  s im ila r ge l-sh ift assays. As a re su lt, b o th  th e  m yo b last a n d  the 
m y o tu b e  nu c lear ex trac ts  recogn ized  th e  El sequence, g iv ing  rise  to  th ree  
sh ifted  com plexes M l, M2 an d  M3 (Fig. 3-12). The m obilities of these  th ree 
com plexes w ere  sim ilar be tw een  m yoblast and  m yo tube  extracts, ind icating  
th a t th e  p ro te in  con ten ts are  sim ilar, if no t identical. T he M2 com plex w as 
th e  p red o m in an t species at low  p ro te in  concen tra tions (Fig. 3-12, lanes 5 & 
9), w hereas M3 ap p ea red  to be  a m inor com plex. The M l com plex w as both 
th e  fastest m ig ra ting  a n d  the  second m ajor com plex. In teresting ly , the  M l 
com plex  o f the m yotubes extracts ap p ea red  to be m ore  in tense  than  th a t of 
th e  m yoblasts ex tracts (Fig. 3-12, lanes 7 & 12). In contrast, the M2 com plex 




Fig. 3-10. SDS-PAGE of the purified  GST-MyoD proteins. Lane M, protein 
m arkers. Lanes 1 an d  4, in p u t of the cell lysates for GST and  GST-MyoD, 
respectively. Lanes 2 and  5, fractions of the final w ash  through  of these tw o 
p ro te in  sam ples. Lanes 3 and  6 , e lu ted  fractions o f GST and  GST-MyoD, 
respectively, w ith  their positions indicated.
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Fig. 3-11. EMSA com petition  assays for b in d in g  of th e  GST-M yoD pro teins 
to  E l enhancer sequence. E l D N A  fragm en ts w ere am plified  by  PCR w ith  
oligo p rim ers that w ere 5’ end-labeled  w ith  [y32P]-ATP an d  w ith pB1067 (Fig. 
3-9) as the  D N A  tem plate. Lanes 1, free probe. L ane 2, w ith  3 tig  of GST 
ad d ed . L ane 3, w ith  3 p g  o f GST-M yoD ad d ed . L ane 4-5, w ith  th e  MCK 
com petito r oligo at 500 and  1000 ng , respectively, and  3 |ig  of GST-MyoD.
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Fig. 3-12. EMSA titra tion  experim en ts on E l enhancer sequence. Lanes 2-4, 
w ith  pu rified  GST-M yoD at 0.5, 0.8, an d  1.4 pg, respectively. Lanes 5-8, w ith  
nuc lear ex tracts of m yoblasts (MB) at 3.5, 10.5, 17.5, an d  28 fig, respectively . 
Lanes 9-12, w ith  nuclear extracts o f m yotubes (MT) at 1.8, 5.4, 8 .8 , and  14 pg , 
respectively . Lane 1, free probe.
89
5 & 10). In the  com petition  stud ies , MCK enhancer o ligos com peted  w ith  
the fo rm ation  of M l an d  M2 com plexes, w hile it d id  no t affect the  form ation  
o f the  M3 com plex (Fig. 3-13, lanes 2, 3, 5, & 6 ). These resu lts ind icate  tha t 
nuclear ex tracts of C2C12 cells contain  activ ity  that specifically b ind  to  the  E- 
box of the  E l region, w hich is responsive  to  the fo rm ation  of com plexes M l 
an d  M2. In  ad d itio n , th is b in d in g  activ ity  is a lte red  d u rin g  d ifferen tia tion  
from  m yoblasts to m yotubes.
M yogenic  p ro te in s associate  w ith  non-m yogen ic  bH L H  p ro te in s  in 
vivo  for D N A  recognition  and  tran scrip tiona l activation . O th e r researchers 
have  sh o w n  th a t for m yogenic  p ro te in s to b in d  to E-boxes, their m in im al 
com pelx  m u st be a t least hom o- o r h e te ro d im ers ; fu rth e r , o ligom ers are  
fo rm ed  w h en  th e  p ro te in  reaches h igh  concen tra tions a n d /o r  w hen  there  
a re  m u ltip le  E -boxes p re se n t (T apsco tt et at ., 1991c). T here  is b in d in g  
coopera tiv ity  betw een  the  m yogenic bH L H  pro te in s an d  o th er transcrip tion  
ac tiva to rs (such  as S p l and  MEF-2) for h ig h er level tran sac tiv a tio n  of the  
m uscle-specific  genes (Sartorelli et al.f 1990; G ossett et at., 1989; C serjesi and  
O lson , 1991). MEF-2 p ro te in s a re  the m yocyte-specific tran sac tiv a to r w hich 
has recen tly  been show n  to  in d u ce  h ig h  level tran scrip tio n  of th e  m uscle  
g ene  in conjunction w ith  M yoD  p ro te in  (K aushal et al., 1994).
A no ther line of ev idence  for M yoD  in te rac tion  w ith  the  El sequence 
cam e from  the  D N asel foo tp rin ting  experim en ts (Fig. 3-14). P urified  GST- 
M yoD  p ro te in s specifically pro tected  the  CAGCTG sequence of the  E l region 
(Fig. 3-14A, lan es  4-5). T h is fo o tp r in t w as  d im in ish e d  w h e n  M CK 
com petito r oligo w as ad d ed  to the b ind ing  reaction (Fig. 3-14A, lane 6 ), and  it 
w as absen t w hen  no p ro tein  w as ad d ed  (Fig. 3-14A, lane 2) o r GST pro teins 
w ere  ad d ed  to  replace GST-M yoD (Fig. 3-14A, lane 3). The nuclear extracts o f 
C2C12 m yoblasts p ro tected  th ree  DNA reg ions from  D N asel d igestion  (Fig. 3-
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Fig. 3-13. EMSA com petition  assay for b ind ing  of the  C2C12 nuclear extracts 
to E l en h an cer sequence. Lanes 1-3, w ith  17.5 p g  o f m y o b lasts  n u c lea r 
ex tracts (MB). Lanes 4-6, w ith  14 pg  of nuc lear ex tracts of m yo tubes (MT). 
Lanes 1 and  4, no  MCK com petitor oligo. Lanes 2 an d  5, w ith  500 ng of MCK 
oligo. Lanes 3 and  6 , w ith  1000 ng  of MCK oligo.
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Fig. 3-14. D N ase l fo o tp rin tin g  o f the  E l enhancer region . (A) D N asel 
fo o tp rin tin g  of the bo ttom  stran d  E l sequence. E l fragm ents w ere  am plified  
by  PCR w ith  a u p p e r p rim er (-916 to -896) an d  a low er p rim er (-750 to  -770). 
T he D N A  tem pla te  for PCR reaction w as pB1067 (sam e as pB1.2). The low er 
p rim er w as 5' end -labeled  w ith  T4 k inase  an d  [y32p]_ATP a n d  th en  u se d  in 
th e  PCR reaction. Lane 1, M axam -G ilbert G+A sequence  m arker. L ane 2, 
free probe. Lane 3, w ith  5 ng  of GST proteins. Lanes 4-5, w ith  5 an d  10 pg  of 
GST-M yoD, respectively; Lane 6 , w ith  10 pg  of GST-M yoD an d  500 n g  of the 
M CK com petito r oligo. Lane 7, w ith  30 n g  of the  m yoblast nuclear extracts.
(B) S um m ary  of the  foo tp rin ting  p a tte rn  of the  El enhancer reg ion  (u p p er 
s trand). The ind icated  regions a re  the  AT-rich sequence, the  E-box sequence 
C A G CTG , a n d  th e  CAG G rep e a te d  seq u en ce  th a t w e re  p ro tec te d  from  
















14A, lane 7). In addition  to  the CAGCTG E-box region, an AT-rich sequence 
(beg inn ing  ap p rox im ate ly  44 b p  u p stream  of th e  E-box), an d  a CAGG 
rep ea ted  sequence (im m ediately  follow ing the E-box) w ere  recognized  by 
m yoblasts extract in these experim ents (Figs. 3-14A, lane 7; 3-14B).
In sum m ary , resu lts from  bo th  the EMSA an d  D N asel foo tprin ting  
experim en ts ind icate  that M yoD pro tein  can d irectly  contact the  CAGCTG 
sequence of E l, and  that nuclear extracts o f C2C12 cells contain E-box binding 
activ ity . T hus, the transactivation  ability  of M yoD  d em o n stra ted  in the 
transien t transfection stud ies is m ediated th rough  its d irect interaction w ith 
the  E-box sequence of the E l enhancer. Because several specific sequences of 
E l w ere  recognized  by C2C12 nuclear p ro te ins, it is possib le  tha t these 
sequences m ay be th e  poten tial targets o f the  regu la to ry  factors in vivo. 
F urther experim ents are  needed to investigate the identities of the  pro teins 
that bind to these DNA sequences.
3.4 D eterm ination  of the B oundary an d  A ctivity  
o f the  Proxim al Prom oter
From  the dele tion  stud ies d iscussed  above (Fig. 3-9), it has becom e 
clear that the  268 bp  Pst l /X ba  I fragm ent in pB268 contains the  proxim al 
p rom oter an d  M yoD positive response sequences. Therefore, M yoD, Myf5, 
an d  m yogenin  w ere  tested for their abilities to stim u la te  CAT activity  of 
pB268 in cotransfection studies. As show n in Figure 3-15, m yogenic cDNA 
expression  p lasm ids stim u la ted  the CAT activity  o f pB268 2-3 fold in the 
cotransfection experim ents (Fig. 3-15). H ow ever, M yoD transactivation  w as 
a b o lish e d  w h en  M yoD  A N  w as co transfec ted  w ith  pB268 (Fig. 3-15), 
suggesting  that M yoD function requ ires the  in tegrity  o f the transactivation  
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Fig. 3-15. T ransactivation  of pB268 by  the  m yogenic bH L H  factors in C2C12. 
For each m yogenic cD N A  expression  p lasm id , 5 pg  w ere  co transfected  w ith  
pB268. T hese p lasm ids inc luded  pEM SV-M yoD, pEM SV-M yoDAB, pEMSV- 
M yoD A N , pEM SV -m yogenin, an d  pEMSV-Myf5. For a control, pB268 w as 
cotransfected  w ith  pEMSV (+EMSV). Lysate vo lum es w ith  0.5 u n its  of p-gal 
activ ity  w ere analyzed  for CAT assay. The re la tive  value  in  co transfection  
w ith  m yogen ic  exp ression  p lasm id  is re la tiv e  to the  ex p ress io n  level o f 
pB268 in cotransfection  w ith  th e  con tro l p lasm id  pEM SV, an d  is show n  at 
th e  r ig h t s ide  o f each co lum n. T he m ean+SE va lues from  th ree  sep ara te  
experim en ts a re  show n.
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w hen  its cD N A  expression  p lasm id  w as cotransfected  w ith  pB268 (Fig. 3-15). 
T hese  re su lts  fu r th e r  su p p o rt the  p rev io u s  o b se rv a tio n s  th a t M yoD  as a 
tran sac tiv a to r  is d e p e n d e n t on  its in te rac tio n  w ith  o th e r  p ro te in  factors 
th ro u g h  th e  N - te rm in a l tra n s a c tiv a tio n  d o m a in  (D av is  et al., 1987). 
A lthough  it is u nab le  to b ind  to th e  D N A  sequence, M yoD  A B sh o u ld  still be 
ab le  to  in te rac t w ith  E12 p ro te in  th ro u g h  its H L H  d o m ain . H ow ever, 
because  M yoDAB-E12 (or E47) d im ers are  unab le  to  in terac t w ith  cognate E- 
box sequence, M yoD  A B p ro te in s sequester E -proteins, thereby  red u c in g  the 
m yogen ic  effect of M yoD  a n d /o r  o th er m yogenic bH L H  p ro te in s  (Davis et 
al., 1987). T herefore, the  observed  inh ib ito ry  effect of M yoDAB su p p o rts  the 
co n c lu sio n  th a t M yoD A B is functionally  sim ilar to  Id  p ro te in s  (Jen et al., 
1992).
D N A  sequence  analysis ind icates th a t there  a re  tw o  po ten tia l M yoD 
b in d in g  sites in pB268 (Fig. 3-16A): CAGATG (-186 to  -192, in respec t to 
tran sc rip tio n  s ta r t site  as + 1); an d , CA G CTG  (+41 to +46). To d e te rm in e  
w h e th er these  E-boxes are  functional, sequence de le tions w ith in  the  268 bp  
reg ion  w ere  perfo rm ed . W hen  tran s ien t transfec tion  s tu d ies  w ere  carried  
o u t in C2C12 m yoblasts, the  CAT activities of these de le tion  constructs w ith 
an d  w ith o u t M yoD  cotransfection  a re  sum m arized  in F igure  3-16. Rem oval 
o f th e  50 bp  N h e  l /X b a  I frag m en t ( in c lu d in g  th e  d o w n s tre a m  CAGCTG 
seq u en ce) re d u c e d  th e  p ro m o te r  ac tiv ity , b u t n o t its  tra n sa c tiv a tio n  
in d u c tio n  by M yoD  co transfec tion . This can be o bserved  in F igu re  3-16 
w h e re  th e  CA T activ ity  of pB218 w as no t affected  in co transfec tion  w ith  
M yoD  (Fig. 3-16B), as com pared  to the con tro l ex p erim en t (co transfec ted  
w ith  pEMSV) in w hich there  w as a 70% reduction  from  38.6 in pB268 to 10.7 
in pB218 (Fig. 3-16A). M yoD  s tim u la tio n  m ust re ly  on  the  N -te rm in a l 
transac tivation  dom ain  because cotransfection w ith  M yoD A N  d id  not
Fig. 3-16. Relative CAT activities of the CAT constructs containing sequences of the proximal prom oter in C2C12 
myoblasts. (A) Three deletion m utants (pB218, pB168, and pB118) w ere constructed by digestion w ith 
endonucleases. The CAT activities of these constructs in cotransfection w ith the cDNA expression plasm ids of 
MyoD, MyoDAB, and MyoDAN are summarized. For a control experiment, pEMSV was cotransfected w ith the 
CAT constructs. Lysate volumes with 0.5 units of jl-gal activity w ere analyzed for CAT activity. The locations of 
two E-boxes are shown here. (B) The relative CAT activity of each transfection is presented as a percentage of the 
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enhance  th e  transcrip tion  of pB218. O n the  o ther hand , d irect b ind ing  to the 
E-box seq u en ce  is n o t ab so lu te ly  re q u ire d  for M yoD  fu n c tio n , as co- 
transfec tion  w ith  M yoD AB still induced  the  C A T activity  o f pB218 to about 
38% of th e  induction  level of the  w ild type  M yoD (Fig. 3-16).
F u rth e r rem oval of the 100 bp  Pst l /D r a  in fragm en t (con ta in ing  the 
u p stream  CAGATG) from  pB218 g en era ted  pB118 w hich  on ly  con ta ins the  
118 bp  Dra I I I /N  he I fragm en t (-95 to +23). T he p lasm id  pB118 revealed  a 
m uch  lo w er p ro m o te r activ ity  com pared  to those o f pB218 an d  pB268, and  
could  n o t be  stim u la ted  by M yoD  cotransfection  to  th e  levels of pB218 and  
pB268 (Fig. 3-16). T hus, these resu lts ind icate  tha t the m ajor M yoD  response 
e lem ent resides w ith in  the 100 b p  Psf l /D ra  in fragm ent. It is reasonable  to  
sp ecu la te  th a t the u p s tre am  CAG ATG m ay m ed ia te  the  tran sac tiva tion  of 
M yoD  in th is p ro m o te r region. T his by  no m eans excludes the possib ility  
th a t th e re  is a n  un k n o w n  D N A  b in d in g  site  for a tran scrip tio n  factor o th er 
th an  M yoD  w ith in  th is reg ion  tha t m ay  be im p o rtan t for th e  transactivation  
by  M yoD. For instance, M yoD  pro te in  is kn o w n  to ind irec tly  transac tivate  
m uscle-specific gene  by inducing  o ther m uscle-specific factors such as MEF- 
2 .
In  a sim ila r experim en t, pB168 (con ta in ing  the  168 bp  Dra l l l /X b a  I 
p ro m o te r sequence) show ed  a CAT activity  com parab le  to pB218 (Fig. 3-16). 
H ow ever, M yoD  only  increased the  CAT activ ity  o f pB168 by tw o  fold in the 
c o tran sfec tio n  s tu d ies . F u rth e r, the  tw o  M yoD  m u ta n ts  (M yoD A B and  
M yoD A N ) inh ib ited  the CAT activities of pB168 to m uch  low er levels than 
in pB218 (Fig. 3-16). Therefore, the 50 b p  Nhe l /X b a  I sequence  (containing 
CAGCTG) ap p ea red  to  be a m inor M yoD  response  elem ent. W hen the  tw o 
E-boxes co-existed  (as in pB268), a synerg istic  effect w as observed  in w hich 
th e  p ro m o te r  ac tiv ity  of pB268 w as g re a te r  th an  the  su m m atio n  of the
100
v a lu es for pB218 and  pB168 (Figs. 3-16A an d  B). A lternative ly , o th er cis- 
e lem en ts w ith in  the  Nhe l /X b a  I reg ion  m igh t cooperate  w ith  the  u p stream  
E-box in  response  to  M yoD  activation.
T aken together, resu lts here  ind icate  that the  sequence be tw een  Pst  I 
an d  Dra III sites is critical for M yoD stim ula tion  o f the  proxim al p rom oter. 
T he sequence  be tw een  Nhe  I and  Xba I site  does no t have  p ro fo u n d  im pact 
in  re g u la tio n  o f th e  p ro m o te r  ac tiv ity  in  re sp o n se  to  M yoD . M yoD  
stim u la tion  does no t necessarily  require  E-box p resen t, since pB l 18 th a t does 
n o t con ta in  an  E-box sequence  w as also s tim u la te d  by M yoD. F u rther, 
because  the  CA T activ ity  o f pB118 w as the  low est am ong  these fou r CAT 
constructs (Fig. 3-16), the  118 b p  Dra III/ N h e  I p ro m o te r sequence in pB118 
con ta in s the  core p ro m o te r e lem ent of th is proxim al p rom oter.
To illu stra te  the m uscle-specific transcrip tion  p a tte rn  o f th is prox im al 
p ro m o te r, CAT activities of these  four p ro m o te r constructs w ere  assayed  in 
C2C12 m yoblasts and  m yotubes (Fig. 3-17). In these results, the  relative CAT 
ac tiv itie s  of pB268, pB218, an d  pB118 in  m yo tu b es w ere  n o t sign ifican tly  
increased  w hen  com pared  in m yoblasts. H ow ever, the relative CAT activ ity  
o f pB168 w as in c re a se d  from  17 in m y o b la s ts  to  52 in  m y o tu b e s . 
In te res tin g ly , the  CA T activ ity  o f pB268 in m y o tu b es  a p p ea re d  to  be  the 
a d d itiv e  of the  activ ities of pB218 and  pB168, w hich  is d is tin g u ish ed  from  
th e  synerg istic  effect observed  in m yoblasts. These observations im ply  that 
d iffe re n t co m b in a tio n s o f th e  tra n sc rip tio n  fac to rs m ay  be  in v o lv ed  in 
tran sc rip tio n a l in itia tio n  from  th is prox im al p ro m o te r d u rin g  m yogenesis. 
F u rth e rm o re , th e  in d iffe ren ce  in the  CA T ac tiv itie s  of pB268 b e tw een  
m y o b last a n d  m y o tu b e  s tages m ay  be d u e  to  th e  fact th a t a ve ry  low  
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Fig. 3-17. C om parison  o f the  CA T activ ities of th e  p rox im al p ro m o ter CAT 
p lasm ids d u rin g  C2C12 d ifferentiation . Cells w ere  fed w ith  g ro w th  m edium  
(for m y o b lasts , MB) o r d iffe ren tia tio n  m ed iu m  (for m y o tu b e , MT) a fte r 
tran sfec tio n . L ysate  vo lum es w ith  0.5 u n its  o f the  fi-gal a c tiv ity  w ere  
an a ly zed  for CAT activ ity . T he re la tive  CAT activ ity  is rep re sen ted  as a 
pe rcen tag e  o f the  C A T activ ity  of pSV2CAT. The m ean+SE  va lues from  




To fu r th e r  u n d e rs ta n d  the  ro le  o f M yoD  in  tran sac tiv a tio n  o f the 
p rox im al p ro m o te r, para lle l tran s ien t expression  s tu d ies  w e re  rep ea ted  in 
th e  N IH 3T3 fib rob last cells. The re la tive  CA T activ ities o f the  p roxim al 
p ro m o te r constructs in C2C12 and  3T3 cells w ere  com pared . S urprising ly , 
the  CAT activities o f pB268, pB218 and  pB168 w ere  m uch  h igher in 3T3 than  
in  C2C12 cells (Figs. 3-16B & 3-18). For instance, the relative CA T activ ity  of 
pB268 in C2C12 m yoblasts w as abou t 60% of th e  pSV2CAT level, w hereas it 
w as 250% of th e  pSV2CAT level in 3T3 cells. O n th e  o th er h an d , pB118 
rem ained  u n ch an g ed  in its CA T activ ity  betw een these tw o  cell lines (Figs. 
3-16B an d  3-18). M yoD  cotransfection  d id  not s tim u la te  CA T activ ity  for 
each o f th e  CA T constructs  (Fig. 3-18). R ather, it show ed  som e d eg ree  of 
inh ib ition  as the CAT activity  of pB218 w as reduced  sign ifican tly  by  M yoD 
cotransfection  (Fig. 3-18). Even though  th e  CA T activ ity  of pB218 (w ithout 
M yoD  cotransfection) w as h igher than  that of pB268, it w as no t statistically  
d ifferen t (Fig. 3-18).
F rom  th ese  resu lts , it is fu rth e r confirm ed  th a t pB118 con ta ins the  
co re  p ro m o te r  sequence, an d  its p ro m o ter activ ity  is co n sis ten t from  one 
cell-type to another. It is also revealed tha t the 100 b p  Pst l /D ra  m  an d  the  50 
b p  N he  l / X b a  I reg ions su rro u n d in g  the  core  p ro m o te r  (see Fig. 3-16A) 
con ta in  the signals for regu la ting  p ro m o ter activ ity  in 3T3 cells. H ow ever, 
the  100 b p  Pst l /D ra  III region has m ore p ronounced  effects than  does the 50 
b p  N h e  I/X b a  I region. Since the  full length  p ro m o ter of pB3.0 w as w eaker 
th an  the  prox im al p ro m o ter of pB268 in bo th  the C2C12 and  3T3 cells (Figs. 
3-5, 3-9A, & 3-18), it is suggested  th a t the negative  reg u la to ry  activ ity  of a 
seq u en ce  u p s tre am  con tro ls the  ac tiv ity  of the  p rox im al p ro m o te r. This 
p ro m o te r , o n  th e  o th e r h an d , w as h ig h ly  in d u c ib le  in re sp o n se  to the  
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Fig. 3-18. Relative CAT activities of the PFK-CAT plasmids in 3T3 fibroblasts. CAT plasm ids were cotransfected 
with pEMSV (-MyoD) and pEMSV-MyoD (-*-MyoD) into 3T3 cells, respectively. Lysate volumes with 0.5 units of (J- 
gal activity were analyzed for CAT assay. The relative CAT activity after subtracting the background activity of 
pCAT-Basic, is presented as a percentage of the CAT activity of pSV2CAT The m ean ±  SE values for three 
separate experiments are used to plot this graph.
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In addition , these results also indicate that ectopic expression of MyoD 
in 313 cells m ay negatively  regulate  the proxim al prom oter. The negative 
function  of M yoD  has not been  p rev io u sly  rep o rte d  an d  n eed s to  be 
confirm ed. It is possib le  that the  versatile  p ro te in -p ro te in  in teractions of 
M yoD w ith  o ther m usde-specific  and  ubiqu itous transcrip tion  factors allow  
M yoD to in tercept the d iverse g row th  or d ifferentiation  signals in the cells 
an d  to  respond  depend ing  o n  its d im eriza tion  p a rtn e r, w ith  e ither up - o r 
d o w n -reg u la tio n  of m uscle  gene expression. A lternatively , th e  negative  
regu lation  of M yoD in fibroblasts m ay be d u e  to an indirect m echanism  in 
w h ich  M yoD  ac tiv a tes  an o th e r fac to r w hose  ex p ress io n  in h ib its  the 
proxim al prom oter activity of the RM-PFK gene. M utation of these tw o E- 
boxes w ithin  the 268 b p  prom oter region will p rov ide m ore d irect evidence 
to  clarify th is argum ent.
DNA sequence analyses revealed that the core p rom oter o f 118 bp 
sequence  does not have  a TATA-like e lem ent th a t is recognized  by the 
TATA b ind ing  pro tein  (TBP) w hich fad lita tes the transcrip tional initiation 
p rocess . R ather, th e re  is on ly  an  in itia to r- lik e  (In r-lik e ) e lem en t 
su rro u n d in g  the  transcrip tion  initiation site. Sequence com parison  (Fig. 3- 
19) revealed  that the Inr of RM-PFK gene (CTCTTGCCAGTCTGA, w ith  +1 
position  underlined ) shares h igh  hom ology w ith  the  In r sequences o f the 
fo llow ing  gene: ra t c-m os p ro to -o n co p ro te in  (L eno rm and  et at., 1993); 
m ouse  p rim ase  p49 (Prussak et at., 1989); SV40 m ajor la te  p rom o ter (Ayer 
an d  D ynan, 1990; Roy et at., 1991); term inal deoxynucleo tidy l transferase  
(TdT) (Sm ale and  Baltim ore, 1989); hum an  leukocyte in te rferon  (LelF-J) 
(U llrich  et at., 1982); adeno-associated v irus type 2 P5 p ro m o ter +1 region 
(P5+1 elem ent) (Setoef at., 1991); and , HIV In rl and  Inr2 (Roy et at., 1991).
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Fig. 3-19. C om parison  of the  RM-PFK Inr sequence  w ith  Inr o f o th e r genes. 
T he tran sc rip tio n  in itia tio n  site  is u n d e rlin ed  an d  is su rro u n d e d  by  the 
p y rim id ine-rich  sequence.
1 0 6
3.5 Detection of Multiple Protein Binding Sequences within 
the Proximal Promoter Region
D N asel fo o tp rin tin g  ex p erim en ts  w ere  carried  o u t to  see if th is Inr 
reg ion  could  be recognized  by  p ro tein  factors from  the nuclear extracts. As 
show n  in F igure  3-20, th is py rim id ine-rich  Inr reg ion  w as indeed  p ro tec ted  
b y  th e  n u c le a r  ex trac ts  of the C2C12 m yob lasts  a n d  m y o tu b es  from  the 
D N ase  d ig es tio n , su g g estin g  th a t th is In r-like  seq u en ce  is th e  p ro m o te r  
e lem ent. A no ther A G -rich reg ion  a ro u n d  -74 to  -65 w as specifically  bo u n d  
b y  m y o tu b e  n u c lea r ex trac ts  (Fig. 3-20). In co n trast, n u c lea r ex trac ts  o f 
m yob lasts  d id  no t show  such  b in d in g  in th is region. T he CAGCTG E-box 
(located  d o w n stream  of the Inr sequence) and  a sho rt reg ion  (GACCATCG) 
located a few  base pairs dow nstream  from  this E-box w ere  also bound  by the 
nuc lear ex tracts of C2C12 (Fig. 3-20). Further, the  upstream  CAGATG E-box 
(as in pB218) w as recognized by  the C2C12 nuclear ex tracts of m yoblasts and  
m yotubes (Fig. 3-21). O verall, the  DN A pro tec ted  regions w ere  b roader w ith  
the  nuclear ex tracts of m yoblasts than  w ith  that o f m yotubes.
T herefo re , as su m m arized  in Fig. 3-22, th e re  a re  m u ltip le  specific 
D N A  sequences th a t w ere  recognized  by th e  p ro te in  factors o f the  C2C12 
nuclear ex tracts. This is an  im plication  of the  po ten tia l regu la to ry  functions 
o f the  p ro te in s  that recognize these D N A  sequences.
EMSA experim en ts w ere  perfo rm ed  to  investiga te  the  D N A -bind ing  
p ro file  o f th e  n u c lea r ex trac ts  an d  of th e  p u rif ie d  G ST-M yoD  on th is 
p rox im al p ro m o te r. P u rified  G ST-M yoD  asso c ia ted  w ith  th is  p ro m o te r  
sequence to  g ive  rise to th ree  m ajor com plexes (Fig. 3-23, lanes 7-8). These 
com plexes w ere  absen t in the  b in d in g  reaction incubated  w ith  no  p ro te in  or 
w ith  GST (Fig. 3-23, lanes 1-5), an d  w ere  p rev en ted  by the ad d itio n  o f MCK 
enhancer (not show n here). T hus, GST-M yoD appeared  to  specifically
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Fig. 3-20. D N asel foo tp rin ting  of th e  p ro m o te r 268 b p  reg ion  (top  strand). 
L anes 1 an d  9, M axam -G ilbert G+A sequence m arker. Lanes 2, 5, an d  8, no  
p ro te in s  ad d ed . L anes 3 an d  4, w ith  nuc lear ex tracts of m y o tu b es (70 pg). 
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Fig. 3-21. D N asel fo o tp rin tin g  of th e  p ro m o te r  268 b p  reg ion  (bo ttom  
strand). L ane 1, M axam -G ilbert G+A sequence m aker. Lanes 2, 5, 6, an d  9, 
n o  nuc lear ex tracts added . Lanes 3 an d  4, w ith  nuc lear ex tracts of m yotubes 
(30 an d  40 pg, respectively). Lanes 7 and  8, w ith  nuclear ex tracts of m yoblasts 
(30 an d  40 pg, respectively). The CAGATG E-box sequence is underlined .
no
P s t  I
I
1 9 6  CTGCAGATGG GTTCCTCTCG GGGAGGGAGG GACTAGGGAG
- 1 5  6 GGATTAGCCA GGACTTTTGA GTCTTGGGCT TGATTACTGT
D r a  I I I
I
- 1 1 6  GGCATTTCAG CTTGTCATTC CACAGGGTGT GGCTCTCCCT
_ 7  6 <5g a a g a a g t c __c ^ g a g t t c c c  AGGCTGCAAA GCTGAGGTGG
I *
- 3 6  TGGAGTGGGA GAGCCTGCCT GAGGTGGCTC TTGCCAGTCT
N h e  I
+ 6  GACGAAGCTG TCGCTTGAGC TAGCGGCACC TTGACCCAGC
+ 4 6 TGTGTCCTAA C|TGACCATCG TCJTTGCCTTC TAGA
I
X b a  I
Fig. 3-22, S um m ary  of the  fo o tp rin tin g  p a tte rn  of the  p rox im al p ro m o te r 
268 b p  sequence. Tlie p ro tec ted  E-boxes are  sing ly  u n d e rlin ed  a n d  th e  Inr- 
like  seq u en ce  is d o u b ly  u n d e rlin ed . T he rec tan g le  rep re se n ts  p ro tec ted  
sequences w ith  nuclear extracts of C2C12 m yoblasts and  m yotubes. The oval 
rep resen ts  a m yotube-specific p ro tec ted  sequence. The a rro w  rep resen ts  the 
+1 tra n sc r ip tio n  s ta r t  s ite  o f th is  p ro m o te r . R estric tion  en d o n u c lea se  
recognition  sites a re  indicated.
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Fig. 3-23. EMSA titra tio n  experim en ts on  th e  p ro m o te r 268 bp  sequence. 
L ane 1, free p robe. L anes 2-5, w ith  GST at 0.19, 0.57, 0.95 an d  1.5 p g , 
respectively . Lanes 6-8, w ith  GST-M yoD a t 0.53, 0.9 and  1.4 pg , respectively . 
Lanes 9-12, w ith  3.5, 10.5, 17.5 an d  28 p g  of m yoblast nuc lear ex tracts (MB), 
respectively . Lanes 13-16, w ith  1.75, 5.25, 8.75, an d  14 p g  o f m yo tube  nuclear 
ex trac ts (MT), respectively . The ex p o su re  p eriod  for MB b in d in g  w as one 
half o f th a t for M T b ind ing .
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recognize  th e  E-box sequences of the p ro m o te r region. T he nuc lear extracts 
of bo th  m yob lasts  a n d  m yo tu b es fo rm ed  m u ltip le  D N A -pro te in  com plexes 
u p o n  b in d in g  to the  p ro m o ter (Figs. 3-23, 3-24, & 3-25). A s th e  am o u n ts  of 
the  n u c le a r  ex trac ts  in  th e  b in d in g  reac tio n  in c re ased , p ro te in  b in d in g  
revea led  a coopera tive  p a tte rn  (Fig. 3-23, lanes 9-16). T he nu c lear ex tracts 
th a t w ere  trea ted  at 47°C for 10 m in  (to  inactiva te  TBP protein) reduced  the 
m obility  o f com plex Q  (Figs. 3-24, lanes 5; 3-25, lanes 4). As show n  in Figure 
3-24, the  Q  com plex  in  th e  b in d in g  reac tions w ith  the  m yo b last n u c lea r 
p ro te in s w as com peted  by the cold p robe  Dra lU /N h e  I (lane 10). In contrast, 
the MCK oligos an d  tw o o ther cold p robes (Psf l /D ra  III an d  Nhe 1/Xba I) d id  
n o t p rev en t the  Q  com plex fo rm ation  (lanes 6-9). H ow ever, th e  Q  com plex 
in  th e  b in d in g  reaction  incubated  w ith  the  m y o tu b e  nu c lear ex trac ts  w as 
specifically  com peted  b y  the  ad d itio n  of the MCK o ligo  (Fig. 3-25, lane  5). 
T hus, th e  core  p ro m o te r sequence  Dra U l /N h e  I is co rresp o n d in g  to the 
fo rm ation  of th e  Q  com plex. The com plexes M l, M2, and  M3 a p p ea red  to be 
th e  w eak  com plexes u n d e r  these  co n d itio n . It w as u n c le a r  from  these  
resu lts  w he ther they  cou ld  be com peted  by the  E-box contain ing  com petitors.
Taken together, the  resu lts p resen ted  here  suggest tha t M yoD  as a GST 
fusion  can specifically b ind  to the proxim al p ro m o te r sequence, an d  th a t not 
o n ly  th e  E-box b in d in g  p ro te in  b u t a lso  o th e r  fac to rs can  b in d  to  th is  
p ro m o ter sequence. Even though  the d o w n stream  E-box can be  recognized  
in vitro an d  even  th o u g h  it is closer to  the Inr sequence  than  th e  upstream  
E-box, it do es no t h av e  g rea t im pact on  the  reg u la tio n  o f th e  prox im al 
p rom o ter. The Q  com plex a p p ea red  to  be  re ta rd ed  by the  p ro te in s of the 
C2C12 nu c lear ex tracts th a t recogn ize  the  core p ro m o te r sequence. W hen 
these  ex tracts w ere  trea ted  at 47°C and  ad d ed  to th e  b ind ing  reactions, the 
m obility  of the  Q  com plex w as slightly  reduced . Because TBP p ro te in  can be
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Fig. 3-24. EMSA com petition  assays for b in d in g  of the  m yob last nuc lear 
ex tracts to p rom oter 268 b p  sequence. Lanes 2-4, w ith nuclear ex tracts at 3.5, 
8.8, a n d  15 pg , respectively. Lime 5, w ith  15 p g  o f the  nuc lear ex tracts heat- 
trea ted  a t 47°C for 10 m in. Lanes 6-7, w ith  15 pg  of the  nuc lear extracts and  
M CK oligo  at 100 and 300 ng, respectively . L anes 8-10, w ith  15 p g  of the 
nuc lear ex tracts w ith  the  add ition  of 200 n g  of the  cold p robes Nhe l /X b a  I, 
Pst I f  Dra III, and  Dra U l/N h e  I fragm ents, respectively. L ane 11, w ith  15 pg  
o f the nuclear extracts and  300 ng of the non-specific o ligo  AT.
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Fig. 3-25. EMSA co m p etitio n  assays for b in d in g  o f the  m y o tu b e  nuclear 
ex tracts to p rom oter 268 b p  sequence. Lanes 1-3, w ith increasing  am oun ts of 
m y o tu b e  nuc lear ex tracts from  3.5 to 7.0, a n d  14 pg . Lane 4, w ith  14 p g  of 
h e a t- tre a te d  e x trac ts  (47°C , 10 m in). L ane 5-6, w ith  14 p g  o f th e  nuclear 
ex tracts w ith  the ad d itio n  o f 300 ng  of the MCK oligo an d  the  non-specific 
oligo AT, respectively.
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inactivated  by this heat-treated condition (Roy et a/., 1993b), the results here 
im ply that TBP m ay be involved in the form ation of the  Q  complex.
In sum m ary , there  are  m ultip le  p ro te in  recognition sequences located 
w ith in  th e  268 bp  proxim al p rom oter reg ion . Since GST-M yoD pro teins 
specifically  b o u n d  to  th is p rom oter sequence  in the  EMSA stu d ied , it is 
suggested that the M yoD transactivational effect can be m ediated  by its direct 
association w ith  the E-boxes of this p rom oter sequence. Further, these E- 
boxes w ere specifically recognized by the C2C12 nuclear proteins, suggesting 
th a t they  m ay be th e  functional reg u la to ry  e lem en ts in vivo. The Inr 
sequence is highly  hom ologous to the Inr elem ent of the  adenov irus m ajor 
late  p rom oter (AdM L) w hich w as show n to be the b ind ing  sequence of the 
transcrip tion  in itiation factor TFII-I (Roy et a/., 1991); thus, it is possible that 
TFII-I or its re la ted  factor m ay be invo lved  in th e  fo rm ation  of the  Q  
com plex in the  EMSA experim ents p resen ted  here.
TFII-I p ro te in  (120 Kd) b inds to the  In r e lem ent of the  AdM L, and  
m ediates a novel pa thw ay  of transcrip tion  in itiation (Roy et al.f 1991; Roy et 
al„ 1993a and  b). Interestingly, th is pro tein  also d irectly  b inds to an E-box 
sequence CACGTG a ro u n d  -60, w hich is a h igh-affin ity  E-box for USF 
protein  (a bH LH  protein). M oreover, Myc and  USF, tw o of the H LH  proteins 
recognizing E-boxes, have been dem onstra ted  to directly  in teract w ith TFII-I 
(Roy et al., 1993a; Roy et al.r 1993b) -- possibly through their bHLH dom ains -- 
as if TFII-I is also a bH LH  protein. The cooperative interaction of TFII-I and  
USF a t both the Inr and  the E-box p rovide a possible explanation for M yoD 
function. It w ou ld  be in te resting  to illu stra te  w h e th er M yoD  and o ther 
m yogenic bH LH  factors could m ake such interaction w ith TFII-I.
In add ition , the m yotube-specific sequence GGAAGAAGTCC (Fig. 3- 
22) is sim ilar to the MEF-2 site (Yu et al., 1992; M artin et a i ,  1993). MEF-2 is
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a n o th e r  m uscle-specific  tran sc rip tio n a l a c tiv a to r th a t coopera tes w ith  the 
m yogen ic  bH L H  p ro te in s  to  s tim u la te  m uscle  gene  tran sc rip tio n  to  h igher 
levels. A no ther reg ion  (GACCATCGTCT) fo llow ing th e  d o w n stream  E-box 
(Fig. 3-22) w as also p ro tec ted  by  an  u n k n o w n  factor of the  nuclear extracts. 
T herefo re , fu rth e r experim en ts a re  needed  to iden tify  th e  nu c lear p ro te ins 
th a t in te rac t w ith  th e  p rox im al p ro m o te r  o f  th e  RM -PFK g ene , an d  to  
u n d e rs ta n d  their roles in th e  regu la tion  of the  p ro m o te r activity.
3. 6 Characterization of Another Muscle-Specific Promoter
R e su lts  from  m R N A  d e te c tio n  e x p e r im e n ts  h a v e  sh o w n  th a t 
m R N A -b l an d  m RN A -b2 of th e  RM-PFK accum ulated  p refe ren tia lly  in the 
skeletal m uscle (Fig. 1-3). The b l and  b2 m R N A s are  the  a lterna tive  sp licing  
p ro d u c ts  from  th e  sam e tra n sc rip tio n  s ta r t  s ite  b  (Fig. 1-3). S equence 
ana ly ses show ed  th a t there  is a TA TA -like sequence  (TTATTTATT, at -30 
w ith  respec t to  th e  tran scrip tio n  s ta r t site  b  as +1) sim ila r to  th e  TFII-D 
b in d in g  site  (CAATATTATTTAAGGAC) p rev io u s ly  re p o rte d  (H ahn  et al., 
1989). T o de linea te  the  p ro m o te r b  sequence, several PFK-CAT constructs 
c o n ta in in g  d iffe re n t seq u en ces  u p s tre a m  a n d /o r  d o w n s tre a m  o f th is  
p u ta tiv e  TA TA -like seq u en ce  w ere  m a d e  (Fig. 2-7) an d  tes ted  for th e ir 
p ro m o te r activities.
T ransfection  s tu d ie s  w ere  p e rfo rm ed  in  C2C12 m yob lasts . pB1.4 
con tains the  1.4 Kb up stream  sequence includ ing  transcrip tion  sta rt sites b, c, 
a n d  d , w h e rea s  pB671 on ly  co n ta in s  th e  671 b p  seq u en ce  a ro u n d  the 
tran scrip tion  s ta rt site b  (Fig. 2-7). The CAT activ ity  of pB1.4 w as tw ice as 
h igh  as th a t of pB671 (Fig. 3-26). H ow ever, these tw o constructs reached the 
sam e  C A T activ ity  levels u p o n  M yoD  co transfec tion . M yoD  s tim u la te d  
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Fig. 3-26. R ela tive  C A T ac tiv itie s  o f the  p ro m o te r  b c o n ta in in g  CA T 
constructs. T hese constructs w ere  cotransfected  in to  C2C12 w ith  pEMSV (- 
M yoD ) o r pEM SV -M yoD  (+M yoD ), resp ec tiv e ly . C A T ac tiv itie s  w ere  
m easu red  as a percen tage  of the  expression  level of pSV2CAT. pCAT-Basic 
(pBasic) w as u sed  as the  n eg a tiv e  contro l. The re la tiv e  v a lu e  in M yoD  
co tran sfec tio n  is re la tiv e  to  th e  exp ress ion  level o f th e  C A T co n stru c t in 
co transfec tion  w ith  the  con tro l p lasm id  pEMSV, a n d  is show n  o n  th e  rig h t 
s ide  o f each colum n. The m ean from  tw o  separa te  experim en ts is show n.
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T hese  re su lts  in d ic a te  th a t th e  671 b p  frag m e n t o f pB671 h a rb o rs  the  
p ro m o te r b  sequence. W hen the  p ro m o te r activ ities of pB671, pB l 18, and  
pB268 w ere  com pared  in C2C12 cells (Figs. 3-16B vs 3-26), th e  activ ity  level o f 
pB671 w as co m p arab le  w ith  th a t o f pB118 (con ta in ing  th e  p rox im al core 
p ro m o te r) , a n d  w as m u ch  lo w er th a n  th a t o f pB268 (co n ta in in g  th e  
p ro x im a l p ro m o te r) . W hen  fu r th e r  e x am in ed  in  3T3 f ib ro b la s ts , th e  
p ro m o te r activ ity  o f pB671 w as n early  undetec tab le  (Fig. 3-18). T hese results 
su g g est th a t p ro m o te r b o f 671 b p  sequence  is on ly  activated  in the  m uscle 
cells, a n d  has low er ac tiv ity  th an  does the  p rox im al p ro m o te r. Because 
M yoD  d id  n o t stim u la te  the transcrip tion  o f pB671 to a level sim ilar to that 
of pB268, it  is poss ib le  th a t the  m usc le-specific ity  o f p ro m o te r  b  is no t 
reg u la ted  by the  M yoD  factor. In an  ea rlie r ex p erim en t (no t sh o w n  here), 
th e re  w as no  detectab le  activ ity  from  the  p ro m o ter of pB1.8 w hich contains 
th e  5' p o rtion  1.8 kb sequence of the  3 kb  p ro m o ter region (Figs. 2-5 & 2-7). 
T his re su lt  in d ic a te s  th a t th e  re g u la to ry  e lem en t(s) fo r p ro m o te r  b is 
p robab ly  no t w ith in  th is 1.8 kb fragm ent. The E2 enhancer reg ion  defined  by 
th e  d e le tio n  ex p erim en ts  (Fig. 3-9) is located  w ith in  this 1.8 kb  sequence, 
w hereas the  HI enhancer an d  tw o o th er negative  regu la to ry  regions (R1 and 
R2) a re  located dow nstream  of th is 1.8 kb sequence. Thus, the E2 enhancer is 
n o t e ssen tia l for th e  reg u la tio n  of p ro m o te r  b  activ ity . It is u n k n o w n  
w h e th er the  E l enhancer and  negative  regu la to ry  reg ions a lso  p lay  ro les in 
contro lling  the  activ ity  of the  p ro m o ter b.
A n am b ig u o u s o b se rv a tio n  w as th a t p rim er ex tension  ex p erim en ts  
h ad  d e tec ted  a tran scrip tio n  s ta rt site  d o w n stream  of a TATA sequence  — 
th a t is, 236 b p  d o w n s tre a m  o f the  tra n sc r ip tio n  s ta r t  s ite  b  (Fig. 2-7). 
H ow ever, SI m app ing , as w ell as R N ase pro tec tion , d id  no t reso lve th is start
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site (Xiao, 1995). T hus, pB256 w as co n stru c ted  to an sw er the  question  of 
w h e th er o r not th is TATA sequence h ad  any p rom o ter activ ity  (Fig. 2-7).
The p lasm id  pB256 in tran sien t transfection  s tu d ies  d id  show  a CAT 
activ ity  sim ila r to  th a t o f pB671 (Fig. 3-26) w ith o u t M yoD  co transfec tion , 
fu rth e r, M yoD  en h an ced  the  CAT activ ity  o f pB256 to six fo ld , w hich  is 
a b o u t 50% of th e  in d u c tio n  level o f pB671. The h ig h e r tran sac tiva tion  of 
M yoD  for pB671 is probably  because there  are  tw o pu ta tive  E-boxes (CATCTG 
an d  CAAGTG) w ith in  this 671 bp  sequence com pared  to  on ly  one  in the 256 
b p  region (CAAGTG). Shortening 26 b p  at the  3’ end  o f the  256 b p  fragm ent, 
as in  pB230w t (Fig. 2-7), d id  not change th e  p ro m o te r activ ity  (Fig. 3-27). 
M u ta tio n  a t the  G-C stem  loop  seq u en ce  (pB230m u) d o w n stre am  of the 
TA TA  se q u en c e  s lig h tly  in c re a se d  th e  p ro m o te r  a c tiv ity  (Fig. 3*27). 
T herefore, the  ev idence  d id  not su p p o rt the  o rig inal specu la tion  th a t this G- 
C stem  loop  p rev en ts  fo rm ation  of a tran scrip tiona l com plex  a t this TATA 
region . W ithou t fu rth e r  experim en ts, it is u n k n o w n  a t th is  p o in t w he ther 
th is  TA TA -box is an  a u th e n tic  p ro m o te r  e lem en t in vivo. S ite-d irec ted  
m u ta g e n e s is  a n d  an  in vitro  tra n sc r ip tio n  sy stem  can p ro v id e  fu r th e r  
in fo rm ation  to  answ er th is question .
T aken to ge ther, it is be lieved  th a t, u n lik e  th e  p rox im al p ro m o te r, 
p ro m o ter b is m uch  w eaker and  is activated  at a m uch  low er level in m uscle 
cells by  M yoD  co transfection . T hus, these  tw o  m uscle-specific  p ro m o te rs  
ex am in ed  a re  co m p o n en ts  of a com plex  co n tro llin g  m ech an ism  for the  
m uscle-specific  tran scrip tion  of the RM-PFK gene. The p rox im al p rom o te r 
is the  m ajor p ro m o te r that is transac tivated  by the m yogenic bH L H  protein . 
T he sequence w ith in  the  3 kb 5 '-flanking reg ion  is capable of regu la ting  this 
p ro x im al p ro m o te r . H o w ev e r, the  re g u la to ry  se q u en c e  fo r th e  d is ta l 
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Fig. 3-27. M u ta tio n  effect o f the G-C stem  loop  d o w n stream  o f the  TATA 
seq u en ce  on th e  p ro m o te r activ ity . T he p la sm id  pB230m u con ta in s the 
su b s titu ted  bases w ith in  th e  G-C stem  (Fig. 2-7), w hereas pB230wt contains 
th e  w ild  type  sequence. P lasm ids w ere  cotransfected  in to  C2C12 cells w ith  
e ith e r  pEM SV (-M yoD ) o r  pEM SV -M yoD  (+M yoD ). CAT ac tiv itie s  are  
p resen ted  as a percen tage  o f th e  expression  level of pSV2CAT. The p lasm id  
pC A T -B asic (pBasic) co n ta in in g  no p ro m o te r  w as u sed  for a n eg a tiv e  
co n tro l. T he re la tiv e  v a lu e  in  M yoD  co tran sfec tio n  is re la tiv e  to the  
ex p re ss io n  level of th e  CAT co n stru c t in co transfec tion  w ith  th e  con tro l 
p lasm id  pEMSV, an d  is show n  at the righ t s ide  of each colum n. The m ean 
from  tw o  separa te  experim en ts is show n.
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specific  reg u la to ry  seq u en ce  o f th e  m o u se  m uscle  PFK gene w as located 
betw een  -4800 an d  -3900 b p  (G ekakis and  Sul, 1994); thus, it is w orthw hile  to 
in v estig a te  the  reg u la to ry  function  of the  D N A  sequence  fa rther u p stream  
o f th e  3 kb flank ing  reg ion  of the RM-PFK gene. The proxim al p ro m o ter of 
the  h u m an  m uscle  PFK gen e  is reg u la ted  by the  m u ltip le  S p l sites at the  
tran sc rip tio n  s ta rt site  (Johnson  an d  M cLachlan, 1994); th u s , th e  possib le  
invo lvem en t o f o th er tran scrip tion  factors such  as S p l, MEF-2 rem ains to be 
illu stra ted . In  any even t, these  observations ind icate  that the transcrip tional 
regu la tion  o f the m am m alian  m uscle PFK genes is different.
F u rth e rm o re , the fact that sim ila r levels o f m R N A s-a an d  m R N A -b 
acc u m u la te d  in  the  skele ta l m usc le  (Xiao, 1995) d id  no t ag ree  w ith  the  
s tren g th s  o f these  tw o  p rom o ters. Because a lte rna tive  sp licing  is involved  
in  th e  p ro d u c tio n  o f th e  m R N A -b species, it is po ss ib le  th a t th e  post- 
tran sc rip tio n a l even ts  m ay co n tribu te  to th e  reg u la to ry  m echan ism  of the 
RM -PFK gene.
A s a m etab o lic  e n zy m e, PFK gen e  tra n s c r ip tio n  is u n d e r  bo th  
d ev e lo p m en ta l con tro l a n d  g ro w th  control. This d isse rta tio n  has p ro v id ed  
som e p re lim in a ry  ev idence  for th e  m uscle-specific  reg u la tio n  o f the  RM- 
PFK g en e  a t th e  tran sc rip tio n a l level. A t least tw o  p ro m o te rs  a re  u p - 
reg u la ted  by  the  m yogenic bH L H  pro te in s in skeletal m uscle  cells. If th is is 
th e  case , th is  is the  firs t re p o r t  o f the  m usc le-specific  tra n sc r ip tio n a l 
reg u la tio n  of the m uscle PFK gene, ind icating  that the  u n d e rs tan d in g  of the 
tran scrip tiona l control o f th is gene  has begun.
CHAPTER 4
SUMMARY, CONCLUSIONS, AND FUTURE STUDIES
4.1 Summary and Conclusions
In th is d issertation , the m uscle-specific transcrip tional m echanism  of 
th e  rabb it m uscle p h o sp h o fru c to k in ase  gene  w as in v estig a ted  in tissue 
cu ltu re  cells by using  the CAT reporter gene system . The 3 kb 5’-flanking 
seq u en ce  of the  RM-PFK gene w as exam ined  in  o rd e r  to  define  the 
prom oters an d  the regu latory  regions that are responsive to transactivation  
by the  m yogenic bH LH  transcrip tion factors such as MyoD, m yogenin, and  
Myf5.
P lasm id pB3.0 (containing a CAT coding region  driven  by the 3 kb 
PFK prom oter sequence) w as expressed in the m ouse C2C12 and  the prim ary  
rabbit skeletal m uscle m yoblasts (Figs 3-1 to 3-4), and  was also expressed in 
the 3T3 fibroblasts (Fig. 3-5). This expression w as stim ulated  by the  muscle- 
specific bH LH  transcription factor MyoD du ring  cotransfection (Figs. 3-1 to 3- 
5). M yoD transactivated the CAT gene expression of pB3.0 to 10 and 2 fold in 
C2C12 and  3T3 cells, respectively (Fig. 3-5). A long w ith M yoD, tw o o ther 
m yogenic bH L H  factors (Myf5 and  m yogenin) s tim u la ted  the  CAT gene 
expression  of pB3.0 in C2C12 cells (Fig. 3-6) as w ell as in the  prim ary  
m yoblasts (Fig. 3-7). T hus, the  transac tiva tion  activ ities of these three 
m yogenic factors were in the descending o rder of M yoD > Myf5 > m yogenin 
(Figs. 3-6 & 3-7). Therefore, resu lts presented here indicate for the first tim e 
that the muscle-specific bHLH transcription factors p lay  an im portan t role in 
the  contro l of the m uscle-specific tran scrip tion  of th is PFK gene. This 
m uscle PFK gene is the  first glycolytic enzym e that has been show n to be 
regulated by m yogenic bHLH proteins.
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O f th ese  m yogen ic  bH L H  p ro te in s , th is s tu d y  focused  on  M yoD  
m ain ly  b ecau se  o f its  s tro n g  tran sac tiv a tio n  ac tiv ity  to w a rd s  PFK gene  
tran sc rip tio n  (Figs. 3-1, 3-6 & 3-7). Both its N -te rm in a l tran sac tiv a tio n  
d o m ain  a n d  its basic reg ion  (D N A  b ind ing  and  p ro te in  in terac tion  dom ain) 
w ere  req u ire d  for M yoD  function  (Fig. 3-6), w hich  fu r th e r  confirm ed  the  
e a rlie r  fin d in g s  by  o th e r  research  g ro u p s. T hus, M yoD  tran sac tiv a tio n  
req u ire s  d irec t con tact w ith  its cognate  D N A  b in d in g  seq u en ce  E-box and  
association  w ith  o th er transcrip tion  factors.
D N A  seq u en ce  d e le tio n  ex p e rim en ts  led  to  th e  c o n stru c tio n  o f a 
series of the  CAT p lasm id s con ta in ing  d iffe ren t 5 '-flank ing  reg ions of the  
PFK gene. A fter close exam ination  of th e  CAT activities of these  constructs, 
tw o  m ajor p o sitiv e  a n d  tw o  n eg ativ e  reg u la to ry  reg io n s w ere  id en tified  
along w ith  the  proxim al p rom oter region (-195 to +73) (Figs. 3-8 & 3-9).
T he positive  region, El (-916 to -758), d ram atica lly  enhanced  the CAT 
activ ity  of th e  proxim al p ro m o te r in the M yoD co transfection  experim en ts 
(Fig. 3-9). EM SA s tu d ie s  rev e a le d  th a t p u r if ie d  G ST-M yoD  fu sio n s  
p h y sic a lly  b o u n d  to  the E l seq u en ce  (Fig. 3-11). T he M CK en h an c e r 
o lig o n u c leo tid e  (con ta in ing  CACCTG E-box) specifically  p rev e n ted  M yoD  
from  b in d in g  to th is  E l se q u en c e  (Fig. 3-11). D N ase l fo o tp r in tin g  
e x p e rim e n ts  sh o w ed  th a t G ST-M yoD  rec o g n ize d  th e  C A G C TG  E-box 
sequence (-827 to -821) (Fig. 3-14). In add ition , nuclear extracts o f the C2C12 
m yoblasts an d  m yotubes contained  E-box b ind ing  activ ity  (Figs. 3-12 & 3-13), 
a n d  p ro tec ted  severa l reg ions from  D N asel d ig es tio n  (Fig. 3-14). These 
regions included  the CAGCTG E-box sequence, an  AT-rich sequence (-886 to 
-863, CGCTCAAATAAATAAGTG X i l l ), an d  a CAGG repea ted  sequence (- 
810 to  -795, CAGGTCAGGAAGACAGG) (Fig. 3-14).
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The RM-PFK gene  con ta ins m u ltip le  p rom oters. This w as ev idenced  
by  the detection  o f m u ltip le  tran scrip tion  s ta rt sites d is trib u ted  along  the 3 
kb  5 '-flank ing  reg ion  (X iao/ 1995). T he  m R N A s tran sc rib ed  from  the 
p ro x im al p ro m o te r  (or p ro m o te r  a) a n d  from  the  d is ta l p ro m o te r  b  a re  
p re fe re n tia lly  a c c u m u la te d  in  th e  sk e le ta l m u sc le  tis su e  (Xiao, 1995). 
C oncom itan t w ith  these  findings, p lasm id  pB671 (-2313 to -1642, in respect to 
th e  p ro x im al tra n sc rip tio n  s ta r t  s ite  as  +1) c o n ta in e d  th e  p ro m o te r  b 
sequence and  h ad  detectab le  CAT activity only in the  C2C12 cells (Fig. 3-26). 
In  c o n tra s t to  pB671, pB268 co n ta in e d  th e  p ro x im a l p ro m o te r  268 b p  
sequence  (-195 to +73) and  show ed  m uch  h igher CA T activ ities in bo th  the 
C2C12 an d  3T3 cells (Figs. 3-16 to 3-18).
In C2C12 cells, M yoD  stim u la ted  CAT activ ities of b o th  pB268 and  
pB671 (Figs. 3-16 & 3-26). H ow ever, the  stim u la ted  expression level of pB268 
w as m uch  h igher than  th a t of pB671 (Figs. 3-16 & 3-26). T hus, th e  proxim al 
p ro m o te r  is considered  the  m ajor p ro m o te r in  re sp o n se  to tran scrip tio n a l 
ac tiv a tio n  by  M yoD. T he sequence  de le tion  s tu d ie s  su g g est th a t M yoD  
transac tiva tion  w as p robably  m ed ia ted  th rough  th e  CAGATG (-192 to -187) 
an d  the CAGCTG (+40 to +45) E-box sequences (Fig. 3-16). In particu lar, the 
CAG ATG E-box p ro v id ed  m ost of the  M yoD  stim u la tio n  of the  proxim al 
p ro m o te r; thus, it is th e  crucial E-box for M yoD  function  (Fig. 3-16). As 
show n  in  the  D N asel foo tp rin ting  experim ents, these  tw o  E-boxes w ere also 
recognized  by the  E-box b in d in g  activity in the nuclear ex tracts of m yoblasts 
a n d  m yotubes (Figs. 3-20 to 3-22).
In 3T3 fib rob lasts, M yoD  transac tiva tion  w as less effective than  in 
C2C12 (Figs. 3-5, 3-16 & 3-18), w hich agrees w ith  p rev io u s observations by 
o th e rs  (D avis et al.r 1987). H o w ev er, an  in h ib ito ry  e ffect on  th e  CAT 
activ ities of pB218 (contain ing  CAGATG) an d  pB168 (con ta in ing  CAGCTG)
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by M yoD  cotransfeclion  w as also observed  (Fig. 3-18). P lasm ids pB218 and  
pB168 bear a com m on core p ro m o te r sequence (-95 to +23, see pB118) w hich 
d irec ted  CA T gene  expression  at a  constitu live ly  low er level (Figs. 3-16 to 3- 
18). T w o D N A  reg ions w ith in  th is  118 bp  core  p ro m o te r sequence  w ere 
p ro tec ted  by the  C2C12 nuclear p ro te in s from  the  D N asel d igestion  (Fig. 3- 
20). T hese  seq u en ces  in c lu d e d  a m y o tu b e-sp ec ific  reg io n  (-76 to  -64, 
G G A A G A A G TCC), an d  th e  reg ion  su rro u n d in g  th e  tran scrip tio n  s ta r t site  
re fe rred  to  as In r w hich  w as recogn ized  by  b o th  m yob last an d  m y o tu b e  
n uc lear extracts. Even though  it has no t been dem o n stra ted  to be a tru e  Inr, 
th is py rim id ine-rich  sequence (-8 to  +7, CTCTTGCCAGTCTGA) is sim ilar to 
the  in it ia to r  e lem en ts  of sev era l g en es  (Fig. 3-19). O n e  of th ese  In r 
sequences, th a t is the  Inr of the  ad en o v iru s m ajor la te  p ro m o te r, has been 
p rev io u s ly  show n  to be the recognition  sequence  of the  tran scrip tion  factor 
TFII-I (Roy et at., 1991,1993a & 1993b).
Since th e re  is no TATA elem ent w ith in  th is PFK prox im al p ro m o te r 
region , it is im plied  tha t TFII-I o r its re la ted  p ro te in  factor m ay be involved  
in th e  tran sc rip tio n a l in itia tio n  o f the RM -PFK prox im al p ro m o ter. The 
h igh  level transcrip tion  from  this p rom o te r ap p ea rs  to requ ire  bo th  the core 
p ro m o te r an d  its  su rro u n d in g  sequences (Figs 3-16 to 3-18). T hat m u ltip le  
sequences w ere  recogn ized  in vitro im plies th a t p ro te in s  w hich  recognize 
th ese  D N A  seq u en ces m ay p lay  ro les in the  reg u la tio n  o f th e  p rox im al 
p ro m o te r.
It rem ain s unc lear w h y  M yoD  inh ib ited  CA T activ ity  of pB218 and  
pB168 in  3T3 cells (Fig. 3-18). It is a lso unclear w hy the de tec ted  levels of 
m R N A s from  th e  prox im al p ro m o te r an d  th e  d ista l p ro m o te r b  w ere  very  
sim ila r in sp ite  of th e ir d ifferen t p ro m o te r s treng ths. It is possib le  that a
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po st-tran sc rip tio n a l e v en t cou ld  co n trib u te  to  the  m uscle-specificity  of th is 
PFK gene.
N evertheless, th e  ev idence  so  far suggests tha t th e  prox im al p rom o te r 
activ ity  is n o t res tric ted  to m uscle  cells. T hat th e  C A T activ ity  of pB3.0 
(con tain ing  the  full leng th  p ro m o ter sequence) w as m uch  low er than  th a t of 
pB268 (co n ta in in g  th e  p ro x im al p ro m o te r  sequence) (Figs. 3-5 & 3-16) 
su g g es ts  th a t an  u n k n o w n  n e g a tiv e  re g u la to ry  m ech an ism  co n tro ls  the  
ac tiv ity  of th is  p ro x im a l p ro m o te r. T he n e g a tiv e  re g u la to ry  reg io n s 5' 
u p s tre am  of th e  proxim al p ro m o te r m ay  serve  th is function , a n d  w o u ld  be 
w o rth  fu rth e r  investiga tion . A lternative ly , D N A  m eth y la tio n  m ay  p lay  a 
ro le  in  the  n eg a tiv e  reg u la tio n  of the tissue-specific ity . M y p re lim in a ry  
re su lts  in d ic a te d  th a t m e th y la tio n  of p la sm id s  pB3.0 o r  pB1.2 in vitro 
re d u c e d  th e ir C A T activ ities m ore  th an  50% in  C2C12 cells. T he M yoD  
tra n sac tiv a tio n  o f the  m e th y la ted  p la sm id s  w as re d u c e d  to  50% o f the 
u n m eth y la ted  pB3.0 level.
F inally , the  possib le  p ro m o te r e lem en ts of the  p ro m o te r b  have been 
in te n d e d  to be  iden tified . The ev idence  h ere  d em o n s tra te s  th a t a 265-bp 
sequence (w hich is included  in the  671-bp sequence of pB671) d o w n stream  of 
th e  transcrip tion  s ta rt site  b  con tains p ro m o ter activ ity  (Fig. 3-27, see pB265). 
A perfect TATA-box sequence is located w ith in  th is reg ion  an d  is possib ly  
th e  p ro m o te r  e le m e n t in  pB256. H o w ev e r, a tra n sc r ip tio n  s ta r t  site  
d o w n stream  of th is TATA sequence w as no t consisten tly  de tec ted  by using  
d iffe re n t d e te c tio n  m e th o d s  (Xiao, 1995). T h u s, w h e th e r  th is  TATA 
sequence  is a functional p ro m o te r e lem en t in vivo rem a in s u n d e te rm in e d . 
O n th e  o th er h an d , a possib le  functional TATA elem ent for th e  p ro m o te r b  
lies a t th e  -31 to -23 reg ion  (TTATTTATT, w ith  reference  to tran scrip tio n  
sta rt site b as +1).
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In conclusion , the  3 kb 5 '-flanking sequence of the RM-PFK gene 
con tains the  p ro m o te r an d  the  regu la to ry  e lem en ts th a t w ere  show n to 
resp o n d  to the  tran sac tiva tion  by  the m yogenic bH L H  p ro te in s. Tw o 
m uscle-spedfic  prom oters of the RM-PFK gene w ere exam ined in this study. 
T h e ir d iffe re n t p ro m o te r  s tru c tu re s  m ay  d e te rm in e  th e ir  d iv e rg e n t 
m ech an ism s o f tran sc rip tio n a l reg u la tio n . T he TA T A -less p rox im al 
p ro m o te r con ta ins an in itia to r e lem ent as w ell as several o th er nuclear 
p ro te in  b ind ing  sites (including E-boxes). This p rom o ter in the  content of 
pB268 is a lso  activated in non-m uscle cells, indicating  that som e negative 
control m echanism  exists at the  upstream  region to  p reven t its expression 
in tissues o ther than m uscle. Furtherm ore, there  are  tw o positive and tw o 
negative regu latory  regions which are located w ith in  the region betw een the 
transcrip tion  start sites a and b. These regu latory  sequences w ere show n to 
contro l the  proxim al p rom oter activity. F urtherm ore, the transactivation  
effect of M yoD w as show n to be m ediated through  its direct interaction w ith 
th e  cognate  sequences o f the E l enhancer in vitro. O n  the  o th er hand , 
ano ther m uscle-spedfic  p rom oter, p rom oter b, is a w eak p rom oter and  m ay 
contain  a TATA-box sequence. The M yoD cotransfection d id  not stim ulate 
the  activ ity  of this p rom oter to the  level as w as seen w ith  the  proxim al 
prom oter. Thus, it is possible that prom oter b is not m ainly regulated by the 
m yogenic bH L H  factors. Therefore, the  proxim al p ro m o te r is the m ajor 
p rom oter of the  RM-PFK gene that is transactivated by the  m yogenic bHLI I 
p ro te in s . The transcrip tiona l m echanism s of these  tw o  m uscle-specific 
prom oters are different.
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4J2 Future Studies
O n e  of the  im p o rta n t issu es in  th is  resea rch  w as th a t th e  rab b it 
m yogen ic  bH L H  pro te in s h av e  n o t been  iden tified . It is d ifficu lt to  judge  
w h e th e r  d ifferen tia l tran sac tiv a tio n  of th e  RM -PFK gene  by  these  bH L H  
factors w as no t d u e  to their differential expression . D etection of the  m RN A s 
of these  bH L H  genes from  the rabb it skeletal m uscle  tissue o r p rim ary  cells 
by  N o rth e rn  b lo t (u sin g  th e ir  u n iq u e  cD N A  seq u en ces as p ro b es) can 
p ro v id e  usefu l in fo rm ation  to d iscrim inate  against th is possibility .
A  se c o n d  q u e s tio n  th a t m u s t  b e  a d d re s s e d  is w h e th e r  th e  
tra n sc rip tio n  s ta r t  s ite  of p la sm id  pB268 (w hich  co n ta in s  th e  p rox im al 
p ro m o te r)  in 3T3 an d  C2C12 m atches w ith  th e  au th en tic  p o sitio n  in  the  
rabb it m uscle  tissue. This can be  d o n e  by  a p rim er ex tension  experim en t 
u s in g  iso la ted  m R N A s from  th e  tran sfec ted  cells an d  the  o lig o  p rim er 
p o sitio n ed  a t th e  5’ en d  of the  CAT coding  sequence  (such  as p rim er CAT- 
R24). This synthetic  oligo has been used  as a sequencing  p rim er for selection 
of the  corrected  CAT deletion constructs.
The m uscle-specific expression  m echan ism  of th e  proxim al p rom o ter 
is not very  clear at this point. It w ill be  in teresting  to  see w hether pB268 and  
o th e r  CA T co n stru c ts  co n ta in in g  th e  p rox im al p ro m o te r  h av e  an y  CAT 
activ ity  in  cells from  o th er tissues (such as liver, heart, b ra in , k idney) w here 
th e  m R N A s tra n sc r ib e d  u n d e r  th e  d ire c tio n  o f th is  p ro m o te r  w ere  
u n d e tec ted . F u rther clarification  of p ro m o te r e lem ents such  as Inr and  E- 
boxes w ill a lso  be an  in te re s tin g  to p ic  in  th e  fu tu re . S ite -d irec ted  
m u tag en esis  w ill be  usefu l to  confirm  the functions o f these c is-e lem en ts . 
A lterna tive ly , syn the tic  o ligos of these D N A  sequences can  be used  as the  
p robes for EMSA com petition  stud ies, and  for iden tify ing  the  p ro te in  factors 
th a t b ind  to  these  sequences.
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M uch has rem a in ed  u n k n o w n  ab o u t th e  s tru c tu re  of p ro m o te r  b. 
T he p u ta tiv e  TA TA  e lem en t (TTATTTAT) w h ich  lies u p s tre a m  o f the  
tran sc rip tio n  s ta r t site  b  needs to  be  con firm ed  by  m u ta tio n  an d  de le tion  
s tu d ies . A n u n so lv ed  m y ste ry  is w h y  th is p ro m o te r  in  pB671 is m uch  
w eak er co m p ared  to the  prox im al p ro m o te r. It w o u ld  be w o rth w h ile  to 
reco n stru c t the  CA T p lasm id  so as to  de linea te  th e  basal p ro m o te r region. 
A n un ique  Bsm I site 84 bp  upstream  of the  p u ta tiv e  TATA site  can be used  
to  rem ove the  257 b p  sequence at the 5’ end  of the  p ro m o te r insert of pB671. 
System atic  de le tion  in the  3' to 5' d irec tion  of the  sequence  d o w n stream  of 
the  transcrip tion  sta rt site  b will a llow  identification  of any  sequence w ith in  
this reg ion  that is necessary  for the p ro m o ter activity.
T he p o ten tia l in v o lv e m en t o f o th e r  m usc le -spec ific  tran sc rip tio n  
factors in  h igh  level tran scrip tion  o f th is m uscle gene is certain ly  w o rth y  of 
fu r th e r  in v es tig a tio n . S p l, MEF-2, a n d  M -CA T b in d in g  p ro te in  a re  the 
possib le  ta rg e ts  of th a t research. The AT-rich sequence  w ith in  the  positive  
reg u la to ry  reg ion  E l resem bles a MEF-2 b in d in g  site. T hus, it w ill no t be 
s u rp r is in g  to  find  o u t th a t M EF-2 a n d  M yoD  c o o p e ra tiv e ly  in d u ce  
tran scrip tio n  of th is PFK gene. Furtherm ore , the  CAT activ ities of p lasm ids 
pB3.0 a n d  pB268 d id  n o t reveal sign ifican t increase  d u r in g  C2C12 cell 
d ifferen tia tion  u n d e r  the  assay conditions; thus, it rem ains unclear w he ther 
it is because  a low  percen tage  of the  cells fused  to form  m yo tubes o r it is 
b e c a u se  o th e r  im p o r ta n t  m usc le -spec ific  re g u la to ry  e le m e n ts  a re  no t 
in c lu d ed  in the  3 kb 5' sequence  tested. T herefore, the  5' sequence  farther 
u p s tre am  o f the 3 kb reg ion  an d  the  sequence  d o w n stre am  of the  ATG 
tra n s la t io n a l  in i t ia t io n  co d o n  a re  w o r th y  o f fu r th e r  in v e s tig a tio n . 
F u rtherm ore , a m yocyte cell line tha t read ily  form s m yotubes w ou ld  be also 
be tter su ited  to address th is issue.
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F in a lly , th e  u ltim a te  goa l o f th is  re se a rc h  is to  u n ra v e l th e  
physio log ical significance of w hy  th e  rabb it m uscle  PFK gene has m ultip le  
p ro m o te r s ,  w ith  e v e ry  o n e  h a v in g  its  o w n  e x p re s s io n  p a t te rn .  
U n d e rs tan d in g  the struc tu ra l fea tu res an d  th e  reg u la to ry  m echan ism s of the 
o th e r  tw o  p rom o te rs  (c an d  d) is requ ired  for th is pu rpose . U ntil w e  know  
w h e th er all six m R N A s of this PFK gene have th e  sam e coding  capacity, it is 
d ifficult to suggest any  explanation. If they  have  the sam e capacity , then  the 
com plex  p ro m o te r s tru c tu re  an d  th e  com plicated  transcrip tiona l regu la tions 
e n su re  th a t th is PFK gene m ain tains its active and  inducib le  sta tu s w here  its 
activ ity  is d em a n d ed , even w hen  som e of its p ro m o te rs  a re  sh u t-d o w n  by 
m u ta tio n  o r o th er inactiva tion  m echan ism s in the  cells.
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APPENDIX A
RESTRICTIO N ENDONUCLEASE D IG ESTIO N  M AP O F THE 
3 KB S’-FLANKING SEQUENCE O F TH E RM -PFK GENE
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JUN 9 6 iggij
Ms. Haiqing Fa Schiltz 
322 Choppin Hall 
Biochemistry Dept.
Louisiana State University 
Baton Rouge, LA 70803 
Tel: (504) 388-8790 
Fax: (504) 388-4638 or 388-5321
Editorial Office 
525 B Streer, Suite 1900 
San D iego, CA 97101 4495
Deaj Sir or M adam ,
I am  w n tin g  this letter to request the perm ission  for using a figure for my Ph.D. 
d issertation . T he figure is F igure 3 in paper "S equence d iversity  in the 5‘ untranslated 
reg ion  o f rabbit m uscle phosphofructokinase m R N A ", 1990, B iochem . Biophys. Res. 
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J u l y  7,  1995
PERMISSION GRANTED, p r o v i d e d  t h a t  1) c o m p l e t e  c r e d i t  i s  g i v e n  t o  the  
s o u r c e ,  i n c l u d i n g  t h e  Academic  P r e s s  c o p y r i g h t  n o t i c e ,  2) t h e  m a t e r i a l  
to  be u s e d  h as  a p p e a r e d  i n  o u r  p u b l i c a t i o n  w i t h o u t  c r e d i t  o r  
a c know le dgem en t  t o  a n o t h e r  s o u r c e  and 3) I f  c o m m e r c i a l  p u b l i c a t i o n  
s h o u l d  r e s u l t ,  you mus t  c o n t a c t  Academic P r e s s  a g a i n .
We r e a l i z e  t h a t  U n i v e r s i t y  M i c r o f i l m s  mus t  ha ve  p e r m i s s i o n  Lo s e l l  c o p i e s  
of  y o u r  t h e s i s ,  and we a g r e e  t o  t h i s .  However,  we must  p o i n t  o u t  c h a t  we 
a re_ npT g l v i n g / p e r m i l s i ' o n  f o r  s e p a r a t e  s a l e  of  y o u r  a r t i c l e .
C h e r y  X / ' f .  U n g e r  
P e r m i b i S i n n s  D ^ p a r f n p n  
A C A D E M I C  P R E S S ,  I N C .  
O r l a n d o ,  FL. 3 2  8 8  7
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Baton Rouge. LA 70803
Tel: (504) 388-8790
Fax: (504) 388-4638 or 388-5321
Editorial Office
American Society for Biochemistry &
M olecular Biology, Inc.
9650 Rockville Pike 
Bethesda. M D 70811
Dr it Sir or Marhrn,
I am writing this letter to request the perm ission for using a figure for my Ph.D. 
dissertation. The figure is Rg. I in title "Structure of the mouse liver phosphpofructokiuTse 
gene", in paper Isolation and characterization of the transcriptionally regulated mouse liver 
(B-type) phosphofiuctokinase gene and its prom oter", 1991, J. Biol, Chem., Vol. 266. 
No. 13, pp. 8086 8091. I will appreciate your prompt response. Thanks.
r*) t, 4. t i  J
S incerely.
JUN 2 2 1995
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Ms. Haiqing Fu Schilct 
322 Choppin HaU 
Biochemistry Dept.
Louisan* State University 
Baton Rouge, LA 70803 
Tel: (504) 388- 8790 
Fax: (504) 388-4638 or 388*5371
Editorial Office 
C ell Press 
50 church Surer
Cainbtidge, Massachusetts 02138 
D ear Sir o r Madam.
I am writing this letter to request the perm ission for using a figure for m y Ph.D 
dissertation. The figure is Figure 7b in title "Gvervievv of the M yoD -D N A  com plex", in 
paper ' Crystal structure o f  MyoD bHLH dom ain-D N A  com plex, perspectives on DNA 
recognition  and im plications for transcriptional activation ', 1994, Cell, Vol. 77, pp. 451- 
4 59. I will appreciate your p tocnp 'ret [icuse. Thanks.
H a iq in g  F u  S ch i l tz
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Ms. Haiqing Fu Schilet 
322 Choppin Hail 
Biochemistry Dept 
I n r i - n t n i  State University 
Baton Rouge, LA 70803 
Tel: (504) 388 8790 
Fa*; (504) 388-4638 or 388-5321
Editorial Offices 
Gecles A Devtkrpmen'
Cold Spring HaTbor Laboratory Press
Box 100,1  Bungtown Road
Cold Spring Harbor. New York 11774-2203
Dear Sir or Marfani.
1 ant writing this Letter to request the permission for using a figure for my Ph-D. 
dissertation. The figure is Figure 1 to otie ’Hypothetical regulatory pathway for muscle 
determination and differentiation', in paper "bHUl factors in muscle development: dead 
lines and commitments, what to leave in and what to leave out', 1994, Cenes A  Dev., Vol 
S. pp. I -8. I will appreciate yon prompt response. Thanks.
P t r n l i i l o n  g r a n t e d  b y  cue c o p y r i g h t  o v n r r ,  c o n t i n g e n t  u p o n  the c o n s e n t  o f  the 
o r i g i n a l  a u t h o r ,  p r o v i d e d  c o u p l e  re c r e d i t  is g j v e n  to t h e  o r i g i n a l  s o u r c e  a n d  
copyright date.
C o l d  S p r i n g  M a c h o r  L a b n  r a  c o c y . P . O  Bo v  , o o ,  t o l a  S p r . n g  H i r b u ;  h e w  : o r k  i l r j  o
C_7ĥe>* (fj (f?S~
S incere ly ,
Haiqing Fu Schilu
PAT E k  ( 7j ~ l  ( ** C
• r j r e a  f* (}>
VITA
H a iq in g  (H elen) w as b o rn  o n  June  24, 1962 in  H a in an , P eop le 's  
R epublic  o f C hina. She g rew  u p  in th is beau tifu l sub-trop ical is land  w hich  
is loca ted  in  the  South  C h ina  Sea. In  1979, she a tte n d e d  college a t South  
C h in a  N o rm al U n iv e rs ity  in G u a n g zh o u , th e  cap ita l o f th e  G u a n g d o n g  
(C antong) province. She received  a B. S. a t Biology, a n d  fin ished  a t top  five 
of her class in 1993. She w as active in spo rts an d  m usic as w ell th a t she had  
partic ip a ted  an d  w on in m any  cam pus w id e  com petitions.
H e r in te re s t  in  sc ience  w a s  g ra d u a lly  d e v e lo p e d  th ro u g h  h e r  
ch ild h o o d , a n d  w as m ostly  in flu en ced  by her m en to r of u n d e rg ra d u a te  
research , P rofessor Pan Rui-chi, w hose  p lan t physio logy  textbook has being  
u se d  for years in C hina. She w en t on to Z ho n g sh an  U niversity  to p u rsu e  
h e r M aster's d eg ree  in p lan t physio logy  in  1993. The th ree-year g rad u a te  
school carrier in Z hongshan  has tu rn ed  o u t to be the  invaluab le  m om en t of 
h e r life. She w as a p a rt o f the G rad u a te  S tuden t C ouncil, the  e d ito r of the 
G ra d u a te  School Jou rna l. H e r th es is  p ro jec t w as the  b iochem ical an d  
physio log ica l s tu d ie s  o f co tton  b u d  abscission  d u e  to th e  e n v iro n m en ta l 
stress.
She lectured  p lan t physio logy a t the  u n d e rg ra d u a te  sen ior level at her 
alma mater for tw o  years after receiv ing  her M. S. d eg ree  in 1986. Later she 
w o rk ed  in the  C h inese  In terna tional T rust and  Investm en t, Inc. before  she 
cam e to LSU in  the  S p ring  o f 1989. W hile in LSU, she first jo ined  Dr. N. 
M ura i's  lab  in the  D epartm en t of P lan t Physiology and  Patho logy , and  later 
e n te re d  th e  Ph.D . p ro g ram  o f th e  B iochem istry  D e p a rtm en t. She has 
w o rk ed  in  the  lab o ra to ry  of Dr. S im on C h an g  in o rd e r  to  co m p le te  her 
degree. H er p rim ary  focus w as to characterize  the p ro m o te r n s-e lem en ts of
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the  rab b it m u sc le  p h o sp h o fru c to k in a se  gene, a n d  fu nc tiona lly  s tu d y  the 
m uscle-specific  tran sc rip tio n  ac tiva to r M yoD  a n d  re la ted  p ro te in s  in the 
transcrip tiona l control of th is PFK gene. She w as a teach ing  assistan t for the 
u n d e rg ra d u a te  b iochem istry  lab o f sen io r level, a n d  th  freshm en  level o f 
biology lab.
W hile in  g ra d u a te  school, she  m et an d  fell in love w ith  her g rad u a te  
s tu d e n t fellow  R. L ouis Schiltz , w h o  soon  becam e h e r h u sb a n d  a n d  the 
fa ther o f h e r son Stephen.
A fter receiv ing  h e r Ph.D . deg ree , she  w ill h ead  to  N ational In stitu te  
of H ealth  to  d o  post-doctoral train ing  a long  w ith  her h u sb an d  an d  son. She 
h as  becom e v e ry  in te re s te d  in th e  fu n d a m e n ta l re sea rch  o f ho w  the  
tra n sc r ip tio n  ac tiv a to rs  o f ce llu la r o r v ira l a c tiv a te  tra n sc rip tio n  of the  
specific genes. H er goal is to p u rsu e  an  active academ ic carrier. As for her 
p e rso n a l goa l, sh e  w o u ld  like  to  h a v e  o n e  m o re  ch ild  to  k eep  the  
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